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ABSTRACT
The predisposing factors leading to the development of
sleep apnoea/hypopnoea syndrome (SAHS) in many cases are
unclear. Snoring, a prerequisite for SAHS, runs in
families. There have been reports of familial SAHS in
several families but this may have resulted from an
association with obesity. I have therefore investigated
whether SAHS is familial.
In a pilot study breathing and oxygen desaturation data
during sleep in 40 first degree relatives of 20 non obese
SAHS patients has been compared with that in
retrospective controls. Ten out of 40 relatives had >15
apnoeas+hypopnoeas/hr of sleep and 8 had >5 4%
desaturations/hr. These frequencies of irregular
breathing (p<0.005) and desaturation (p<0.0001) are
significantly higher than in the British population.
A case control study has therefore been performed
examining sleep symptoms, sleep studies, upper airway
calibre by acoustic reflectance and facial structure by
cephalometry in first degree relatives of non obese
(BMI<30 kg/m2) patients with SAHS and matched controls
drawn from a general practitioner's register.
Fifty one relatives of 32 SAHS patients were matched with
51 controls for sex (25 male), age (36 SD 14, 35 SD 14
yrs) and BMI (24 SD 4, 24 SD 3 kg/m2) on a one to one
basis. More relatives than controls reported snoring
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(48% vs 12%, p=0.0002), excessive daytime sleepiness (56%
vs 32%; p=0.01), sleeping against will (20% vs 4%;
p=0.01), and nocturnal choking (16% vs 2%; p=0.01).
Relatives had higher apnoeas+hypopnoeas per hour of sleep
(median 13 vs 4/hr; p<0.0001), more arousals from sleep
(median 30 vs 17/hr; p<0.0001), higher 2%/hr (p=0.04) and
higher 3%/hr (p=0.04) desaturation frequency than the
controls. The relatives had more light sleep (p=0.006)
and less slow wave sleep (p=0.03) than the controls. The
relatives had smaller pharyngeal volume (19 SEM 1, 23 SEM
1 mis; p=0.01), smaller mandibles (Go-Gn 84 SEM 1, 87
SEM 1 mm; p-0.03), retroposed maxillae (SNA angle 81 SEM
1, 86 SEM 1 deg; p<0.0001), retroposed mandibles (SNB
angle 78 SEM 1, 82 SEM 1 deg; p<0.0001), longer (p=0.03)
and wider uvulae (p<0.0001) than the controls.
In a pilot study to determine whether there might be any
association between SAHS and Sudden Infant Death
Syndrome, it was found that 8 unexpected sudden infant
deaths were reported in 28 SAHS families compared to none
in 35 control families (p<0.01). This preliminary
observation requires independent verification.
Thus SAHS is familial and this family tendency is
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Sleep apnoea/hypopnoea syndrome (SAHS) is due to repeated
upper airway collapse during sleep. The upper airway
includes the extrathoracic trachea, larynx, pharynx and
the nasal passages. The pharyngeal component of the
upper airway is limited cranially by the nasopharynx and
caudally by the glottic opening. The pharynx is the
final common pathway for the transmission of air, liguids
and solids and therefore serves several functions like
deglutition, phonation and respiration (Henderson-Smart
DJ, 1984). Swallowing and phonation dictate that pharynx
be a collapsible tube with co-ordinated neuromuscular
actions. The pharynx is therefore, a soft tissue
structure and lacks a rigid bony support (Bosma JF,
1988). As it also serves as a conduit for airflow, the
pharynx is liable to inspiratory narrowing which, in some
people, progresses to subtotal or total pharyngeal
collapse. During wakefulness, the pharyngeal patency is
largely maintained by neuromuscular activity which not
only maintains a patent airway for breathing but also
coordinates this with the digestive and phonatory
functions of the pharynx. This supervision of the
pharyngeal airway may be disrupted during sleep with
resultant luminal compromise. In those with small
pharynx during wakefulness (Rivlin J et al, 1984, Bradley
TD et al, 1986a, Schwab RJ et al, 1993), this further
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narrowing during sleep may result in severe narrowing or
closure of the pharynx heralding obstructive sleep
apnoea.
SAHS causes daytime sleepiness and impaired daytime
performance (Greenberg GD et al, 1987, Findley LJ et al,
1986) and results in increases in road traffic accidents
and mortality from cardiovascular and cerebrovascular
events (Partinen M et al, 1990). Repeated upper airway
narrowing during sleep results in recurrent arousal from
sleep, with consequent sleep fragmentation (Bonnet M et
al, 1992) and recurrent transient hypertension (Knight H
et al, 1987). It occurs at least in around 0.3% of adult
men (Stradling JR et al, 1991a) and may occur in upto 2-
4% of middle aged men and 1-2% of middle aged women
(Jennum P et al, 1992, Young T et al, 1993).
Historical aspects
SAHS is not a new disease but was described in ancient
literature. Dionysius of Heracliea, the ruler and tyrant
in Pontis in the era of Alexander the Great, was
extremely obese. He was reported to suffer from
difficulty in breathing during sleep and pathological
daytime sleepiness. Long sharp needles were used to jab
him in the belly to keep him awake and breathing (Wadd W,
1822) .
Magas, King of Cyrene, died in 258 BC and "was weighted
down with monstrous masses of flesh in his last days; in
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fact he choked himself to death" (Athenaeus, 1863). In
1816 William Wadd described several cases with features
suggestive of typical sleep apnoea. A good account of
this disease appeared in 1837 in Charles Dicken's 'The
Pickwick Papers'. The term 'Pickwickian' however was
coined in 1918 by Osier in the 8th edition of his book
'The Principles and Practice of Medicine'.
In 1877, WH Broadbent published a case report in the
Lancet about Cheyne Stokes breathing in a patient with
cerebral haemorrhages. He noted that a similar pattern
of breathing could be observed in an elderly subject
especially while sleeping supine and snoring. He
described 'breathing pauses' and gasps presumably due to
recurrent upper airway obstruction.
R Canton, in 1889, presented to the Clinical Society of
London 'a case of narcolepsy' but the clinical features
described seem typical of sleep apnoea. In the same
year, Morrison reported a similar case of an elderly
obese man with worsening drowsiness accompanied by
cyanosis, snorting and choking in sleep.
The first account of disordered breathing in sleep as a
specific sleep disorder was given by SW Mitchell in 1890
when he described a patient with probable central sleep
apnoea.
In 1897, L Lamacq linked upper airway obstruction with
sleep disorders. In 1898 W Wells described a further 10
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patients with obstructed nasal breathing 8 of whom
complained of daytime sleepiness.
In 1937 Spitz described three cases with most of the
clinical features of sleep apnoea. However, the
relationships between sleepiness, sleep disordered
breathing, polycythaemia and right sided failure were not
properly appreciated.
In 1955, HO Sieker et al published the report of four
patients under the title 'Cardiopulmonary syndrome
associated with extreme obesity'. Though they
contributed little to the understanding of the
pathophysiology of the syndrome, they did reverse many
aspects of the syndrome by simple weight reduction.
Though CS Burwell et al in 1956 described the a patient
with sleep apnoea, it is likely that their patient had
obesity related hypoventilation syndrome.
In 1966, H Gastaut performed overnight polysomnography of
a Pickwickian patient and was the first to report
multiple obstructive apnoeas and arousals. He concluded
that the nocturnal sleep deprivation and disruption was
responsible for the excessive daytime sleepiness.
In 1975 Sutton advocated the use of progesterone and in
1982, Brownell the use of protryptiline in the treatment
of sleep apnoea. In 1976, tracheostomy was found to
'cure' the disease by bypassing the obstruction
(Guilleminault C et al). In 1981 positive upper airway
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pressure applied through the nose was shown to be
effective in the reversal of sleep apnoea syndrome
(Sullivan CE et al, 1981). In the same year surgical
treatment of the disorder was described with
uvulopalatopharyngoplasty (Fujita S et al).
Definitions
An apnoea, in adults is defined as complete cessation of
oronasal airflow for at least 10 seconds (Guilleminault C
et al, 1978). A validated definition of hypopnoea is a
greater than 50% reduction of thoracoabdominal movement
for at least 10 seconds (Gould GA et al, 1988). This
definition gives a truer estimate of clinically
significant hypopnoea freguency as it is significantly
closer to the arousal frequency than flow related
definitions. Alternative definitions of hypopnoeas like
over 75% or 25% reduction in thoracoabdominal movements
under and over estimate the frequency of arousals and
desaturations (Gould GA et al, 1988).
Apnoea signifies complete occlusion of the upper airway
while hypopnoea a nearly complete occlusion (West P et
al, 1985). Hypopnoeas are as important as apnoeas in the
developement of symptoms and of the sleep related
desaturation and arousal characteristics in the SAHS
(Gould GA et al, 1988).
The total number of apnoeas and hypopnoeas per hour slept
has been termed the 'Apnoea Hypopnoea Index-AHI'. Though
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the association of an AHI that is greater than 5, 10 or
15 with the development of a specific clinical picture
has not been absolutely established (Phillips BA et al,
1992), our group's definition in young or middle age
patients of SAHS is the presence of more than 15 apnoeas
plus hypopnoeas per hour slept in conjunction with at
least two major symptoms (Gould GA et al, 1988). It
seems that the definitions based on an AHI of 5
(Guilleminault C et al, 1984a) or 10 (Bradley TD et al,
1985) maybe too lax and many normal subjects fulfill such
criteria (Gould GA et al, 1988, Young T et al, 1993).
Pathology and pathophysiology of the SAHS
Snoring, hypopnoeas and apnoeas result from recurrent
upper airway narrowing and occlusion during sleep
(Remmers JE et al, 1978). Approximately half the
patients with the SAHS obstruct their upper airways
behind the tongue and the remaining half behind the soft
palate (Hudgel DW et al, 1988, Chaban R et al, 1988).
Many patients obstruct the upper airway at multiple
levels during sleep (Morrison DL et al, 1993).
The upper airway intraluminal pressure during inspiration
is subatmospheric and this tends to suck the pharynx
closed (Harper RM et al, 1978). During wakefulness, this
tendency of the upper airway to collapse is actively
opposed by the upper airway dilator muscles (Wheatley JR
et al, 1991). Retroglossal airway patency is maintained
by the combined actions of the genioglossus, geniohyoid
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and omohyoid which exhibit inspiratory phasic
contractions (Sauerland EK et al, 1981, Weigand DA et al,
1990). Retropalatal patency is maintained by the muscles
of the soft palate, the actions of which are still
incompletely understood. Palatoglossus depresses the
soft palate onto the base of the tongue and maintains a
patent retropalatal airway (Kuehn DP et al, 1982) for
nasal breathing, the preferred route of breathing during
sleep (McNicholas T et al, 1982). Levator palatini and
perhaps palatopharyngeus (Kuehn DP et al, 1982) lead to
velopharyngeal closure and open the oral breathing route.
Tensor palatini tenses the soft palate, opens up the
auditory tube and may also retract the soft palate away
from the posterior pharyngeal wall (Tangel DJ et al,
1991). However, the actions of this muscle are complex
and ill understood. Some of these muscles of the soft
palate may also show inspiratory phasicity during
wakefulness and sleep (Hairston LE et al, 1981).
Sleep related hypotonia and relaxation of levator
palatini (Tangel DJ et al, 1993) and tensor palatini
(Tangel DJ et al, 1991) has recently been shown.
Decreased tensor activity is thought to cause airway
narrowing in the area posterior to the soft palate
predisposing to apnoeas and hypopnoeas. A fall in
genioglossal activity during NREM sleep in SAHS patients
(Remmers JE et al, 1978) and a decrease in EMG levels of
genioglossus group of muscles during apnoeas has also
been demonstrated (Suratt PM et al, 1988). SAHS patients
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have been shown to have higher awake genioglossal
activity compared to controls. This may indicate reflex
activation of genioglossus as a compensatory phenomenon
(Mezzanotte WS et al, 1992). This neuromuscular
compensation present during wakefulness in SAHS patients
may be lost during sleep leading to airway collapse.
Upper airways which are narrow when awake are more likely
to narrow critically during sleep (Sauerland EK et al,
1976) .
Many studies have shown that patients with SAHS have
smaller upper airways than control subjects (Bradley TD
et al, 1986a, Harponik EF et al, 1983, Hoffstein V et al,
1984, Rivlin J et al, 1984, Shepard JW et al ,1990,
Suratt PM et al, 1985, Stein MG et al, 1987) largely due
to abnormalities in bony and soft tissue craniofacial
architecture. The upper airways of these patients may
also be excessively compliant and floppy (Remmers JE et
al, 1978). These patients have increased nasal
resistance which increases the upstream airway resistance
and hence increases the collapsing intraluminal pressure
during inspiration (Zwillich CW et al, 1982).
Periodic breathing during sleep is a normal phenomenon
(Phillipson EA, 1978). The factors contributing to
periodic breathing during sleep include disappearance of
wakefulness induced stimuli that obscure the normal
oscillatory respiratory centre output, sleep induced
changes in chemosensitivity and the changing neural
18
control during the instability of sleep onset (Phillipson
EA, 1978). Periodic breathing induces periodic changes in
the upper airway and respiratory muscle activity with
wane of neural drive to both muscle groups (Onal E et al,
1982). The decrease in drive to upper airway muscles
with resultant rise of upper airway resistance and higher
negative inspiratory pressures for a given respiratory
muscle activity leads to upper airway passive collapse
(Remmers JE et al, 1978). By further increasing upper
airway resistance, anatomical abnormalities of the upper
airways would contribute to obstruction (Suratt PM et al,
1983). Thus, the pathogenesis of obstructive sleep
apnoea may involve both central respiratory and
peripheral upper airway mechanisms. A role of recurrent
arousals with hyperventilation leading to hypocapnia and
central apnoeas has also been proposed in idiopathic
central sleep apnoea (Xie A et al, 1994).
Restoration of the patency of the near or totally
occluded upper airway of these patients during sleep is
achieved by an arousal which owing to its brevity is not
recalled by the patient (Bonnet M et al, 1992). The
arousal is caused by the large negative intrapleural
pressure swing as the patient struggles to breathe
against an occluded upper airway (Gleeson K et al, 1990).
It is not directly a result of resultant hypoxaemia as
arousal may occur without significant desaturation
(Guilleminault C et al, 1988a). It may be that upon
reaching a certain strength of contraction, the
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inspiratory muscles trigger a reflex originated by the
subatmospheric pressure in larynx, tension receptors in
the chest wall, metabolic changes in the muscles (Vincken
W et al, 1987) or by mechanoreceptors in the contracting
respiratory muscles (Kimoff RJ et al, 1994). The sensory
information from this reflex may be relayed to the
central nervous system resulting in arousal. After the
arousal and reestablishment of upper airway patency the
subject falls asleep again with the same cycle of airway
narrowing, occlusion and arousal recurring all night,
especially when the breathing pattern is periodic (Onal E
et al, 1982). The resultant sleep disruption and
fragmentation and not hypoxaemia result in excessive
daytime sleepiness (Roehrs T et al, 1989, Colt HG et al,
1991) and impaired daytime performance (Cheshire K et al,
1992, Roehrs T et al, 1994). Sleep fragmentation, and to
a lesser extent sleep deprivation, in normal subjects
have also been shown to increase upper airway
collapsibility by reducing the upper airway dilator
muscle activity either directly or via the release of
endorphins (Seres F et al, 1994).
Cardiorespiratory consequences of SAHS
Normal sleep in otherwise fit subjects results in
reduction in heart rate, ventilation and blood pressure.
Heart rate decreases by 5-8% during NREM sleep (Khatri IM
et al, 1967, Bristow JD et al, 1969) and is variable
during REM with mean rates approximating resting awake
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values. Mean arterial pressure decreases by 5-9% during
light NREM sleep and 8-14% during slow wave sleep as
compared to resting awake values (Coccagna G et al, 1971,
Khatri IM et al, 1967). Arterial blood pressures during
REM sleep fluctuate and are about 5% higher than
immediately preceeding or succeeding values during NREM
sleep. Pulmonary artery pressures during sleep stay
largely unchanged (Lugaresi E et al, 1978).
Patients with SAHS have cyclical fluctuations in heart
rate (Zwillich C et al, 1982), blood pressure (Davies RJO
et al, 1993, Shepard JW, 1985), cardiac output
(Guilleminault C et al, 1986a, Lin YC et al, 1983) and
systemic oxygen delivery. These are likely to have
adverse long term hemodynamic consequences.
Heart rate has been shown to be higher during post
apnoeic ventilatory period than in the last few seconds
of apnoea and this has been attributed to apnoeic
bradycardia (Zwillich C et al, 1982b). Continuing
unsuccessful inspiratory efforts against an obstructed
upper airway during an obstructive apnoea lead to falls
in systolic and diastolic blood pressures, the magnitude
of the fall being a semiquantitative indicator of the
degree of respiratory effort (Lea S et al, 1990). A
recent study found falls in systolic blood pressure
related to inspiration progressively increased from
normal sleep, through snoring and snoring with arousals,
to frank obstructive sleep apnoea (Davies RJO et al,
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1993). Negative pleural pressures during obstructive
apnoeas increase left ventricle afterload (Karam M et al,
1984 ) and at fixed lung volume increase lung blood
content (Brower R et al, 1985). These, together with
worsening arterial hypoxaemia, increase pulmonary
arterial pressures and pulmonary artery wedge pressures
during apnoeas.
With the resumption of ventilation and termination of
apnoeas, the heart rate increases (Zwillich C et al,
1982b) along with a marked increase in systolic and
diastolic blood pressures (Shepard JW, 1985). The post
apnoeic rise in blood pressure was initially thought to
be due to hypoxaemia developing during the end of apnoea
(Shepard JW, 1985). Changes in cardiac hemodynamics
(Parish JM et al, 1990) may also in part explain this
post apnoeic blood pressure rise. However, similar
blood pressure rises occur after central sleep apnoea
(Davies RJO et al, 1991) where there are no intraapnoeic
inspiratory efforts and also in the periodic leg movement
disorder (Ali NJ et al 1991) where there are no
respiratory or blood gas disturbances. All these
syndromes involve recurrent arousals from sleep which are
now believed to be a major cause of post apnoeic blood
pressure rise (Ringler J et al, 1994).
Arousals are associated with a fall in arterial
baroreceptor activity (Smyth HS et al, 1969) which leads
to a rise in sympathetic neural tone (Hornyak M et al ,
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1991) via the efferent limb of the baroreflex loop.
This increase in sympathetic tone leads to peripheral
vasoconstriction with an ensuing rise in blood pressure.
The arousal induced blood pressure rise is smaller during
REM than NREM sleep and arousal stimuli that do not
cause EEG arousal still produce a blood pressure rise,
presumably due to the activation of brain stem arousal
mechanisms (Davies RJO et al, 1993).
The long term complications and associations of untreated
SAHS may be systemic hypertension (Lavie P et al, 1984)
though a recent study indicates that SAHS is not an
independent risk factor for hypertension (Stradling JR et
al, 1990a). Sleep apnoea also increases the risk of
excessive vascular mortality due to myocardial
infarctions (Hung J et al, 1990) and cerebrovascular
accidents (Partinen M et al, 1985) probably as a result
of pulsatile blood pressure disturbances during sleep
(Davies RJO et al, 1994).
Symptoms
Snoring: Loud, intermittent and habitual snoring is the
hallmark of sleep apnoea and is seen in 94% of SAHS
patients (Whyte KF et al, 1989, Hoffstein V et al, 1993).
It is a major cause of marital strife and often leads to
the use of separate bedrooms.
Absence of snoring mitigates against a diagnosis of sleep
apnoea but by no means excludes it. By the time of
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referral snoring is usually present in all body postures
rather than in supine position alone. It is often
worsened after alcohol consumption.
Excessive daytime sleepiness: Present in about 88% of the
cases, excessive daytime sleepiness is a major symptom of
SAHS (Whyte KF et al, 1989). Many patients complaint of
dozing off while watching television, reading or during
other monotonous activities. Advanced sleep apnoea
patients often fall asleep in the middle of a meal or
conversation. They may also fall asleep while driving
and there is considerable evidence that sleep apnoea is
responsible for many automobile accidents (Findley L et
al, 1989, Stradling JR et al, 1991, George C et al, 1987.
Stradling JR, 1989).
Abnormal motor activity during sleep: 36% of the SAHS
patients complain of restless sleep (Whyte KF et al,
1989) with freguent tossing and turning during the night.
Some of these movements may be associated with nocturnal
hypoxaemia while others may represent nocturnal
myoclonus, a condition often associated with the SAHS.
Unsatisfying sleep: A combination of loud snoring and
abnormal motor activity during sleep may result in
disrupted sleep with frequent arousals. Many patients
Bwith full blown SAHS have several hundreds of such
arousals throughout the night leading to sleep
fragmentation and manifesting as unrefreshing sleep in
35% of the patients.
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Witnessed apnoeas: In over 70% of the cases a clear
history of witnessed apnoeas is obtained (Hoffstein V et
al, 1993) and the presence of apnoeas witnessed by the
patient's spouse is the most useful point in the
patient's history differentiating patients with SAHS from
others referred for investigation (Crocker BD et al,
1990).
Nocturnal choking: Reported by 26% of patients (Whyte KF
et al, 1989), this is frightening sensation which may
seem to last up to a minute in duration. In most
patients, arousal from sleep is immediately accompanied
by upper airway patency. The choking sensation is
apparently due to upper airway dilator muscle tone
returning only after the patient has woken up.
Morning headaches; Diffuse or predominantly frontal
morning headaches are reported by 24% of patients (Whyte
KF et al, 1989) and are a non specific feature of this
condition.
Irritability, nocturia and decreased libido are reported
by 11%, 10% and 6% of the patients with SAHS.
Symptoms due to complications of SAHS: Secondary
polycythaemia due to chronic hypoxaemia, ventilatory
failure and peripheral oedema due to pulmonary
hypertension, chronic cor pulmonale with congestive
cardiac failure may be present in patients with long
standing and severe SAHS.
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The history should also enquire into alcohol consumption
and whether the patient takes alcohol at bedtime.
Hypnotic and sedative medicines at bedtime have an effect
similar to alcohol by aggravating upper airway
obstructive events. Sleep deprivation and shift work
should be noted. History of smoking, respiratory
allergies and of working environment should also be
sought.
Physical examination
General examination; This includes noting the extent of
overall obesity as well as abdominal and neck girth.
Overt retrognathia, acromegaly or myxoedema should be
sought. Peripheral oedema, polycythaemic appearance and
the presence or absence of cyanosis should be noted.
Oronasomaxillofacial examination: On the intraoral
inspection, size and consistency of the tongue, presence
or absence of pharyngeal oedema, hyperaemia, appearance
and size of the soft palate, length and position of the
uvula and tonsillar size should be noted. Increased
nasal resistance becomes obvious with inspiratory
collapse of the nostril.
Diagnostic techniques
A confident diagnosis of the SAHS can only rarely be made
from history (Viner S et al, 1991, Crocker BD et al,
1990) or physical examination alone (Viner S et al,
1991).
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Oximetry and overnight videoinq the patient
The British Thoracic Society guidelines indicate that
oximetry alone or combined with video recording is
sufficient to diagnose many patients with SAHS (BTS News,
1990). Visual scoring of an overnight oxygen saturation
tracing is of considerable diagnostic value and permits
a correct diagnosis of SAHS to be made from the
characteristic desaturation pattern in up to two thirds
of patients (Douglas NJ et al, 1992). A normal overnight
oxygen saturation trace however does not exclude sleep
apnoea and such patients with suggestive symptoms need
further evaluation. Visually observing a patient at
night may be sufficient to diagnose SAHS though in
around a third of patients the correct diagnosis may be
missed (Harponik EF et al, 1984).
Overnight polysomnography
The alleged gold standard for the diagnosis of SAHS is
overnight polysomnography which, the American and
Australian guidelines state, must be performed if SAHS is
a possibility (Martin RJ et al, 1985 , McAvoy RD, 1988).
Polysomnography confirms the diagnosis, ascertains the
severity of physiological disturbance during sleep which
then acts as a guide to further therapy, looks for
alternative diagnoses like the periodic limb movement
disorder and evaluates the response to nasal continuous
positive airway pressure therapy (CPAP). Polysomnography
records oxygen saturation by oximeter, thoracoabdominal
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movements by impedance plethysmography, oronasal airflow
by temperature or exhaled C02 sensors,
electroencephalogram, electrooculogram, submental and
anterior tibial electromyogram. These techniques allow
recording sleep stages and nocturnal arousals,
quantitation of apnoeas and hypopnoeas and measurement of
the extent of oxyhemoglobin desaturations.
Polysomnography can diagnose and quantitate the leg jerks
in the periodic limb movement disorder and may suggest
narcolepsy by the presence of abnormally early REM sleep.
The usefulness of polysomnography has recently been
questioned as recording of sleep quality and duration is
of little diagnostic benefit (Douglas NJ et al, 1992).
Evaluation of upper airways in SAHS
It is important to assess the upper airway to understand
the pathophysiology of SAHS and to predict the efficacy
of treatment.
Cephalometry: Lateral radiograph cephalometry describes
craniomandibular abnormalities and soft tissue contours
of the upper airways.
In a study of 10 SAHS patients, Riley R et al, 1983,
showed that the cephalometric measurements of interest in
patients with SAHS were uvula length, distance between
mandibular plane and hyoid bone, posterior airspace and
maxillomandibular discrepancies. Jamieson A et al, 1986,
found that 150 Of 155 SAHS patients studied had at least
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2 significant cephalometric abnormalities. They found
that SAHS patients have retroposed mandibles, different
cranial base flexure, inferiorly placed hyoid and longer
and thicker soft palates than controls.
Strelzow W et al, 1988, studied 90 SAHS patients and
found that over 50% of the 52 cephalometric measurements
were different in these patients from controls.
Cephalometric measurements correlated with disease
severity and could distinguish between patients with
different severities of SAHS. Likewise, Partinen M et
al, 1988a, found that in SAHS patients a reduction in
size of posterior airspace below 5 mm and hyoid to
mandibular plane distance of over 24 mm correlated with
AHI irrespective of BMI. In another study of 30 SAHS
patients, DeBerry-Borowieski B et al, 1988, found
maxillary retrognathia, longer hard palates, abnormally
low placed hyoids, small posterior airspaces, elongated
lower and mid face along with thicker and longer soft
palates when compared to controls. Numerous other studies
have demonstrated similar bony and soft tissue
differences on cephalometric examination between patients
and controls (Lyberg T et al, 1989, Maltais F et al,
1991, Lowe AA et al, 1986) and some have shown that
cephalometric measurements have a predictive value in
determining the success rate of upper airway surgery
(Guilleminault C et al, 1984b).
These reports suggest that SAHS patients have smaller
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upper airways owing to differences in craniofacial
anatomy. This may reduce pharyngeal dimensions at
different levels and impair pharyngeal stability.
The value of cephalometric analysis, therefore, is to
assist in the clinical perception of pharyngeal geometry,
thereby assisting in the design and planning of a
surgical procedure.
Acoustic reflectance
This technique is based on the analysis of sound waves
reflected from the airway. Measurement of the amplitude
of these reflections and their times of arrival at a
sensing microphone permits construction of a plot of
airway area versus distance from the microphone
(Hoffstein V et al, 1991). It was initially used as a
static technique by Rivlin J et al, 1984, who showed
small pharyngeal areas in SAHS patients than in non
apnoeic controls. Similar results were reported by
Bradley TD et al, 1986a. Acoustic reflectance is also
useful in dynamic studies to assess the effect of change
of lung volume (Bradley TD et al, 1986a, Hoffstein V et
al, 1984), body position and applied transmural pressure
(Brown IG et al, 1985) on pharyngeal area. These results
indicate that SAHS patients have increased pharyngeal
compliance than controls.
Other methods for assessing upper airway size and
function in these patients are computerised tomography,
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magnetic resonance imaging, fiberoptic and
videofiberoptic studies, cine-CT scans and measurements
of upper airway pressures and resistances. To
demonstrate further extent of pharyngeal collapse during
sleep, somnofluroscopy and pharyngeal endoscopy under
sedation have also been used.
Treatment of SAHS
General measures
Dietary control of weight may be successful in obese
patients (Harman EM et al, 1982). They should be advised
not to take alcohol (Krol RC et al, 1984) and sedatives
(Craddock M et al, 1987) at bedtime. Patients with
myxoedema, acromegaly, retrognathia or major
nasopharyngeal abnormalities should be treated
appropriately.
Drug treatment
Protryptiline, medroxyprogesterone and acetazolamide
have been tried but have no role in the treatment of SAHS
(Douglas et al, 1991).
Nasal continuous positive airway pressure (CPAP1
Since first introduced in 1981 (Sullivan CE et al), nasal
CPAP has become the treatment of choice for SAHS, being
effective both for obstructive and central sleep apnoea
(Issa F et al, 1986). Acting as a 'pneumatic
splint'(Sullivan CE et al, 1981, Popper RA et al, 1986),
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CPAP maintains pharyngeal patency and eliminates apnoeas
and hypopneas (Sullivan CE et al, 1984). Long term CPAP
usage has been shown to improve survival (He J et al,
1988). Treatment has also been shown to improve
nocturnal breathing pattern (Sullivan CE et al, 1981),
nocturnal sleep quality (Sanders MH, 1984) objective
daytime sleepiness (Lamphere J et al, 1989), mood
(Derderian SS et al, 1988), driving (Findley L et al,
1989) and cognitive functions (Engleman HM et al, 1994a).
Surgical treatment of SAHS
Tracheostomy: Though tracheostomy cures SAHS by
bypassing the upper airway obstruction and improves
survival (Partinen M et al, 1988b), tracheostomy is only
recommended in an emergency situation in which CPAP is
unsuccessful or unavailable.
Uvulopalatopharyngoplasty: In this procedure, the
posterior margins of the soft palate and the redundant
lateral pharyngeal wall mucosa are resected (Fujita S et
al, 1981). Though effective in curing snoring, this
surgery does not cure SAHS (Wetmore SJ et al, 1986). In
addition, several perioperative deaths have been reported
with this procedure which anyway has not been shown to
affect survival in these patients (He J et al, 1988).
Some patients with failed surgery subsequently find CPAP
intolerable due to the absence of an effective seal
between soft palate and the tongue with resultant loss of
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pressure through the mouth (Douglas NJ, 1991). For these
reasons, this procedure is not advocated for treating
SAHS.
Experimental procedures: Inferior saggital osteotomy with
hyoid myotomy and suspension (Riley R et al, 1986a), Le
Fort type 1 mandibular osteostomy (Bear SE et al, 1980,
Kuo PC et al, 1979, Ferber R et al, 1983, Wittig R et al,
1983 ), Maxillomandibular and hyoid advancement
procedures (Riley R et al, 1986b), mandibular
repositioning appliances (Clark GT et al, 1993) and
electrical stimulation of the tongue (Miki H, 1989,
Edmonds LC et al, 1992) are not recommended routinely in
the treatment of SAHS.
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CHAPTER 2
RISK FACTORS AND GENETICS OF SAHS
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I
RISK FACTORS AND GENETICS OF SLEEP APNOEA/HYPOPNOEA
SYNDROME
The commonly acknowledeged risk factors for obstructive
sleep apnoea are obesity, male sex, middle age, endocrine
abnormalities like hypothyroidism and acromegaly,
craniofacial structural abnormalities, alcohol
consumption, cigarette smoking, nasal obstruction,
abnormal ventilatory chemosensitivity, periodic
breathing, adenotonsi1lar hypertrophy and having an
increasing number of relatives affected by sleep apnoea.
Obesity
Though obesity is by no means a prereguisite, many
patients with SAHS are obese (Guilleminault C et al,
1978). So striking and monstrous was obesity in cases of
sleep apnoea available in ancient literature that
accurate and vivid descriptions of SAHS were given by
historians of that time (Athenaeus). Obesity again was a
prominent feature of Charles Dicken's description of
sleep apnoea in The Pickwick Papers.
Approximately half of the SAHS patients weigh more than
30% of their ideal body weight. Between one half and one
third of patients are within 30% of ideal body weight and
around 20% of patients within 15% of ideal body weight
(Douglas NJ, 1991). Another earlier study found that 85%
of the patients had a body mass index of over 30 kg/m2
(Whyte KF et al, 1989). However, this percentage is
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falling progressively with greater recognition that SAHS
also occurs in non obese.
Not only does obesity predispose to sleep apnoea (Burwell
CS et al, 1956, Seiker HO et al, 1955) but weight loss
results in improvement in upper airway obstruction
(Harman EM et al, 1982, Brownman CP et al, 1984, Smith PL
et al, 1985, Rubinstein I et al, 1988, Suratt PM et al,
1987). All anthropometric indices of obesity whether
generalised as reflected by body mass index, truncal as
reflected by waist circumference or neck fat as reflected
by neck circumference are significantly higher in
patients reguiring higher CPAP pressures. The pressure
reguired to abolish apnoeas is related to obesity and
severity of sleep apnoea (Engleman HM et al, 1994b,
Miljeteiz H et al, 1993).
Regional adiposity may also be important in the genesis
of sleep apnoea. SAHS patients have thicker necks than
non apnoeic snoring controls with external neck
circumference, body mass index, age and internal neck
circumference accounting for 39% of the variability in
the apnoea/hypopnoea frequency (Katz I et al, 1990).
Magnetic resonance imaging has shown that more fat is
present in those areas surrounding the collapsible
segments of pharynx in patients with SAHS compared to
equally obese control subjects without SAHS (Horner RL et
al, 1989). They found large deposits of fat
posterolateral to the oropharyngeal airspace at the level
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of the soft palate in patients with SAHS. Fat deposits
were also found in the soft palate and streaking the
tongue in these patients. Another study demonstrated
that adipose tissue is deposited adjacent to the
pharyngeal airway in patients with SAHS and that the
volume of this tissue is related to the presence and
degree of obstructive sleep apnoea (Shelton KE et al,
1993). Furthermore, they found that the pharyngeal
adipose tissue volume did not correlate with the body
mass index indicating that the volume of parapharyngeal
adipose tissue is not dependent only on the degree of
obesity. In a resection study, more adipose tissue has
been observed in surgically removed uvulas from patients
with SAHS than in uvulas from non-obese subjects obtained
at autopsy (Stauffer JL et al, 1989).
Obesity may cause upper airway obstruction by multiple
mechanisms. Obesity may narrow the neck by mass loading
(Koenig JS et al, 1988, Katz I et al, 1990). This mass
loading of the neck may stress the remaining muscle tone
during sleep and further contribute to occlusion during
sleep (Katz I et al, 1990).
Another mechanism of upper airway collapse could be
parapharyngeal adipose tissue compressing the upper
airway. This would explain why sleep apnoea develops
when subjects gain weight and improves when they lose
weight. The location of adipose tissue lateral to the
airway could also explain why the airway has been
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observed to collapse laterally when observed
endoscopically. Presumably pharyngeal airway that has
been narrowed from lateral encroachment of tissue is more
likely to collapse during sleep , when the tongue moves
posteriorly, than the airway that has not been narrowed
laterally (Shelton KE et al, 1993).
A third mechanism of upper airway collapse due to
adiposity is the increase in pharyngeal compliance
promoting complete occlusion during sleep. Fatty
infiltrates in the muscles may directly interfere with
upper airway muscle function (Katz I et al, 1990, Horner
RL et al, 1989) or may change the intrinsic elastic
properties of the pharyngeal wall and surrounding
structure (Oslen LG et al, 1988). However, the increase
in pharyngeal compliance due to fat is disputed (Brown IG
et al, 1985) .
Lastly, obesity has been shown to cause greater reduction
in pharyngeal size in SAHS patients as compared to
controls as lung volume is reduced (Hoffstein V et al,
1984). Thus, in suscepitible persons obesity may
predispose to upper airway occlusion by reducing upper
airway size indirectly, secondary to a decrease in lung
volume, rather than directly narrowing the airway
aperture. This may also in part explain the improvement
in sleep apnoea by CPAP or weight reduction by an




Clinically, SAHS is recognised more in males than
females. In one series men accounted for 88% of
patients (Guilleminault C et al, 1988b). Two other
series found that over 80% of the patients were men
(Whyte KF et al, 1989, Guilleminault C et al, 1978a).
Likewise snoring, which is a prerequisite for obstructive
sleep apnoea, exhibits a male preponderance as 25% of men
and 15% of women were found to be habitual snorers in one
epidemiological survey (Lugaresi E et al, 1980). In a
survey conducted among married couples 86% of the
husbands were considered habitual snorers by their wives
and 57% of wives were considered so by their husbands
(Norton PG et al, 1985).
Although underreporting of symptoms of abnormal breathing
during sleep by females has been suggested (Redline S et
al, 1994) the sex differences may in part be explained by
the effects of testosterone upon ventilation and
chemosensitivity (White DP et al, 1985a). SAHS has been
induced by testosterone administration both in
hypogonadal males (Schneider BK et al, 1986) and females
(Johnson MW et al, 1984). Testosterone may promote fat
deposition in the neck thereby narrowing the upper airway
(Douglas NJ, 1991). Another proposed mechanism of
testosterone induced SAHS is an increase in upper airway
collapsibility during sleep (Cistulli PA et al, 1994).
In another study, women were found to have less severe
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SAHS than their male counterparts despite having a
slightly greater degree of morbid obesity. These
investigators believe that this difference in severity
could possibly be due to sex differences in body fat
distribution and the female propensity towards lower body
adiposity with less fat deposition around the pharynx
(Millman RP et al, 1993).
Another possible explanation of the male preponderance of
SAHS could be gender related differences in size and
mechanical properties of the pharynx. Though men have
larger pharynxes than women, men have a larger change in
pharyngeal area with changing lung volume. Thus larger
pharynxes in men may be more than offset by a greater
change in pharyngeal size with changing lung volume
contributing to the greater incidence of SAHS in men
(Brooks LE et al, 1992).
Age
Chronic snoring is frequent with ageing (Mondini S et
al, 1983). The prevelance of snoring is relatively low
among young people but increases significantly in both
sexes after the age of 35 (Lugaresi E et al, 1980).
Although SAHS occurs in all age groups, most patients
present in middle age (Ancoli-Isreal S, 1989) and the
incidence of obstructive sleep apnoea increases after the
age of 40 (Clark GT et al, 1993). A recent study found
the prevelance of sleep disordered breathing at apnoea
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hypopnoea scores of >5, >10 and >15 to be significantly
higher in men aged between 40-49 years than among those
30-39 years old. Apnoea hypopnoea scores of 5 or higher
were more prevelant in women in the age group 50-60 years
than among younger women.
Endocrine abnormalities
Endocrine disorders like hypothyroidism predispose to
snoring and obstructive apnoeas (Orr WC et al, 1981,
Rajagobal KR et al, 1984) probably by inducing
myxoedematous structural changes in the upper airways and
altered muscle contractility. Acromegaly predisposes to
sleep apnoea (Perks WH et al, 1980a, Mezon BJ et al,
1980 ) as it is also associated with macroglossia,
thickening of the pharyngeal mucosa and changes in the
facial cartilaginous or bony architecture (Flecther EC et
al, 1986). In addition, patients with active acromegaly
have been demonstrated to have increased ventilatory
responsiveness to hypercapnia contributing to central
apnoeas (Grunstein RR et al, 1994). Although in
myxoedenatous patients sleep apnoea is usually reversible
following restoration of euthyroid state with thyroxine
(Rajagobal KR et al, 1984), this may not always be the
case (Grunstein RR et al, 1986).
Craniofacial skeletal abnormalities
Retrognathia and micrognathia (Tammeling GJ et al, 1972,
Coccagna G et al, 1976, Conway WA et al, 1977) are rare
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but potentially surgically correctable facial bony
abnormalities that predispose to sleep apnoea.
Mandibular retrognathism has been demonstrated in 16% (De
Berry-Boroweicki B et al, 1988) to 60% (Riley R et al,
1983) of cases with SAHS. This abnormal skeletal
pattern, by reducing the posterior air space, reduces
the resting airway dimensions behind the tongue and
predisposes to upper airway obstruction during sleep.
Moreover, the number of apnoeas has been shown to
correlate with the total posterior displacement of the
mandible (Rivlin J et al, 1984). Mandibular osteostomy
with advancement results in improvement in sleep apnoea
in cases with overt retrognathia (Kuo PC et al, 1979,
Bear SE et al, 1980).
The hyoid bone is frequently abnormally low in SAHS
patients as indicated by an increased mandibular plane to
hyoid distance and gonion-gnathion-hyoid angle.
Guilleminault C et al, 1984b found a low hyoid in 25 out
of 30 SAHS patients and in 4 of the 6 patients who did
not improve after palatopharynagoplasty and mandibular
osteotomy. Riley et al, 1983, found an inferiorly placed
hyoid in SAHS patients and demonstrated that those
patients who did not improve after palatopharyngoplasty
had a low hyoid placement and smaller posterior airspace
than the ones who improved with surgery (Riley R et al,
1985). An abnormally low position of hyoid in SAHS
patients has also been found by others (Jamieson A et al,
1986, Stretzow W et al, 1988, De Berry-Borowiecski et
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al, 1988, Lyberg T et al, 1989, Zucconi M et al, 1992).
A lower than normal hyoid placement relocates the tongue
backwards in the hypopharynx and narrows the retroglossal
airway. Combining inferior sagittal osteotomy with hyoid
myotomy and suspension has been advocated as the surgical
procedure to widen the hypopharynx (Riley R et al,
1986a). Retroposition of maxilla in patients with SAHS
has also been demonstrated by numerous investigators. In
a sample of 25 adult male SAHS patients, Lowe AA et al,
1986, found posteriorly positioned maxilla in addition to
other craniofacial abnormalities. Stretzow W et al,
1988, demonstrated a short maxilla in 90 SAHS patients.
De Berry-Borowiecski et al, 1988, demonstrated retroposed
maxillae in 30 adult patients with SAHS. A posteriorly
placed maxilla narrows the pharynx behind it and places
the soft palate closer to the posterior pharyngeal wall
thereby narrowing the passage between nasopharyngeal and
oropharyngeal airway. A combined maxillomandibular and
hyoid advancement (Riley R et al, 1986b) enlarges the
pharynx at all levels and has been advocated as treatment
for selected SAHS patients.
In addition to these skeletal discrepancies, soft tissue
abnormalities like enlarged tongue, longer soft palates
and wider uvulae in patients with SAHS have been reported
by many workers (Riley R et al, 1983, Riley R et al,
1985, Lowe AA et al, 1986, De Berry-Borowieski B et al,
1988, Stretzow W et al, 1988, Lyberg T et al, 1989,
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Stauffer JL et al, 1989).
Alcohol consumption
Alcohol can induce both snoring and obstructive apnoeas.
Alcohol acts by inducing peripheral vasodilation and
consequently nasal mucosal swelling (May M et al, 1973,
Robinson RW et al, 1985) by a depressant effect on the
respiratory centres in the medulla and by reducing upper
airway dilating muscle tone.
In many normal people, ingestion of a small amount of
alcohol at bedtime increases the apnoea frequency (Taasan
VC et al, 1981a). Older subjects are more vulnerable to
this effect of alcohol while both premenopausal as well
as post menopausal women seem to be relatively resistant
to the development of obstructive apnoeas after a modest
amount of bedtime alcohol (Block AJ, 1984, Block AJ et
al, 1985). However, habitual snorers may develop
prolonged apnoeas after alcohol ingestion (Issa FG et al,
1982). This tendency of the upper airway to obstruct is
more in the first 1-2 hours of sleep when the blood
alcohol concentrations are highest (Issa FG et al, 1982,
Scrima L et al, 1982).
Alcohol seems to have a selective depressant action on
the activity of upper airway dilator muscles and this has
been demonstrated for genioglossal activity both in
animals (Bonora M et al, 1984) and in human subjects
(Krol RC et al, 1984). Alcohol seems to depress the
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brainstem reticular activating system with more profound
effects on the neural mechanisms serving genioglossus and
perhaps other upper airway muscles than for those serving
the muscles of the respiratory pump. This effect of
alcohol on upper airway muscle tone is less pronounced in
women (Block AJ, 1984, Block AJ et al, 1985). Pharyngeal
inspiratory airflow resistance has been shown to increase
during the first hour after alcohol intake (Robinson RW
et al, 1985) and less negative intrapleural pressures are
required to collapse the upper airway after alcohol
intake (Issa FG et al, 1984). Heavy snorers and SAHS
patients who have preexistent anatomically narrowed
airways (Harponik EF et al, 1983) or defective upper
airway muscle function (Issa FG et al, 1984) are more
susceptible to alcohol and abstinence from alcohol before
bedtime is an important part of therapy.
The long term effects of alcohol on SAHS are less clear
cut. Abstinent alcoholics have been reported to have an
increased frequency of apnoeas and hypopnoeas (Tan ETH et
al, 1985). A significant but weak correlation between
alcohol consumption and the frequency of nocturnal oxygen
desaturation has also been shown in a population study
(Stradling JR et al, 1991a). However, like another
(Kauffmann F et al,1989) this study did not find any
significant correlation between alcohol consumption and
history of snoring. Similarly, another recent study
found that patients with SAHS do not have a higher
current or lifetime alcohol consumption than controls
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(Jalleh R et al, 1992). Thus although acute alcohol
ingestion increases apnoea frequency in predisposed
individuals, patients with SAHS do not drink excessively.
Nasal obstruction
Nasal obstruction is increasingly recognised as a cause
of disturbed breathing during sleep, including apnoeas,
hypopnoeas and arterial oxygen desaturation. This holds
true both for naturally occuring partial nasal
obstruction (McNicholas WT et al, 1982) as well as for
induced total nasal occlusion (Zwillich CW et al, 1981).
Deviated nasal septum has been reported to cause the
syndrome, with surgical correction reversing the SAHS
(Olsen KD et al, 1981). Posterior nasal packing
increases the number of apnoeas during sleep and has been
associated with unexpected sudden death during sleep
(Taasan VJ et al, 1981b).
Several reasons have been suggested to explain this
association of nasal obstruction with sleep apnoea. The
first is the effect on central respiratory drive of
breathing via the nasal route. The available data on
this issue is conflicting (Widdicombe JG, 1986). Several
human (McBride B et al, 1981, Douglas NJ et al, 1983) and
animal studies (Fisher JT et al, 1985, Mortola JP et al,
1988) report a depressant effect of nasal airflow on
respiration. Other studies, some directly measuring
ventilation during conditions of altered nasal airflow
(McNicholas WT et al, 1993) and others indirectly by
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finding increase in apnoeas after nasal anaesthesia have
supported a stimulant effect of nasal airflow on
breathing in adult human subjects during sleep (White DP
et al, 1985b, McNicholas WT et al, 1987). Further
evidence of a stimulant effect of nasal airflow comes
from another study which reported an increase in
genioglossal and alae nasi EMG activity in awake humans
breathing through the nose, an effect which could be
blocked by nasal anaesthesia (Basner RC et al, 1989).
A second explanation lies in the observation that nasal
route of breathing has a higher airflow resistance than
does the oral route (Proctor DF, 1977, Cole P, 1988,
Tanaka Y et al, 1988). With reduced nasal patency and
ineffect increased nasal resistance, a greater
inspiratory force is required to breathe. This yields
higher negative intrapharyngeal pressures resulting in
partial upper airway collapse. With the relaxation of
upper airway dilator muscle activity during sleep, this
high negative intrapharyngeal pressure could well produce
complete pharyngeal obstruction.
Finally, it has now been documented that nasal
obstruction can effect breathing pattern during sleep
with central apnoeas being a commonly encountered events
(Zwillich CW et al, 1981).
Adenotonsillar enlargement
Upper airway obstruction is a well known cause of sleep
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disruption in toddlers and school children and in most
cases is caused by adenotonsillar enlargement (Carroll J1
et al, 1992, Guilleminault C et al, 1981a, Van Someran VH
et al, 1990, Stradling JR et al, 1990b, Mangar D et al,
1977, Orr WC et al, 1981b, Richardson MA et al, 1980).
Enlarged tonsils and adenoids are very common and result
in obstructive sleep apnoea in 0.7-1.3% of 4-5 years olds
(Ali NJ et al, 1993). Likewise there are reports of SAHS
in patients with upper airway tumours (Zorick F et al,
1980). SAHS has also been described in children with
sickle cell disease, possibly due to an increased
prevelance of adenotonsillar hypertrophy in this age
group (Samuels MP et al, 1992). Although serious
consequences are rare, pulmonary hypertension has been
described with severe tonsillar hypertrophy. Most cases
of SAHS with this underlying cause can be dealt
successfully by adenotonsillectomy (Guilleminault C et
al, 1983, Eliaschar I et al, 1980).
Smoking
Smoking has been shown to increase the likelihood of
snoring (Bloom JW et al, 1988). The prevelance of
snoring in children has also been found to be higher in
smoking households thereby emphasising the role of
passive smoking (Corbo GM et al, 1989). Smoking may
induce upper airway hyperaemia and congestion and
increase upper airway resistance thereby predisposing the
airway to collapse.
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Periodic breathing and ventilatory chemosensitivity
abnormalities
Periodic breathing is often seen in association with
congestive heart failure (Harrison TR et al, 1934),
exposure to high altitude (Lahiri S et al, 1983),
neurological disease (Brown HW et al, 1961) and
idiopathic central sleep apnoea associated with
hypocapnia (Bradley TD et al, 1986b, Bradley TD et al,
1992, Naughton M et al, 1993). Periodic breathing during
sleep in patients with heart failure may cause symptoms
of sleep apnoea (Takasaki Y et al, 1989) and induce both
central and obstructive apnoeas (Alex CG et al, 1986,
Dowdell WT et al, 1990).
Though during wakefulness ventilation is controlled both
by metabolic as well as by behavioural systems, during
NREM sleep it is controlled almost solely by the
metabolic control system with ventilation being tightly
linked to afferent inputs from chemoreceptors and
intrapulmonary vagal receptors (Sullivan C et al, 1978).
Several mechanisms may explain the genesis of periodic
breathing in heart failure. Prolonged circulation time
causes time delays in the recognition of arterial blood
gas tensions within the lungs by chemoreceptors (Khoo MCK
et al, 1982, Guyton AC et al, 1956) and may result in or
more probably prolong periodic breathing cycle length
(Khoo MCK et al, 1982). Likewise, reduction in lung
volumes may fail to dampen oscillations in arterial
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blood gases due to reduced 02 and C02 stores in the lungs
(Khoo MCK et al, 1982, Cherniack NS et al, 1986). The
most probable mechanism, however, seems to be hypocapnia
induced by hyperventilation (Naughton M et al, 1993,
Dowell AR et al, 1971, Berssenbrugge A et al, 1983) very
often mediated by the stimulation of pulmonary irritant
and juxtacapillary receptors due to pulmonary congestion
(Churchill ED et al, 1929, Sackner MA et al, 1991,
Bradley TD et al, 1992).
The onset of NREM sleep is characterised by a withdrawal
of the wakefulness drive to breathe with an increase in
the ventilatory threshold for paC02 (Bradley TD et al,
1992). Chemical drive remains the sole ventilatory
stimulus. If paC02 is below normal at the onset of
sleep, the difference between this value and the paC02
which will stimulate ventilation is exaggerated so that
central apnoeas occur until the paC02 rises to the
ventilatory threshold. When the paC02 is near the
apnoeic threshold, the slight perturbations caused by
an arousal are sufficient to reduce the paC02 to below
the critical level necessary to precipitate a central
apnoea (Xie A et al, 1994, Khoo MCK et al, 1991,
Berssenbrugge A et al, 1983). Thus such apnoeas are the
consequence and not the cause of arousals. The greater
apnoea hypopnoea frequency in stage 1 and 2 of NREM sleep
than in slow wave sleep is explained by the lower paC02
and increased arousability in stages 1 and 2 with a
resultant tendency to hyperventilate. Once slow wave
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sleep is reached, ventilation becomes rhythmic under
metabolic control. As the control of breathing during
REM sleep is independent of chemical and metabolic
stimuli and arousability to chemical stimuli blunted
(Douglas NJ et al, 1982a, Douglas NJ et al, 1982b),
central apnoea/hypopnoea frequency in REM may be less
than that in NREM sleep.
Genetics- A common denominator for some of the risk
factors for SAHS
Many of the risk factors described above are themselves
thought to be genetically determined in a major part.
This is true for obesity (Stunkard AJ et al, 1986a,
Stunkard AJ et al, 1986b), craniofacial structure
(Lundstorm A et al, 1984), ventilatory control
abnormalities (Kawakami Y et al, 1984, Fleetham JA et al,
1984) and alcohol consumption (Schuckit MA, 1985, Goodwin
DW, 1987). In reports of single families, some of the
inherited risk factors have been shown to cause familial
sleep apnoea. These risk factors include abnormal
craniofacial anatomy (Guilleminault C et al, 1986b),
defective ventilatory control (El Bayadi S et al, 1990)
metabolic diseases like mucopolysaccharidosis (Perks WH
et al, 1980b) and defective motor activity of the tongue
during sleep (Strolh KP et al, 1978). However despite
this sporadic data, the relationship of familial sleep
apnoea to the inheritance/familial aggregation of these
specific risk factors still remains unclear.
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Inherited diseases associated with SAHS
SAHS has been described with heriditary ataxias like
autosomal dominant olivopontocerebellar degeneration
(Chokroverty S et al, 1984). SAHS has also been reported
with other autosomal dominant disorders like myotonica
dystrophica (Guilleminault C et al, 1978b) and
achondroplasia (Fremion AS et al, 1984) as well as with
autosomal recessive conditions like mucopolysaccharidosis
(Perks WH et al, 1980b). There are also reported
associations of SAHS with chromosomal disorders like
Down's syndrome (Stebbens VA et al, 1991) and with other
diseases having a genetically determined predisposition
like multiple sclerosis (Manon-Espaillat R et al, 1986).
Family reports on the inheritance of SAHS
The first well documented report of obstructive sleep
apnoea in family members was by Strohl KP et al in 1978.
They described two sons (body mass index 47.4 kg/m2 and
25.4 kg/m2) and their father (body mass index unknown)
with severe hypersomnolence and obstructive sleep apnoea.
A third son (body mass index 28.3 kg/m2), a snorer but
otherwise asymptomatic, was shown to have upper airway
obstruction during sleep. Genioglossal EMG recordings in
two symptomatic sons showed loss of tonic activity in
early stages of NREM sleep when upper airway obstruction
occurred. The asymptomatic son showed loss of tonic
activity during REM sleep when sleep apnoeas occurred.
Two sudden deaths occurred in this family. A 30 years old
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brother (body mass index unknown), also a snorer, died
while asleep and the death was attributed to other
reasons though no autopsy was performed. A 4 month old
daughter of the asymptomatic son died of presumed sudden
infant death syndrome. Ventilatory responses to C02 were
normal in all family members tested. These authors
concluded that the familial factors predisposing to SAHS
may be a genetic abnormality of the motor activity of
tongue during sleep.
In the same year, another study undertaken at the
Gainesville Veterans Administration Hospital, Florida,
and described by J Elliot provided further evidence that
some cases of SAHS have a heriditary factor. This study
of a Georgia family described episodic apnoea,
hypoventilation and oxygen desaturation in a 39 years old
male patient displaying classical sleep apnoea as well as
in his 9 year old son and 32 year old brother. Despite
adenotonsillectomy, the 9 year old son continued to have
episodic sleep apnoea.
In 1980b, Perks WH et al described in two brothers aged
18 and 25 years and having Scheie's syndrome- a
mucopolysaccharidosis characterised by short stature,
micrognathia, corneal clouding, hepatosplenomegaly,
raised urinary mucopolysaccharides and undetectable
levels of alpha-L-iduronidase assayed in cultured
fibroblasts. Both the brothers had excessive daytime
sleepiness, noisy breathing during sleep and an apnoea
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index of 59 and 35 respectively. They believed that in
this family the familial predisposing factor for SAHS was
mucopolosaccharidosis related micrognathia and
macroglossia.
In 1982 Walsh JT et al described sleep apnoea in
combination with open angle glaucoma in 5 members of 2
generations of a family. Three surviving members with
heavy snoring and glaucoma and a fourth with heavy
snoring alone had confirmed sleep apnoea. Severity of
glaucoma, its resistance to surgery and medication,
correlated with a greater number and duration of apnoeas.
Moreover, in contrast to the usual occurence of higher
intraocular pressures later in the day in the garden
variety of glaucoma, these patients with SAHS and
glaucoma exhibited maximum intraocular pressures in the
morning. These observations lead these investigators to
conclude that the sleep apnoea may have resulted in a
morning rise of intraocular pressure in these patients.
They postulated SAHS related changes in venous pressure
and fluctuations in intrathoracic pressure were
responsible for the increase in intraocular pressures.
They did concede however, that sleep apnoea and glaucoma
could be independently inherited without one having an
influence on the other.
In 1986b Guilleminault C et al reported the relationship
between sudden infant death syndrome and adult
obstructive sleep apnoea in 5 families. Six index
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infants from these 5 families had a near miss sudden
infant death syndrome event between 3 and 12 weeks of age
and had polygraphically documented apnoeas during sleep.
Four of their siblings had died of SIDS. The 6 index
infants, their 4 living siblings, 10 parents and 8
grandparents underwent sleep studies. All the adults and
3 index infants had cephalometry and 2 index infants
underwent volume CT scans while awake and asleep.
Several family members of the index infants were shown to
have obstructive sleep apnoea while cephalometric X rays
showed small upper airways particularly behind the base
of the tongue. They concluded that a small posterior air
space in these infants and adult family members was the
common denominator leading to long obstructive apnoeas
which, if sufficiently long, triggered cardiovascular
changes that could cause unexpected infant deaths.
In 1988 Manon-Espaillat R et al described a familial
disorder consisting of sleep apnoea, anosmia, colour
blindness, complex partial seizures and cognitive
dysfunction. Though cognitive dysfunction and recurrent
hippocampal hypoxia with neuronal degeneration and
resultant seizures may be consequences of sleep apnoea
these authors postulated that the association of sleep
apnoea, anosmia, complex partial seizures and cognitive
dysfunction are the manifestations of a mutant gene.
This is because of the low probability of all these
independent afflictions occuring in a single individual
or family. The phenotypic expression of this syndrome
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suggests an autosomal dominant inheritance with
incomplete penetrance.
In 1990 El Bayadi S et al studied 10 members of one
family with 3 generations of subjects with SAHS. They
reported questionnaire data, sleep study data and
ventilatory responses to hyperoxic hypercapnia and
eucapnic hypoxia in some of these subjects. All 10
members reported habitual snoring or nighttime
snorting/gasping while 5 also reported excessive daytime
sleepiness. All had an apnoea hypopnoea frequency of
greater than 10 per hour slept. They demonstrated
markedly diminished ventilatory responses to hypoxia in
all 5 subjects studied and diminished response to
hypercapnia in 3 out of 5 subjects studied. In fact in
the index subject, ventilation decreased with worsening
hypoxia leading them to believe that depressed hypoxic
responsiveness may be the major genetic predisposition to
the disorder. They also found reduces posterior airspace
and increased hyoid to mandibular plane distance in 4
subjects. From the distribution of physiological and
anatomical abnormalities in this family, they concluded a
genetic basis for SAHS (autosomal dominant) and suggested
that the interaction between familial primary ventilatory
control abnormalities and familial anatomic risk factors
is responsible for the genesis of this syndrome.
The familial clustering of symptoms of SAHS have recently
been assessed in a sleep symptom questionnaire based
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study (Redline S et al, 1992a). This study described
more daytime sleepiness and apnoeas in relatives of
patients with SAHS. A progressive increase in risk of
reporting these symptoms was associated with increasing
numbers of relatives reporting the same symptom.
However, sleep studies were not performed in this study
and the possibility of relatives being more aware of the
symptoms could not be excluded.
A preliminary report of a genetic epidemiological study
of risk factors for sleep apnoea has described increased
abnormal breathing during sleep in the families of
patients with SAHS. Familial factors including those
associated with race and craniofacial anatomy were found
to be important determinants of sleep apnoea in younger
subjects (Redline S et al, 1992b).
Further support to the genetic basis of SAHS has been
lended by HLA studies in 32 Japanese patients with this
syndrome (Yoshizawa T et al, 1993). The frequency of
HLA-A2 antigen was markedly increased in SAHS patients
compared with normal controls (81.3% vs 40.6%) and
compared with the Japanese population (40.7%). HLA-B39
was found more frequently in SAHS patients than in
Japanese population but not in the controls. No
significant deviations were seen in the prevelance of
HLA-C and DR antigens between patients and controls. The
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PILOT STUDY ON THE INHERITANCE OF SLEEP APNOEA/HYPOPNOEA
SYNDROME
INTRODUCTION
The aetiology of SAHS in many patients is unclear. As
explained in the previous chapter familial SAHS has been
described in many reports of single families. However,
these reports are confounded by the familial nature of
obesity (Stunkard AJ et al, 1986a & b). Therefore a
pilot study was performed to investigate the hypothesis
that SAHS may be inherited. As one did not wish to
restudy the familial nature of obesity (Stunkard AJ et
al, 1986a & b) , index cases who were relatively non-
obese were selected.
METHODS
Twenty consecutive new patients with SAHS took part in
the study. All these patients had more than 15 apnoeas +
hypopnoeas per hour of sleep in association with at least
two of the major symptoms of SAHS (Gould GA et al, 1988).
All had a body mass index (BMI) of less than 30 kg/ra2.
None had clinical evidence of gross retrognathia,
hypothyroidism or acromegaly.
These 20 patients (17 male) had a mean (SD) age of 55
(10) years, BMI 27.3 (1.6) kg/m2, collar size 41.1 (1.7)
cm, apnoea hypopnoea index 40 (20) per hour of sleep and
arousals 19 (8) per hour of sleep. Arousals were defined
as a return to alpha or theta EEG rhythm for at least 1.5
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seconds with a concomitant increase in EMG tone (Cheshire
K et al, 1992) Each of these index patients was asked to
provide details of all first degree relatives aged 18-75
years who were then approached to participate in the
study. All the relatives were sent a sleep symptom
questionnaire and those living within 150 miles of
Edinburgh were invited for an overnight full
polysomnography at the Scottish National Sleep
Laboratory. All the relatives attending for overnight
polysomnography had lateral cephalometry performed as
well. Local ethics committee approval was obtained for
the study.
Sleep symptom questionnaire
The questionnaire included queries on the date of birth,
collar size, height, weight, alcohol consumption and the
presence or absence of sleep symptoms. Smoking, drug,
family and medical histories were also recorded. Bed
partners where available were asked about the subject's
behaviour during sleep.
Loud snoring was considered present if the bed partner
reported habitual snoring of sufficient intensity to
disturb others.
Nocturnal apnoeas were considered present if the bed
partner reported witnessing episodes of cessation of
breathing, gasping, snorting or struggling for air while
the subjects were asleep.
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Excessive daytime sleepiness was considered present if
the subjects averaged two naps per day when not in bed.
Sleeping against will was considered present if the
subjects reported falling asleep in embarrasing or
dangerous circumstances, for example when driving.
Current alcohol consumption was calculated in units of
alcohol per week.
Current cigarette smoking was judged if the subjects
reported smoking at least one cigarette a day during the
previous month.
Overnight polysomnography
The sleep study included recording airflow at the mouth
and nostrils by thermocouples, thoracoabdominal movement
by inductance plethysmogram, ear lobe oxygen saturation
by Ohmeda Biox 3700 oximeter and an electroencephalogram,
electrooculogram, submental and tibial electromyogram.
All the data was recorded on a 16 channel polygraph
(Specialised Laboratory Equipment). Sleep (Rechtschaffen
A et al, 1968) and breathing pattern (Douglas NJ et al,
1992) were manually scored by standard criteriae.
The parameters calculated from the sleep study were-
Time in bed (TIB): Time in minutes from 'lights out' at
the start of sleep study to the end of study.
Sleep onset latency (SOL): Time in minutes from 'lights
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out7 to the 1st epoch of stage 2 of NREM sleep (sleep
onset).
REM onset latency (REM LAT) : Time in minutes from 1st
epoch of stage 2 NREM sleep (sleep onset) to the 1st
epoch of first cycle of REM sleep (REM onset).
Sleep period time (SPT): Time in minutes from sleep onset
till the end of sleep study. This includes time asleep
and awake.
Total sleep time (TST) : That part of the sleep period
time in minutes when the subject was actually asleep.
Sleep efficiency index (SEI): The ratio of total sleep
time to time in bed and expressed as percentage.
Arousal: A return to alpha or theta EEG frequency for at
least 1.5 seconds with a rise of chin EMG howsoever brief
(Cheshire K et al, 1992).
Apnoea: An episode during sleep of complete cessation of
flow at nose and mouth for at least 10 seconds
(Guilleminault C et al, 1978a).
Hypopnoea: An episode during sleep of over 50% reduction
of thoracoabdominal movement for at least 10 seconds when
compared to the peak amplitude obtained over a 10 second
period that had occured in the last 2 minutes (Gould GA
et al, 1988) .
Arousals/hour: Number of arousals per hour of sleep.
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This is obtained by dividing the total number of arousals
throughout the night by total sleep time.
AHI: Number of apnoeas plus hypopnoeas per hour of sleep.
This is obtained by dividing the total number of apnoeas
plus hypopnoeas occuring throughout the night by total
sleep time.
Lowest oxygen saturation (Lowest Sao2): From the
overnight oximetry tracing.
Cephalometry
Cephalometric roentgenograms were carried out with the
subject both seated erect and lying supine while the beam
was directed at right angles to the head. For the erect
seated position, the subjects gazed forwards with the
Frankfurt horizontal plane parallel to the floor and for
the supine film, upwards. The head was held in natural
posture for both these positions (Moorvees CFA et al,
1958, Bean J et al, 1970, Halperin SL et al, 1959) and
the head position was maintained by the use of a
cephalometric head holder. The subjects kept their
mouths closed with their normal resting occlusion. The
lips were together, tongue relaxed on the floor of the
mouth and the subjects did not swallow during the
exposures. Films were taken with the subjects exhaling
slowly from a deep breath. The X-ray cone was positioned
exactly 5 feet from the radiographic film which was
placed against the left side of the face. Exposure
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windows included the full face superiorly from the
supraorbital ridges down to the bottom of the laryngeal
cartilages including the hyoid bone and base of tongue.
Skeletal discrepancies were evaluated with reference to
the cranial base, which is a plane drawn through sella to
the nasion in natural head position (Riley R et al,
1983) .
The following cephalometric landmarks were identified on
both erect and supine films.
Point A: Subspinale-the deepest point on the
premaxillary contour between anterior nasal spine and
upper central incisor.
Point B: Supramentale-the deepest point on the anterior
mandibular contour between gnathion and lower central
incisor.
ANS: Anterior Nasal Spine-anterior most point on the
nasal spine.
PNS: Posterior Nasal Spine-tip of the spine of the
palatine bone of hard palate.
Ar: Articulare-the intersection of a line along the
posterior border of mandible and the inferior border of
the basilar occipital bone.
Aat: Anterior tubercle of atlas.
Go: Gonion-the point defining angle of mandible (the
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mandibular plane and ramus plane form the mandibular
angle.
Gn: Gnathion-the most outward and elevated point on
the mandibular symphysis.
H: Hyoid bone-the most anterosuperior point on the
body of hyoid bone.
N: Nasion-the most anterior point of the nasofrontal
suture.
S: Midpoint of sella tursica.
PhW: Posterior pharyngeal wall-soft tissue landmark
defining the nasal, oral and laryngeal limits of the
pharyngeal wall.
MP: Mandibular Plane-constructed from gonion to
gnathion.
Ba: Basion-midpoint of the anterior border of the
foramen maganum.
TB: Tongue Base-posteriormost point on the
posterior tongue profile.
UP: Uvula Protrusion-greatest posterior convexity on
the soft palate.
UT: Uvula Tip-apex of the soft palate, ie lowest
point on the soft palate.
Point X: Intersection of lines joining S-Ba and Gn-Go.
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The following distances in millimeters and angles in
degrees were measured on both erect and supine films.
ANS-PNS: Indicates length of hard palate.
Go-Gn: Measures mandibular body size (small in
micrognathia).
S-Go: Measure of mandibular height.
Go-H
H-MP (vertical distance): Measures position of the
hyoid bone with respect to the mandibular
plane.
H-Ar
Go-PhW: If small, this is indicative of retrognathia.
Go-Ar
UP-PhW: Measure of retropalatal space.
UL: Uvula Length-distance from PNS to UT (length of
soft palate).
UW: Uvula Width-at the widest point.
PAS: Posterior Air Space-line drawn through Point B




H-PhW (parallel to MP)
PNS-PhW (parallel to Point B-GO)
TB-PhW (parallel to MP)
PNS-Aat: If small, this indicates maxillary
retroposition.
Go-X-Ba triangle (area of triangle bound by these points)
Go-Ga-H: This angle indicates the position of hyoid
bone.
S-N-A: If small, this angle indicates maxillary
retroposition.
S-N-B: If small, this angle indicates mandibular
retroposition.
Mandibular angle: Angle formed by the intersection of
lines passing through MP and the ramus plane from the
gonion angle.
Neck angle: The acute angle created by the
intersection of a line drawn through the anterior border
of 2nd cervical vertibrae with another line drawn through
the anterior border of 4th cervical vertibrae.





Differences between groups were assessed by the unpaired
and paried Student's t test or chi square test with
appropriate corrections for small numbers and Fisher's
exact test as appropriate. Correlations and 95%
confidence limits were performed with SPSS-PC.
RESULTS
Subject recruitment
Three of the 20 patients had no eligible first degree
relatives. Therefore 17 SAHS patients (15 males)
provided relatives for the study. These 17 relative had
a mean (SD) age of 53 (10) years, BMI of 27.4 (1.6)
kg/m2, collar size (males only) 41.4 (1.6) cm, apnoea
hypopnoea index 41.6 (19.3) per hour of sleep and 18.3
(7.5) arousals per hour of sleep.
These 17 patients had a total of 76 first degree
relatives 61 of whom participated in the study by
completing the sleep symptom questionnaires.
Fourteen of the 76 relatives lived more than 150 miles
from Edinburgh. Six of the remaining 62 relatives
(eligible relatives) stated they were too ill to attend
for sleep studies. Sixteen of the remaining 56 relatives
refused to come to the sleep laboratory for sleep study.
Thus 40 eligible relatives (19 males) had overnight sleep
studies. Of the 16 eligible relatives who refused sleep
68
studies, 12 (9 males) returned the questionnaire. Nine
out of 14 relatives who lived more than 150 miles from
Edinburgh replied to the questionnaire. Therefore,
overall 21 (12 males) of the 36 relatives who did not
have sleep studies replied to the questionnaire. No
questionnaire or sleep study data was available in 15
cases- 6 in the 'too ill' group, 4 in the 'sleep study
refused' group and 5 in 'living more than 150 miles away'
group. 9 of the 22 relatives who did not attend for
sleep studies came from one family.
Thus of a total of 76 relatives-
Group 1. 40 relatives replied to questionnaire and had
sleep studies,
Group 2. 12 relatives who refused sleep studies and 9
who lived more than 150 miles from Edinburgh replied to
questionnaire alone,
Group 3. Neither questionnaire nor sleep studies data was
available in 6 relatives who were too ill to attend for
sleep studies, in 4 relatives who refused sleep studies
and in 5 relatives who lived more than 150 miles from
Edinburgh.
Examining the data for bias due to non participation
The 40 relatives (group 1) with sleep study (and
questionnaire) data can be compared with 21 relatives
(group 2) on whom only questionnaire data is available.
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These 40 relatives (19 male) had a similar sex
distribution as the 21 (12 male) who replied only to the
questionnaire (p=0.5). The remaining 15 cases (group 3)
cannot be included in any comparision analysis as no
data whatsoever is available on them.
Prevalance of snoring: 13 of 40 relatives in group 1
reported loud snoring versus 15 out of 21 in group 2, p=
0.002.
Prevalance of excessive daytime sleepiness: 12 of 40
relatives in group 1 had excessive daytime sleepiness
versus 4 of 21 in group 2, p= 0.5.
Prevalance of witnessed apnoeas: 5 of 40 relatives in
group 1 had witnessed apnoeas versus 2 of 16 in group 2,
p= 0.7.
Sleep studies
Ten (9 males) of the 40 relatives had more than 15
apnoeas + hypopnoeas per hour of sleep (affected
relatives) while the remaining 30 (10 males) had less
than 15 apnoeas + hypopnoeas per hour slept (unaffected
relatives). Eight of the 40 relatives had more than five
4% oxygen desaturations per hour.
The affected relatives were older but not more obese than
the others. The affected relatives had more frequent
arousals from sleep and lower minimal oxygen saturations
than the 30 unaffected relatives. There were no other
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significant differences in polysomnography results
between affected and unaffected relatives.
The polysomnography results in affected and unaffected
relatives are summarised in table 3.1.
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Table 3.1: Characteristics of relatives with >15 A +
H/hour of sleep or <15 A + H/hour of sleep.
>15 A+H/hr <15 A+H/hr P
n 10 30
Sex 9M, IF 10M, 20F 0 .003
Mean 95% CI Mean 95% CI
Age(y) 44 26-58 33 19-67 0.03*
BMI-men
(kg/m2) 27 21-33 25 15-35 0.3
Arousals
per hr 16 7-45 9 2-22 0.009
Lowest
Sa02(%) 81 71-90 87 69-95 0.02*
TIB(min) 417 365-450 414 336-445 0.9
SOL(min) 18 5-34 26 2-59 0.4
REMLAT
(min) 153 26-318 134 65-246 0.6
SPT(min) 393 307-431 382 318-436 0.5
TST(min) 328 239-386 345 201-420 0.3
SEI(%) 79 52-93 85 64-96 0.2
A+H- apnoeas plus hypopnoeas, BMI- body mass index, CI-
95% confidence intervals, * indicates p<0.05.
Arousals as per Cheshire K et al, 1992.
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Correlation of A + H/hour of sleep with anthropometric
measurements
Factors significantly correlated with abnormal breathing
during sleep were sex, body mass index (Pearson's r=0.6,
p<0.01) and age (Pearson's r=0.6, p<0.01) but not collar
size (Pearson's r=0.3, p=0.7). A multiple regression
model showed that BMI and age could explain 43% of the
variability in the A+H/hour of sleep in all relatives.
Questionnaires
Seven out of 10 affected relatives had current bed
partners as compared with 21 of 30 unaffected (p=0.99).
Eight out of 10 affected relatives were loud snorers
compared with 5 of the 30 unaffected (p=0.0005).
Likewise 5 out of 8 affected relatives reported the
presence of witnessed apnoeas compared with none of the
25 unaffected (p=0.0002).
Tables 3.2 and 3.3 list other results of sleep symptom
guestionnaire which were not significantly different
between affected and unaffected relatives.
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Table 3.2- Subject characteristics of affected and
unaffected relatives
Parameter Aff. Rel Unaff. Rel P
Collar size(cm) 41 SEM 1 40 SEM 1 0.5
Alcohol(u/wk) 16 SEM 4 11 SEM 2 0.3
Alcohol at bedtime 3/10 14/30 0.5
Current smokers 2/10 9/30 0.4
SEM-Standard Error of the Mean, u/wk-number of units of
alcohol consumed per week.
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Table 3.3- Other questionnaire results which did not
achieve statistical significance at p<0.05.
Parameter Aff. Rel Unaff. Rel P
Excessive daytime
sleepiness 2/10 10/30 0.7
Sleeping against
will 1/10 0/30 0.3
Restless sleep 2/7 5/21 0.9
Refreshing sleep 5/10 16/30 0.9
Nocturnal choking 1/10 0/30 0.3
Morning headache 0/10 6/30 0.3
Irritability 2/10 4/30 0.7
Nocturia 9/10 20/30 0.2
Decreased libido 1/7 4/30 0.9
Pedal oedema 0/10 5/30 0 . 3
Recent weight gain 6/10 15/30 0.7
Significant past
medical history 8/10 17/30 0.3
Significant past medical history includes history of any




Cephalometric measurements were compared between the 10
affected relatives (9 male) and 10 unaffected relatives
(9 males) matched by priority for sex, family (possible
in 3 cases) and height (Fig 3.1). The measurements which
were different in the affected relatives were the gonion-
gnathion-hyoid angle (affected 30 SEM 2 degrees,
unaffected 21 SEM 1 degrees, p=0.01) and uvular width
(affected 13 SEM 1 mm, unaffected 10 SEM 1 mm, p=0.01).
Tables 3.4 and 3.5 list other cephalometric measurements
in the 10 matched affected and unaffected relatives in
supine and erect postures. These did not achieve
statistical significance at p<0.05.
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Table 3.4- Cephalometric analysis results not reaching
statistical significance in 10 matched affected and
unaffected relatives in supine posture.
Parameter Aff. Rel Unaff. Rel P
ANS-PNS(mm) 59 SEM 2 58 SEM 2 0.9
Go-Gn(mm) 87 SEM 2 85 SEM 2 0.4
S-Go(mm) 97 SEM 2 97 SEM 3 0.9
GO-H(mm) 45 SEM 3 40 SEM 3 0.2
H-MP(mm) 26 SEM 2 22 SEM 2 0.1
H-Art(mm) 113 SEM 4 103 SEM 4 0.1
Go-PhW(mm) 90 SEM 1 91 SEM 3 0.7
Go-Art(mm) 67 SEM 2 66 SEM 2 0.7
UP-PhW(mm) 6 SEM 1 7 SEM 1 0.4
UL(mm) 52 SEM 2 48 SEM 1 0.2
UW(mrn) 14 SEM 1 12 SEM 1 0.1
PAS (mm) 14 SEM 1 15 SEM 2 0.6
UT-PhW(mm) 10 SEM 1 10 SEM 1 0.8
H-PhW(mm) 41 SEM 2 38 SEM 1 0.2
PNS-PhW(mm) 30 SEM 1 32 SEM 1 0.3
TB-PhW(mm) 14 SEM 1 15 SEM 2 0.6
PNS-Aat(mm) 40 SEM 2 41 SEM 1 0.7
Triangle(mm2) 989 SEM 170 967 SEM 116 0.9
S-N-A(deg) 86 SEM 4 83 SEM 1 0.5
S-N-B(deg) 83 SEM 4 80 SEM 1 0.4
Mandibular angle 126 SEM 3 123 SEM 2 0.4
Neck angle 11 SEM 3 10 SEM 2 0 . 8
N-S-Ba(deg) 126 SEM 3 129 SEM 2 0.5
Gn-Go-Aat(deg) 128 SEM 4 127 SEM 4 0.9
Gn-Go-Ba(deg) 134 SEM 4 131 SEM 3 0.5
Abbreviations as described in methods section, SEM-
Standard Error of Mean.
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Table 3.5- Cephalometric analysis results not reaching
statistical significance in 10 matched affected and
unaffected relatives in erect posture.
Parameter Aff. Rel Unaff. Rel P
ANS-PNS(mm) 59 SEM 2 58 SEM 2 0.9
Go-Gn(mm) 87 SEM 2 85 SEM 2 0.4
S-Go(mm) 96 SEM 2 94 SEM 4 0.7
GO-H(mm) 45 SEM 3 42 SEM 2 0.3
H-MP(mm) 28 SEM 1 23 SEM 2 0.1
H-Art(mm) 111 SEM 3 104 SEM 2 0.08
Go-PhW(mm) 83 SEM 1 86 SEM 3 0.4
Go-Art(mm) 67 SEM 2 65 SEM 2 0.5
UP-PhW(mm) 6 SEM 1 8 SEM 1 0.2
UL(mm) 50 SEM 2 47 SEM 1 0 . 4
PAS(mm) 12 SEM 1 13 SEM 2 0.7
UT-PhW(mm) 8 SEM 1 10 SEM 1 0.4
H-PhW(mm) 39 SEM 2 36 SEM 1 0.2
PNS-PhW(mm) 28 SEM 1 31 SEM 1 0.09
TB-PhW(mm) 12 SEM 1 12 SEM 2 0.9
PNS-Aat(mm) 37 SEM 2 38 SEM 1 0.6
Triangle(mm2) 886 SEM 140 1040 SEM 160 0.5
Go-Ga-H(deg) 33 SEM 3 25 SEM 3 0.09
S-N-A(deg) 86 SEM 4 84 SEM 1 0.5
S-N-B(deg) 89 SEM 6 80 SEM 1 0.2
Mandibular angle 126 SEM 3 123 SEM 2 0.4
Neck angle 13 SEM 4 14 SEM 2 0.8
N-S-Ba(deg) 126 SEM 3 129 SEM 2 0.5
Gn-Go-Aat(deg) 125 SEM 4 121 SEM 3 0.5
Gn-Go-Ba(deg) 134 SEM 3 131 SEM 3 0.6
Abbreviations as described in methods section, SEM-




The main conclusions from this pilot study are that 10 of
the 40 first degree relatives of non obese patients with
SAHS had over 15 apnoeas plus hypopnoeas per hour of
sleep. Eight of these 40 relatives had more than five 4%
oxygen desaturations per hour.
There was no in house control group in this study. The
first comparision is with a group of 33 asymptomatic
subjects with a BMI of less than 30 kg/m2 who were
previously studied in the same sleep laboratory. None of
these 33 subjects had more than 15 apnoeas plus
hypopnoeas per hour of sleep (Gould GA et al, 1988) while
8 of the 35 first order relatives in this uncontrolled
study with a BMI of <30 kg/m2 had more than 15 A+H/hr.
This indicates that these relatives had abnormal
breathing during sleep (p<0.005).
The second comparision is with a population study from
Oxford, England on the prevalance of more than five 4%
desaturations per hour during sleep (Stradling JR et al,
1991a) in a normal population. In a random study of 893
middle aged British men that study reported 45 men who
had more than five 4% desaturations per hour. In this
study, using the same oximeter and a similar desaturation
algorithm, 8 out of all 40 (p<0.0001) or 7 out of 19
male relatives (p<0.0001) with more than five 4%
desaturations per hour were found.
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The recruitment of only 40 out of 62 eligible relatives
did not affect these conclusions as the findings in this
study of an increased frequency of desaturation remain
valid even if one assumes that all the 22 relatives who
did not have sleep studies breathed normally during
sleep. These relatives still show an increased frequency
of desaturation (8/62, present study vs 45/893, Oxford
study, p<0.01) and irregular breathing (10/62, present
study vs 0/33 previous study, p<0.05). In addition, the
higher prevalance of snoring in the 21 relatives who
returned the questionnaire but did not have sleep studies
suggests that they would have an even higher frequency of
irregular breathing than those relatives studied. Thus,
the fact that these 21 relatives were not studied biased
against the positive findings of this study.
In the 9 families with 100% coverage, 6/19 relatives
(32%) had more than 15 A+H/hr of sleep as compared to
0/33 (Gould GA et al, 1988) in the previous study
(p=0.002) . The frequency of having more than five 4%
desaturations per hour was also higher in relatives from
the families with full coverage as compared to population
data (Stradling JH et al, 1991a) from the Oxford study
(5/19 vs 45/893, p=0.003).
Despite having only 10 matched pairs of relatives for
comparision, this study indicates that cephalometric
differences between affected and unaffected relatives are
mainly in soft tissues rather than in craniofacial
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skeletal architecture. The study does not prove a cause
and effect relationship between abnormal breathing
during sleep and cephaloraetric abnormalities. Though a
thicker uvula in affected relatives may suggest increased
fat deposition or increased muscle tissue as a primary
abnormality (Stauffer JL et al, 1989) tissue oedema or
inflammatory cell infiltration of the soft palate may be
a consequence of vibration induced injury to the uvula
(Cohn M et al, 1986). Likewise an increased Go-Gn-H




METHODS: CASE CONTROL FAMILY STUDY
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METHODS: CASE CONTROL FAMILY STUDY IN PATIENTS WITH SAHS
In the preceding pilot study described, a higher
frequency of irregular breathing during sleep was found
in relatives of patients with SAHS than in retrospective
healthy unmatched controls. Control subjects, matched
with relatives, were not studied on a prospective basis.
The results obtained on relatives were compared with the
available population data and therefore the match was
imperfect.
However, despite being flawed, the pilot study strongly
suggested familial aggregation of abnormal breathing
during sleep. Therefore a case control study was
designed to determine whether there is genuinely a
familial tendency to SAHS and to identify predisposing
risk factors.
Patient recruitment
Over a 2 years period consecutive patients with SAHS
attending the Scottish National Sleep Laboratory were
recruited for the study. As in the pilot study, all the
index patients had more than 15 apnoeas plus hypopnoeas
per hour of sleep in association with at least 2 major
symptoms of SAHS. As obesity, a risk factor for SAHS, is
itself familial (Stunkard AJ et al, 1986a & b) SAHS
patients with a body mass index of over 30 kg/m2 were
excluded from the study.
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The other exclusion criteriae for the patients were gross
retrognathia, hypothyroidism or acromegaly. SAHS
patients with neuromuscular diseases, congestive cardiac
failure and those on treatment with corticosteroids,
tricyclic antidepressants, hypnotic sedatives and beta
adrenalgic blockers were also excluded from the study.
None of the index patients used in this study were
included in the pilot study.
Recruiting relatives
Each SAHS patient enroled in the study was asked to give
details of all first degree relatives aged 15-75. The
relatives were then contacted individually by post or
sometimes personally in their homes and requested to
participate in the study. In order to obtain as complete
a family cover as possible, all first degree relatives
irrespective of their geographical area of residence were
approached. This amounted to contacting many relatives
living all over Britain as well as overseas.
Finding controls
The control subjects were subsequently recruited from a
local general practitioner register and were matched on a
one to one basis for sex, weight, height and age in that
order with each of the relatives studied. All four of
these measurements were available in approximately 5% of
all control case records surveyed manually in the general
practitioner's surgery. In the first instance, all
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control subjects were contacted by a letter from their
own doctor. Those showing a willingness to participate
were then seen in their homes for detailed explanations.
All the relatives and controls gave written informed
consent for participation and local ethics committee
approval was obtained for the study. All were posted
sleep symptom questionnaire and requested to attend the
sleep laboratory for overnight polysomnography and upper
airway measurements by acoustic reflectance and lateral
cephalometry. The whole procedure in the hospital took
around 14 hours.
Questionnaires
The same questionnaires that were used in the pilot study
were completed by the relatives and their matched
controls. The questionnaire included similar questions
and the various sleep symptoms were defined as in the
pilot study.
Polysomnography
The relatives and controls each underwent one night sleep
study as described in the pilot study. The data were
recorded on paper using a 20 second sleep epoch. Sleep
(Rechtschaffen A et al, 1968) and breathing (Douglas NJ
et al, 1992) were manually scored using standard
criteriae as in pilot study.
For each subject, the actual time spent awake in bed and
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in each of the sleep stages, including movement time,
were measured. Light sleep was defined as total time
spent in stages 1 and 2 combined while slow wave sleep
(deep sleep) as the total time spent in stages 3 and 4
combined of NREM sleep. The time spent in each stage of
sleep, light sleep and slow wave sleep was also expressed
in terms of percentage of sleep period time.
Arousal was defined as a return to EEG alpha or theta
rhythm of at least 3 seconds duration with or without an
increase in submental EMG in NREM sleep or with an
increase in EMG tone in REM sleep.
For comparative purposes three definitions of arousals
were used for scoring sleep records of control subjects.
The first was the current American Sleep Disorders
Association (ASDA) definition which defines an arousal as
a return to EEG alpha or theta rhythm of at least 3
seconds duration with or without an increase in submental
EMG in NREM sleep or with an associated increase in EMG
for at least 3 seconds in REM sleep (Bonnet M et al,
1992). The second was the a modification of ASDA
definition which defines an arousal as a return to EEG
alpha or theta rhythm for at least 1.5 seconds
irrespective of EMG in NREM sleep but accompanied by an
increase in submental EMG for at least 1.5 seconds during
REM sleep. The third definition of arousals was the one
used in the pilot study whereby an arousal was defined as
a return to alpha or theta EEG rhythm of at least 1.5
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seconds with any increase in submental EMG irrespective
of the ongoing sleep stage (Cheshire K et al, 1992).
As there is yet no standard definition of arousals, an
attempt was made to visually identify in the EEG any
atypical features, which might otherwise not be scored as
'arousals' as per current definitions, at the termination
of apnoeas or hypopnoeas. An increase in EEG frequency
of whatever duration or K complexes occuring near the end
of obstructed respiratory events were specifically looked
for. However, these EEG features were not found
consistently through the various sleep stages within and
between different subjects. Likewise, an attempt was
also made to define an arousal as any return, howsoever
brief, in the EEG to alpha or theta frequencies with an
associated EMG criteria. This, however, led to
difficulties in distinguishing true 'arousals' from sleep
spindles which also exhibit EEG frequencies in the same
range. For this reason, this definition of arousals was
abandoned.
The exact number of 2%, 3% and 4% oxygen desaturations
per hour were manually calculated for each subject from
the overnight oxygen saturation tracing.
The rest of the polysomnographic measurements taken and
their definitions are as for pilot study described in the
previous chapter.
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Reproducibility of scoring sleep studies
In 6 relatives and 6 control subjects, the sleep studies
were analysed twice by the same investigator to examine
the reproducibility of scoring. These 12 subjects
covered a large range of observed abnormal breathing
during sleep (median: 31, range: 6-88 A+H/hour of sleep)
as from the initial sleep scoring results. Once
selected, these sleep records were reanalysed by the
polysomnographer after randomising them so that the
results of the second scoring were unaffected by any
memory of their initial scoring.
Two sets of polysomnographic data were thus obtained for
each of the 12 subjects. These sleep parameters were
total time spent awake in bed, total time spent in each
of stages 1-4 of NREM sleep and in REM sleep, total
number of apnoeas+hypopnoeas and arousals throughout the
night and the number of 2%, 3% and 4% oxygen
desaturations per hour.
The comparisions between two sets of data were performed
by Pearson's correlation coefficient. Mean percentage
difference (higher score-lower score/lower score xlOO)
was also calculated for each sleep parameter in this
group of 12 subjects (table 4.1). As correlation does
not best indicate possible systematic differences, each
sleep parameter was also shown as a plot of differences
between the two measurements against their mean (Bland JM
et al, 1986, Fig 4.1 to 4.3). These results suggest that
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there is close agreement between the two scorings for
all the polysomnographic parameters obtained and are well
in keeping with previously published results on
reproducibility of scoring respiratory events (Whyte KF
et al, 1992) .
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Table 4.1 Reproducibility of sleep parameters
Sleep Correlation Mean percentage
parameter coefficient difference j%J
Time awake 0.99 4
Stage 1 NREM 0.99 6
Stage 2 NREM 0.99 3
Stage 3 NREM 0.99 8




2%/hr desats 0.99 5
3%/hr desats 0.99 5
4%/hr desats 0.99 8
All correlation coefficients significant at p<0.001, A+H-
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The methodology and reproducibility of acoustic
reflectance is given in chapter 6 while the methodology
of cephalometry in chapter 3.
Statistical analyses
The various statistical tests as appropriate were
performed using the SPSS/PC.
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CHAPTER 5
RESULTS: CASE CONTROL FAMILY STUDY
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RESULTS: CASE CONTROL FAMILY STUDY IN PATIENTS WITH SAHS
The results in this chapter are given in two separate
sections, 5.1 and 5.2. Section 5.1 gives the
recruitment, questionnaire and sleep study results in the
relatives and control subjects while section 5.2 compares
the results in the matched relative-control pairs. The
first part of section 5.1 gives the results in all SAHS
patients and all their relatives. The second part of
section 5.1 gives the results in all control subjects.
Section 5.1- Results in the whole group
Results in index SAHS patients and their relatives
Patient recruitment
Over a 21 month period, from Nov 1991 to July 1993 , 110
patients were diagnosed to be having SAHS on the basis of
having more than 15 A+H/hour of sleep and at least 2
associated symptoms of SAHS. Out of these 110 patients
45 had a body mass index (BMI) of greater than 30 kg/m2.
Another 10 were excluded from the study because of having
at least one of the conditions mentioned in the exclusion
criteria in the previous chapter. A further 10 subjects,
though otherwise eligible for participation, were still
to be contacted in July 1993 when the study was
terminated. Therefore 45 index SAHS patients (43 male)
participated in the study. They had a mean (95% CI) age
of 51 (28-71) years, BMI of 26.3 (22.6-29.9) kg/m2, A+H
of 42 (16-120) per hour of sleep and arousals (Cheshire K
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et al, 1992) of 47 (13-139) per hour of sleep.
These 45 SAHS patients had a total of 130 first degree
relatives. Twentyfive of the 130 relatives refused to
participate in the study or were uncontactable.
Therefore, no information is available on these 25. The
remaining 105 relatives (51 male) participated in the
study. They had a mean age of 40 (17-75) years.
Sleep questionnaire
Sleep questionnaire data was available in 103 of these
105 relatives. Two relatives did not return the
questionnaire despite repeatedly being requested to do
so. Questionnaire data was also available in 80 of the
82 relatives who underwent sleep studies. Only
questionnaire but not sleep study data was available in
23 relatives.
Table 5.11 gives the summary of sleep symptom
questionnaire data on 103 relatives. Seventy two of
these 103 relatives had current bed partners who helped
the relatives in answering the symptom questionnaire.
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Within 20 mins- 49/103














Significant past history includes history of broken nose
and nose or throat operations in the past.
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Polysomnography
Sleep studies were done in 82 of the 105 relatives. Four
of the 45 index patients had no living first degree
relatives. All 6 eligible relatives of another 3 index
patients refused sleep studies though 4 of them completed
the questionnaire. Thus 38 (36 male) of the 45 index
SAHS patients provided the 82 relatives who underwent
sleep studies. The mean (95% CI) age of these 38 SAHS
patients was 53 (28-71) years, BMI 26.6 (22.8-29.9)
kg/m2, A+H 43 (16-120) per hour of sleep and arousals
(Cheshire K et al, 1992) 47 (13-140) per hour of sleep.
One hundred percent sleep study coverage was achieved in
20 families.
Table 5.12 gives the sleep study data on 82 (41 male)
relatives. These 82 relatives had a mean (95% CI) age of
38 (17-73) years and BMI 25.3 (19.4-33.9) kg/m2.
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Table 5.12 Polysomnography data on 82 relatives
Parameter Mean 95% CI
TIB(min) 427 363-468
Time awake(min) 62 5-204
Sleep Period Time(min) 404 308-454
Total Sleep Time(min) 342 125-429
Sleep Onset Latency(min) 23 3-79
Sleep Efficiency Index(%) 80 39-96
St 1 NREM(min) 20 3-52
St 2 NREM(min) 187 73-304
Light Sleep(min) 207 83-317
St 3 NREM(min) 17 4-50
St 4 NREM(min) 58 9-119
Slow Wave Sleep(min) 75 21-146
REM Sleep(min) 59 9-110
Movement Time(min) 1.8 0-30
Time awake% SPT 18 1-67
St 1 NREM% SPT 5 1-12
St 2 NREM% SPT 46 15-71
Light Sleep% SPT 51 18-74
St 3 NREM% SPT 4 1-12
St 4 NREM% SPT 14 2-30
Slow Wave Sleep% SPT 19 5-38
REM Sleep% SPT 14 3-27
Movement Time% SPT 0.4 0-7
REM Sleep Latency(min) 130 41-299
A+H/hour of sleep 15 2-68
Arousals/hr slept
(Cheshire K et al, 1992) 15 5-42
3SecA (/hour of sleep) 35 20-79
1.5SecA (/hour of sleep) 35 21-85
2% oxygen desaturation/hr 5 0-33
3% oxygen desaturation/hr 3 0-22
4% oxygen desaturation/hr 2 0-17
3SecA- Number of arousals per hour of sleep and defined
as return to alpha or theta EEG rhythm for at least 3
seconds irrespective of EMG in NREM sleep but accompanied
by an increase in submental EMG tone in REM sleep.
1.5SecA- Number of arousals per hour of sleep and defined
as return to alpha or theta EEG rhythm for at least 1.5
seconds irrespective of EMG in NREM sleep but accompanied
by an increase in submental EMG tone in REM sleep.
Arousal definition by Cheshire K et al, 1992- A return to
alpha or theta EEG rhythm for at least 1.5 seconds
accompanied by any rise in submental EMG tone.
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Of the 82 relatives who underwent sleep studies 71 had
more than 5 A+H/hr of sleep, 51 had more than 10 A+H/hr
of sleep and 33 had more than 15 A+H/hr of sleep. Six
out of 82 relatives sleep studied had more than five 4%
oxygen desaturations per hour.
Effect of sex, age and BMI on A+H/hour of sleep in
relatives
There was no effect of sex on A+H/hr slept between 42
male and 40 female unmatched relatives (A+H males 16 SEM
2/hr slept vs females 14 SEM 2/hr; p=0.6). Multiple
linear regression was performed to find the effect of age
and BMI on A+H per hour of sleep in 82 relatives. Both
age (p=0.003, r=0.4) and BMI (p=0.003, r=0.4) correlated
with A+H/hr (fig 5.11) and accounted for 26% of the
variability in this parameter.
Effect of age, sex and BMI on arousals in relatives.
The effect of sex was tested between sexes on arousals
defined by all three definitions used in table 5.12.
Comparision between sexes was done by unpaired t test.
No difference between sexes was found in the number of
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3SecA and 1.5SecA as defined in table 5.12
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Multiple linear regression was performed to find the
effect of age and BMI on arousals in all relatives. Age
correlated strongly with arousals (p=0.0001), defined by
all three definitions, explaining 13-28% of the observed
variability. There was no correlation between BMI and
arousals (p=0.8, 0.2 and 0.1 for above three arousal
definitions respectively).
Combining questionnaire and polysomnography results
Eighty of the 82 patients who underwent polysomnography
completed the questionaire. Excessive daytime sleepiness
was considered present if the subjects averaged two naps
per day when not in bed.
Out of 33 relatives with more than 15 A+H/hr of sleep, 19
had excessive daytime sleepiness, 12 of these being
snorers. Seven snored but were not sleepy.
Out of 51 relatives with more than 10 A+H/hr of sleep, 30
had excessive daytime sleepiness, 17 of these being
snorers. Ten snored but were not sleepy.
Results in the control group
Recruitment
55 of 59 controls approached agreed to participate in the
study. All 55 (30 male) completed symptom questionnaire
and underwent sleep studies. These 55 controls had a
mean (95% CI) age of 37 (18-71) years and BMI 24.4 (19.1-




Table 5.14 gives the questionnaire results in 55 control
subjects. Forty of them had current bedpartners who
helped them with some of the questions in the
questionnaire.
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Sleep study data in 55 control subjects (normative data)
is given in table 5.15.
Table 5.15
Parameter Mean 95% CI 90% CI
Time in Bed(min) 421 287-482 369-456
Sleep Period Time(min) 399 274-466 340-437
Total Sleep Time(min) 334 98-430 106-412
Sleep Onset Latency(min) 23 2-92 4-71
Sleep Efficiency
Index(%) 79 23-96 40-94
Time awake(min) 63 8-284 9-221
St 1 NREM(min) 19 4-56 5-43
St 2 NREM(min) 162 46-260 56-236
Light Sleep(min) 181 60-280 74-269
St 3 NREM(min) 18 1-64 3-35
St 4 NREM(min) 72 2-150 17-134
Slow Wave Sleep(min) 90 5-181 24-157
REM Sleep(min) 62 1-123 10-112
Movement Time(min) 1 0-25 0-9
Time awake %SPT 16 2-74 2-57
St 1 NREM% SPT 5 1-13 1-10
St 2 NREM% SPT 40 14-64 17-59
Light Sleep% SPT 45 19-69 21-65
St 3 NREM% SPT 5 0-16 1-9
St 4 NREM% SPT 18 1-36 4-33
Slow Wave Sleep% SPT 22 1-43 7-39
REM Sleep% SPT 15 1-29 3-27
Movement Time% SPT 0 0-7 0-2
REM Sleep Latency(min) 123 44-337 53-300
A+H/hr of sleep 7 0-52 0-19
Arousals/hr slept
(Cheshire K et al, 1992) 14 3-55 5-34
Arousals/hr slept
(Bonnet M et al, 1992) 21 7-56 8-46
Arousals/hr slept
(Rev 1.5 sec def.) 26 5-67 10-55
2% oxygen desats/hr 3 0-31 0-11
3% oxygen desats/hr 2 0-28 0-7
4% oxygen desats/hr 1 0-17 0-5
SPT- Sleep Period Time
Arousals (Bonnet M et al, 1992) defined as per current
ASDA guidelines of a return to alpha or theta EEG rhythm
for at least 3 seconds irrespective of EMG activity in
NREM sleep but accompanied by a rise of at least 3
seconds submental EMG tone in REM sleep.
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Rev 1.5 sec def.- In house definition of arousals defined
as a return to alpha or theta EEG rhythm for at least 1.5
seconds irrespective of EMG activity in NREM sleep but
accompanied by a rise of at least 1.5 seconds submental
EMG tone in REM sleep.
Arousals (Cheshire K et al, 1992) defined as in table
5.12
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Sleep study data on 47 controls under 60 years of age is
given in table 5.16. These 47 controls had a mean (95%
CI) of 32 (18-58) years and BMI 24 (18.8-32.5) kg/m2.
Table 5.16
Parameter Mean 95% CI 90% CI
Time in Bed(min) 427 379-490 387-457
Sleep Period Time(min) 405 343-469 359-446
Total Sleep Time(min) 351 126-432 221-416
Sleep Onset Latency(min) 22 2-96 4-68
Sleep Efficiency
Index(%) 82 29-96 55-95
Time awake(min) 54 8-232 9-155
St 1 NREM(min) 18 4-57 5-44
St 2 NREM(min) 168 61-262 76-246
Light Sleep(min) 186 74-280 90-270
St 3 NREM(min) 20 2-72 4-37
St 4 NREM(min) 78 21-153 26-138
Slow Wave Sleep(min) 98 34-186 46-162
REM Sleep(min) 67 4-126 16-113
Movement Time(min) 1 0-20 0-0
Time awake %SPT 14 2-65 2-41
St 1 NREM% SPT 4 1-14 1-11
St 2 NREM% SPT 41 18-64 20-61
Light Sleep% SPT 46 21-70 24-65
St 3 NREM% SPT 5 0-18 1-9
St 4 NREM% SPT 19 5-36 6-33
Slow Wave Sleep% SPT 24 9-44 11-40
REM Sleep% SPT 17 1-29 4-28
Movement Time% SPT 0 0-5 0-0
REM Sleep Latency(min) 125 41-346 53-305
A+H/hr of sleep 6 0-30 0-14
Arousals/hr slept
(Cheshire K et al, 1992) 12 3-37 5-27
Arousals/hr slept
(Bonnet M et al, 1992) 18 7-47 8-41
Arousals/hr slept
(Rev 1.5 sec def . ) 23 4-53 8-40
2% oxygen desats/hr 3 0-30 0-10
3% oxygen desats/hr 2 0-26 0-7
4% oxygen desats/hr 1 0-16 0-5
Definition of arousals as in table 5.14
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Three of the 55 control subjects had more than five 4%
oxygen desaturations/hour. Of the 55 controls 3 (all
men) had more than 15, 9 (7 men) had more than 10 and 28
(17 men) had more than 5 A+H/hour of sleep.
Combining questionnaire and polysomnography results
Out of 3 controls with >15 A+H/hr of sleep 1 had
excessive daytime sleepiness, none reported loud snoring
and none reported both these symptoms. Out of 9 controls
with >10 A+H/hr of sleep, 4 had excessive daytime
sleepiness, 1 of them being a snorer. One snored but was
not sleepy.
Effect of age, sex and BMI on A+H/hr in control subjects
There was no effect of sex between 30 men and 25 women on
A+H/hour of sleep (median A+H in men 4.4/hr of sleep vs
median A+H in women 3.6/hr of sleep, p=0.4) though 7 of
the 9 controls with >10 A+H per hour of sleep and all 3
with >15 A+H/hr were men. Multiple linear regression was
performed to find the effect of age and BMI on A+H per
hour of sleep in 55 control subjects. Age correlated
strongly with A+H/hr (p=0.0007, r=0.5), explaining 25% of
the observed variability. There was no correlation
between BMI and A+H/hr (p=0.4, r=0.2).
Effect of aae. sex and BMI on arousals in control
subjects
The effect of sex was tested between 30 men and 25 women
on arousals defined by all three definitions. There was
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no significant difference between these sexes for age
(men 40 SEM 3, women 3 3 SEM 2, p=0.1) . Comparision
between sexes was done by unpaired t test. No difference
between sexes was found in the number of arousals/hr
irrespective of the arousal definition tested (table
Table 5.17 Effect of sex on arousals in control subjects
5.17)
Definition Men Women P
Arousals/hr
(Cheshire K
et al, 1992) 16 SEM 2 12 SEM 2 0.1
3SecA 22 SEM 2 21 SEM 2 0.8
1.5SecA 26 SEM 3 24 SEM 2 0.5
3SecA and 1.5SecA as defined in table 5.12
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Multiple linear regression was performed to find the
effect of age and BMI on arousals in 55 control subjects.
Age correlated strongly with arousals (pcO.OOl), defined
by all three definitions, explaining 26-36% of the
observed variability. There was no correlation between
BMI and arousals (p=0.4).
Section 5.2- Results in matched pairs
Recruitment
Thirty eight index SAHS patients provided 82 relatives
who underwent sleep studies. The first 51 of these 82
relatives were matched one for one with controls. Six of
the 38 index SAHS patients were recruited towards the
latter half of the study and none of their relatives were
included in the match. Therefore 32 index patients
provided at least one relative included in the matching.
These 32 index patients (31 male) had a mean (95% CI) age
of 51 (28-68) years, BMI of 26.5 (22.8-29.9) kg/m2, A+H
of 39 (16-105) / hour of sleep, arousals of 44 (13-140)
/hour of sleep and a collar size of 40 (38-43) cm.
These 32 index patients had a total of 108 first degree
relatives. Ninety one of 108 relatives agreed to
participate in the study and 17 refused or were
uncontactable. Of the 91 relatives who participated only
questionnaire data was available in 16. All of the
remaining 75 relatives underwent sleep studies and 74 of
these completed the questionnaire.
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There were no differences between 51 matched and 40
unmatched relatives in any of the sleep related symptoms
(table 5.21). However, the 51 matched relatives were
younger (age 36 SEM 2 vs 44 SEM 3 years, p=0.02) and
consumed less alcohol (8 SEM 1 vs 12 SEM 2 u/wk, p=0.04)
than the 40 unmatched relatives and proportionately fewer
were current smokers (14/50 vs 19/40, p=0.02).
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Table 5.21 Comparision of sleep related symptoms between



















Out of 55 controls recruited 4 were found to have a
different age, height or weight than what was recorded in
their general practitioner's case notes. Therefore 51
controls were matched to 51 relatives on a one to one
basis (table 5.22).




Age(years) 36 SD 14 35 SD 14
BMI(kg/m ) 24 SD 4 24 SD 3
Questionnaire data
Questionnaire data was available in 50 matched pairs.
There was no difference between groups in smoking habits,
alcohol consumption or collar size. More relatives than
controls reported loud snoring, excessive daytime
sleepiness and nocturnal choking (table 5.23).
Table 5.23 Sleep symptoms that were significantly

















Table 5.24 gives sleep symptoms whose frequency was not
different between relatives and controls in 50 matched
pairs.
Table 5.24 Non significant differences in questionnaire
data between relatives and controls in 50 matched pairs.
Parameter Relatives Controls P
Collar size(cm) 40 SEM 0.4 40 SEM 0.3 0.4
Alcohol(u/wk) 8 SEM 1 8 SEM 1 0.9
Current smokers 14 8 0.3
Witnessed apnoeas 4 2 0.5
Refreshing sleep 26 30 0.4
Restless sleep 13 12 0.9
Repeated
awakenings 35 32 0.5
Morning headache 7 1 0.06
Nocturia 39 34 0.3
Irritability 6 4 0.4
Enuresis 2 1 0.6
Decreased libido 8 8 1.0
Weight gain 19 16 0.5
Pedal oedema 3 1 0.6
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Sleep studies
When compared to controls (fig 5.21) the relatives had
higher A+H/hr (relatives median 13, controls median 4
A+H/hr, p<0.0001). The relatives also had more arousals
(3SecA) than controls (relatives median 30/hr, controls
median 17/hr, 0<0.0001, fig 5.22). The relatives had a
greater sleep disturbance with more light sleep and less
slow wave sleep than controls (table 5.25). There were
no significant differences between relatives and controls
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Table 5.25 Relatives had a different sleep architecture
than controls
Sleep stage Relatives Controls P
St 2 NREM(min) 188 SEM 6 160 SEM 7 0.005
St 4 NREM(xnin) 61 SEM 4 73 SEM 5 0.03
Light Sleep(min) 209 SEM 7 179 SEM 8 0.006
Slow Wave
Sleep(min) 78 SEM 5 91 SEM 5 0.03
St 2 NREM% SPT 46 SEM 1 40 SEM 2 0.02
St 4 NREM% SPT 15 SEM 1 18 SEM 1 0.01
Light Sleep% SPT 51 SEM 2 45 SEM 2 0.02
Slow Wave
Sleep% SPT 19 SEM 1 23 SEM 1 0.01
SPT- Sleep Period Time
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Table 5.26 Sleep parameters which did not differ between
relatives and controls in 51 matched pairs
Sleep parameter Relatives Controls P
Time in bed(min) 427 SEM 3 423 SEM 5 0.4
Sleep Period
Time(min) 408 SEM 4 400 SEM 5 0.3
Total Sleep
Time(min) 349 SEM 9 333 SEM 11 0.3
Sleep Onset
Latency(min) 20 SEM 2 22 SEM 3 0.4
Sleep Efficiency
Index(%) 81 SEM 2 79 SEM 2 0.3
Time awake(min) 58 SEM 7 65 SEM 9 0.5
ST 1 NREM(min) 21 SEM 2 19 SEM 2 0.4
St 3 NREM(min) 17 SEM 1 18 SEM 2 0.6
REM sleep(min) 61 SEM 4 62 SEM 4 0.8
Time awake% SPT 18 SEM 4 17 SEM 2 0 . 8
St 1 NREM% SPT 5 SEM 0.4 5 SEM 0.4 0.5
ST 3 NREM% SPT 4 SEM 0.3 5 SEM 0.4 0.4
REM sleep% SPT 15 SEM 1 15 SEM 1 0.7
REM Latency(min) 136» SEM 9 124r SEM 10 0.4
SPT- Sleep Period Time
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In the 51 matched pairs, more relatives than controls had
greater than 5, 10 and 15 A+H/hour sleep (table 5.27)
Table 5.27 Number of relatives and matched controls











The relatives had more 2% and 3% oxygen desaturations
than controls but there was no difference in the
frequency of 4% oxygen desaturations between relatives
and controls (table 5.28).
Table 5.28 Comparision of oxygen desaturation data
between relatives and controls.
Desaturations Relatives Controls P
2%/hr 6 SEM 1 3 SEM 1 0.04
3%/hr 4 SEM 1 2 SEM 1 0.04







Acoustic reflectometry is a technique that can provide
non invasive estimates of airway cross sectional areas in
reference to distance from the incisors. This is done by
sending an acoustic pulse down a wavetube and into a
subject's airway. The resultant reflections are recorded
by a pressure sensitive microphone and computer system.
Signal analysis consists of separation of the reflected
wave, deconvolution by the incident pulse shape and
airway cross sectional area construction. This area is
displayed as a function of distance (Marshall I et al,
1993) .
This reflectometer is portable, simple to use and
provides a 'real time' display of airway area. The
system is based on a standard microcomputer and permits
the subject to breathe freely room air between
measurements. Helium-oxygen gas mixture, as originally
used by Fredberg JJ et al, 1980, is not required.
The ref lectometer setup is shown in fig 6.1. A
loudspeaker is acoustically coupled to one end of a wave
tube and a pressure sensitive microphone is mounted in
the tube wall near the distal end. The subject is
connected to this end via a mouthpiece. The loudspeaker
to microphone distance is 113 cm and the microphone to
mouthpiece distance is 13 cm. The internal diameter of
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the tube is 16 mm. The dead space in the system is
approximately 10 ml.
Subjects breathe via a hole in the tube wall immediately
proximal to the mouthpiece. To avoid spurious
reflections, the hole is closed by a sliding respiratory
shutter valve 100 ms before an airway measurement is
made. This valve reopens 50 ms afterwards.
A sliding calibration valve just distal to the microphone
permits the wave tube to be closed during calibration of
the apparatus. Airway pressure is monitored by a
pressure transducer connected to the mouthpiece to detect
respiration and allow synchronization of airway
measurements with the phase of breathing.
The loudspeaker is driven to produce a short duration
Gaussian pressure pulse with a nominal full width at half
maximum (FWHM) of 100 ms. This allows temporal separation
of the incident from the reflected waveform even with a
very short microphone to mouthpiece distance.
Though the loudspeaker's natural impulse response lasts
about 2 ms, application to the loudspeaker of a
calculated drive waveform (calculated as part of
calibration procedure by frequency domain inverse filter
method) results in a final incident Gaussian pressure
pulse with a FWHM of 100 ms. The peak pulse pressure of
the incident wave is approximately 200 Pa. The
microphone (Type BL 1785, Knowles Electronics) has a
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sensitivity of 3 mv/Pa and therefore produces a signal of
600 mv in response to the Gaussian pressure pulse. The
reflections of interest are typically 30 dB below this
level, ie 20 iv. In the measurement bandwidth (60 Hz-12
KHZ) the electronic noise from the microphone is 300
microvolts peak to peak, so that the subject to noise
ratio is 30-40 dB. This has been previously found
adequate for the reconstruction algorithm (Ware JA et al,
1969) .
A microcomputer (10 MHZ, 80286, IBM compatible) drives
the loudspeaker and collects the signal from the
microphone preamplifier via a custom high speed analogue
interface card. This card uses buffer memory techniques
to achieve simultaneous analogue output and input at a 40
KHz sampling rate. The loudspeaker drive waveform is
downloaded from the computer into buffer memory and then
automatic high speed output to a Digital to Analogue
Converter (DAC) and power amplifier is initiated.
Likewise, the microphone signal is sampled at high speed
by an Analogue to Digital Converter (ADC), while the data
being stored in a second buffer memory. The data is then





















FIG 6.1 ACOUSTIC REFLECTOMETER
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Reflectometer operation
1. Calibration of the instrument was done by closing
the sliding valve to occlude the wave tube immediately
beyond the microphone. The impulse response of the
loudspeaker/wave tube/ microphone combination was
measured and the drive waveform necessary to produce a
Gausssian pulse calculated. This was then applied to
the loudspeaker and the actual pressure pulse achieved
was recorded.
2. The slide valve was opened and the subject coupled
to the equipment by a mouthpiece. The subject sat
upright with the head in neutral position and was asked
to breathe normally through the mouthpiece. Though nose
clips were not applied, care was taken to ensure that the
subject did nor breathe through the nose during the
measurements.
3. Measurements were taken at functional residual
capacity (FRC) as the computer repeatedly closed the
respiratory shutter valve, excited the loudspeaker,
recorded the pressure wave and reopened the valve.
Separation, deconvolution and area reconstruction
followed each excitation using the reconstruction
algorithm (Ware JA et al, 1969). An average of 5
measurements gave the final area distribution curve.
Though the pressure transducer coupled to the mouthpiece
allows mointoring of airway pressure and synchronization
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of the measurement to the phase of respiration,
measurements can also be taken at various times in the
respiratory cycle in an unsynchronized mode.
A typical area distance curve obtained at FRC with the
subject breathing through the mouth is shown in fig 6.2.
The positions of the anatomical landmarks on this
acoustic curve were obtained from upper airway midline
saggital MRI images as described elsewhere (Marshall I et
al, 1993). They have also been confirmed by different
breathing manoeuvers including glottic closure and
directly measuring the distance from the incisors by
fibreoscopy.
The upper airway distances are measured from the incisors
(I). The first large deflection after the incisors is
the mouth (M) and the first point showing the smallest
area immediately after the mouth is the oropharyngeal
junction (OPJ). This generally falls 100-150 mm from the
incisors.
The part of the curve after oropharyngeal junction is the
pharynx. The point on the acoustic curve showing the
smallest area immediately after the pharynx and generally
170-220 mm from the incisors is the glottis (GLO). The
location of the glottis can also be verified by noting
the variability in the area measurements at this point on
the curve, depending upon the positions of the vocal
cords. The remaining curve after the glottis represents
reflections from the trachea.
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Thus, the part of the curve between oropharyngeal
junction and glottis is the pharynx. The parameters
which were measured from this curve were oropharyngeal
junction area, glottic area, maximum pharyngeal area
(MPA-defined as the largest area anywhere on the curve
between OPJ and GLO), average pharyngeal area (APA) and
pharyngeal volume (PV) obtained by integrating the area
from OPJ to GLO over distance.
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AREA(cm2) Fig.6.2Upperairwaya-distancecurv .I-ncisors,Mmouth OPJ-oropharyngealjunction,GLO-glottis.Tcurvebetwe OPJandGLOisthepharynx.
Reproducibility of acoustic reflectance measurements
Day to day within subject variability of acoustic
reflectance measurements was tested in 6 female subjects
recruited from the laboratory staff. None of these had
any respiratory or sleep related problems. They had a
mean (SD) age of 30 (6) years and mean (SD) BMI of 21.4
(3) kg/m2. The equipment and the protocol was explained
to them.
In all 6 subjects, acoustic measurements of the upper
airway were taken on 8 successive days. On each day the
measurements were taken between 10 am and noon with the
subjects sitting and breathing normally through the mouth
keeping the head in the neutral position. All the
measurements were taken at FRC.
For each subject the mean and SD of 8 measurements for
each acoustic parameter was calculated. SD/mean x 100
for each parameter in that subject gave the within
subject coefficient of variation (CV) for that parameter
(table 6.1). The average of all CVs for a given
parameter in all 6 subjects gave the overall CV for that
acoustic parameter.
The overall CV for oropharyngeal junctional cross
sectional area (OPJ) was 12 SD 6%, maximam pharyngeal
cross sectional area (MPA) 11 SD 3%, glottic cross
sectional area (GLO) 15 SD 6%, average pharyngeal cross
sectional area (APA) 7 SD 2% and pharyngeal volume (PV)
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10 SD 3%. Larger variabilities were seen in OPJ and GLO
cross sectional areas as these parts may be the most
variable parts of the upper airways. APA and PV during
wakefulness were found to be the most reproducible
measurements. Measuring APA minimises the error caused
by longitudinal shift and eliminates the necessity of
comparing pharyngeal areas at a single distance from the
mouth, which may correspond to different anatomic
locations depending upon posture (Brown IB et al, 1987).
The mean day to day CV for the whole upper airway in all
subjects was 11%. This is acceptable in a clinical
physiological technique.
These results are consistent with the 20% day to day CV
for acoustic measurements reported by Marshall I et al,
1993. They found the day to day CV in 5 subjects over 21
days as 13 + 3% for oropharyngeal area and 11 + 3% for
maximum pharyngeal and glottic areas. Likewise, Brookes
LJ et al, 1984, reported a 9+4% day to day CV for
acoustic measurements using his more complex and clumsy
equipment.
The effect of day to day variability on the
reproducibility of acoustic reflectance measurements was
also tested by repeated measures analysis of variance.
No effect of the day to day variability on
reproducibility of acoustic parameters was found (OPJ,
p=0.6; MPA, p=0.8; GLO, p=0.5; APA, p=0.8; PV, p=0.7).
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Table 6.1 Day to day coefficient of variations for 5
different acoustic parameters in 6 subjects studied
repeatedly on 8 days.
OPJ MPA GLO APA PV
Sub 1 4.5 9.6 13.3 8.3 7.6
Sub 2 15.0 7.4 17.6 4.5 6.2
Sub 3 22 . 2 13.1 15. 3 10.3 13 . 9
Sub 4 11.7 14.7 25.0 7.6 14.4
Sub 5 5.8 7.6 8.3 4.7 9.2
Sub 6 13 . 3 11.1 8.6 9.0 6.3
Overall
CV(%) 12.1 10.6 14.7 7.4 9.6
OPJ-oropharyngeal junction area, MPA-maximum pharyngeal
area, GLO-glottic area, APA-average pharyngeal area, PV-
pharyngeal volume, CV-coefficient of variation.
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Acoustic reflectance results in matched pairs
Out of 51 matched relative control pairs acoustic
reflectance data was available in 44 relatives and 46
controls. Acoustic reflectance could not be performed on
all subjects due to occassional reflectometer malfunction
and the inability of some subjects to come to the sleep
laboratory again for these measurements to be taken.
Results of acoustic reflectance were available in 40
matched relative control pairs (table 6.2). There were
significant differences between groups in total
pharyngeal volume and glottic cross sectional area but
not in other variables measured.
Table 6.2 Acoustic reflectance results in 40 matched
pairs.
Parameter Relatives Controls P
Pharyngeal
volume(cc) 19 SEM 1 23 SEM 1 0.01
Glottic area(cm2) 1.7 SEM 0.1 1.9 SEM 0.1 0.05
Oropharyngeal
junction area(cm2) 1.7 SEM 0.1 1.8 SEM 0.1 0.9
Maximum pharyngeal
area(cm2) 2.7 SEM 0.1 2.9 SEM 0.1 0.2
Average pharyngeal
area(cm2) 2.2 SEM 0.1 2.3 SEM 0.1 0.5
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Lateral cephalometry results in matched pairs
Lateral cephalometry was performed in both relatives and
controls in erect position using a cephalostat and the
standard protocol described in chapter 3. The standard
bony and soft tissue landmarks identified and dimensions
measured were the same as in pilot study.
Out of 51 matched relative control pairs, 42 relatives
and 41 controls underwent cephalometric examination while
the rest refused this radiological procedure.
Data from cephalometry was available in 36 matched
relative control pairs. The relatives had retroposed
maxillae and mandibles with shorter mandibles and longer







The cephalometric measurements which were not
significantly different between relatives and controls
are given in table 6.4.
Table 6.3 Cephalometric differences between relatives
and controls.
Parameter Relatives Controls P
Go-Gn(mm) 84 SEM 1 87 SEM 1 0.03
PNS-PhW(mm) 29 SEM 1 32 SEM 1 0.02
S-N-A(deg) 81 SEM 1 86 SEM 1 <0.0001
S-N-B(deg) 78 SEM 1 82 SEM 1 <0.0001
UL(mm) 45 SEM 1 43 SEM 1 0.03
UW(mm) 12 SEM •o 10 SEM 0.3 <0.0001
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Table 6.4 Cephalometric measurements which were not
significantly different between relatives and controls
Parameter Relatives Controls P
ANS-PNS(mm) 41 SEM 1 42 SEM 1 0.5
S-Go(mm) 85 SEM 3 89 SEM 1 0.2
Go-H(mm) 45 SEM 1 44 SEM 1 0.7
H-MP(mm) 24 SEM 1 23 SEM 1 0.2
H-Ar(mm) 85 SEM 2 87 SEM 2 0.2
Go-PhW(mm) 6 SEM 1 5 SEM 1 0.5
Go-Ar(mm) 44 SEM 2 47 SEM 2 0.1
UP-PhW(mm) 14 SEM 1 15 SEM 1 0.3
PAS(mm) 11 SEM 1 12 SEM 1 0.4
UT-PhW(mm) 10 SEM 1 11 SEM 1 0 . 2
H-PhW(mm) 36 SEM 1 37 SEM 1 0.4
TB-PhW(mm) 10 SEM 1 11 SEM 1 0.6
PNS-Aat(mm) 38 SEM 1 39 SEM 1 0.6
Triangle(mm ) 1412 SEM 105 1512 SEM 86 0.5
Go-Ga-H(deg) 27 SEM 1 25 SEM 1 0.2
Mand. angle(deg) 119 SEM 1 117 SEM 1 0.07
Neck angle(deg) 17 SEM 1 15 SEM 1 0.4
N-S-Ba(deg) 146 SEM 1 144 SEM 1 0.2
Gn-Go-Aat(deg) 121 SEM 2 121 SEM 1 0.7
Gn-Go-Ba(deg) 137 SEM 1 136 SEM 1 0.7
A-N-B(deg) 3 SEM 0.4 4 SEM 0.4 0.2
Abbreviations as explained in previous chapters.
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Correlation of A+H/hour of sleep with cephalometry
To identify the subset of cephalometric variables that
are most useful for predicting the number of A+H/hour of
sleep, a stepwise multiple linear regression analysis was
performed in 83 subjects (42 relatives) on whom
cephaloraetric data was available. All 83 subjects were
from the 51 matched pairs. In this sample UW (p<0.0001),
S-Go (pcO.OOOl), PNS-Aat (p=0.003) and triangle area
(p=0.01) were found to be most useful variables, in
decreasing order of importance, explaining much of the
variability in A+H/hour of sleep. Stepwise entry of UW,
S-Go, PNS-Aat and triangle area in this order to the
analysis accounted for 10%, 23%, 29% and 34% of the
variation in A+H/hour of sleep as second, third and
finally all four variables were entered into the model.
The final equation, explaining 34% of the variation in
A+H/hour of sleep, was:
A+H/hr of sleeps 64.1 + 2.9(UW) - 0.7(S-Go) - 1(PNS-Aat)
+ 0.008(triangle).
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Normative cephalometric data in controls
Table 6.5 gives normative lateral cephaloraetric data in
erect posture in 24 male and 17 female control subjects
who underwent cephalometric examination.
Table 6.5 Normative lateral cephalometry data.
MALE FEMALE
Parameter Mean 95% CI Mean 95% CI
n 24 17
Age (years) 35 22-58 29 23-42
BMI (kg/m2) 26 20.5-32.7 22 18.5-23.9
ANS-PNS(mm) 42 33-61 40 32-58
Go-Gn(mm) 88 77-98 84 77-95
S-Go(mm) 93 81-108 82 75-88
Go-H(mm) 49 39-63 38 25-50
H-MP(mm) 26 15-37 20 9-32
H-Ar(mm) 93 72-115 78 67-93
Go-PhW(mm) 4 -8-14 5 0-15
G-o-Ar (mm) 47 32-63 44 34-56
UP-PhW(mm) 15 4-26 15 9-23
tTL(mm) 44 37-51 42 34-51
UK(mm) 11 7-13 9 6-13
FAS(mm) 12 8-21 12 8-21
UT-PhW(mra) 11 3-21 10 6-15
H-PhW(mm) 39 27-48 32 28-35
PNS-PhW(mm) 32 27-49 32 22-41
TB-PhW(mm) 11 3-25 10 6-17
PNS-Aat(mm) 38 32-44 39 34-45
Triangle(mm3) 1588 546-3040 1427 688-2031
Go-Gn-H(deg) 29 17-45 21 11-32
S-N-A(deg) 86 78-94 85 79-93
S-N-B(deg) 83 76-89 81 75-89
A-N-B(deg) 3 -3-8 4 -2-7
Ma.nd. angle (deg) 118 106-131 115 103-131
Neck angle(deg) 16 5-32 16 4-23
N-S-Ba(deg) 141 130-150 147 144-156
Gn-Go-Aat(deg) 119 111-134 122 110-145
Gr-Go-Ba (deg) 136 125-155 136 125-153
143
The sex differences in cephalometric variables are given
in table 6.6. These indicate that men have bigger
mandibles (Go-Gn, S-Go) , lower hyoid bones (Go-H, H-MP,
H-Ar, Go-Ga-H angle), more acute cranial flexure (N-S-Ba
angle) and wider uvulae (UW) than women.
Table 6.6 Gender differences in cephalometric variables
Parameter Men Women P
n=24 n=17
ANS-PNS(mm) 42 SEM 1 40 SEM 2 0.3
Go-Gn(mm) 88 SEM 1 84 SEM 1 0.008*
S-Go(mm) 94 SEM 1 82 SEM 1 <0.0001
Go-H(mm) 48 SEM 1 38 SEM 1 <0.0001
H-MP(mm) 25 SEM 1 20 SEM 2 0.02*
H-Ar(mm) 93 SEM 2 78 SEM 2 <0.0001
Go-PhW(mm) 4 SEM 1 5 SEM 1 0.6
Go-Ar(mm) 48 SEM 2 44 SEM 2 0.2
UP-PhW(mm) 15 SEM 1 15 SEM 1 0.5
UL(mm) 44 SEM 1 41 SEM 1 0.08
UW(mm) 11 SEM 0.5 9 SEM 0.5 0.003*
PAS(mm) 12 SEM 1 12 SEM 1 0.5
UT-PhW(mm) 11 SEM 1 10 SEM 1 0.5
H-PhW(mm) 39 SEM 1 32 SEM 1 <0.0001
PNS-PhW(mm) 32 SEM 1 32 SEM 1 0.9
TB-PhW(mm) 11 SEM 1 10 SEM 1 0.5
PNS-Aat(mm) 38 SEM 1 39 SEM 1 0.6
Triangle(mm2) 1588 SEM 114 1427 SEM 91 0.3
Go-Gn-H(deg) 28 SEM 2 21 SEM 2 0.004*
S-N-A(deg) 86 SEM 1 85 SEM 1 0.6
S-N-B(deg) 83 SEM 1 81 SEM 1 0.3
A-N-B(deg) 3 SEM 0.5 4 SEM 0.6 0.3
Mand. angle(deg) 118 SEM 1 115 SEM 2 0.2
Neck angle(deg) 15 SEM 2 16 SEM 1 0.6
N-S-Ba(deg) 141 SEM 1 147 SEM 1 <0.0001
Gn-Go-Aat(deg) 119 SEM 1 122 SEM 2 0.3
Gn-Go-Ba(deg) 135 SEM 2 136 SEM 1 0.7
* indicates results significant at p<0.05
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CHAPTER 7
RELATIONSHIP BETWEEN ADULT SAHS AND SIDS
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Relationship between adult SAHS and the Sudden Infant
Death Syndrome (SIDSK
This part of the study was undertaken to find whether the
incidence of unexpected infant deaths is higher in
families having adults with SAHS in comparision with
control families. A secondary aim was to find possible
differences in facial morphology between adults in
families having both SIDS and adult SAHS and in families
having only adult SAHS when compared with matched adults
from control families.
Methods
From the first degree relatives of all SAHS patients
recruited in the study (as described in the 'patient
recruitment' section of chapter 4) one relative from each
SAHS family was selected at random. This relative and
its matched control were requested to complete another
questionnaire enquiring 'Were there any unexpected infant
deaths under one year of age' in upto 4 generations in
each family and what the cause of death was, if known.
The relative and the control approached were also asked
to supply information on the number of family members
considered in each generation in question. For families
reporting unexpected infant deaths in any generation,
whereever available, details of the infant's age at the
time of death, its sex, mother's age at the time of
infant death, time of the the year the death occured,
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infant's birth weight and gestational maturity were also
enquired. Questions as to whether the mother received
normal medical care during pregnancy, whether anyone in
the household was a current smoker, whether it was a
multiple pregnancy, whether the baby was breastfed and
received up to date immunizations, whether the parents
were employed and whether the mother took addictive
unprescribed drugs during pregnancy were also asked.
The index relatives approached from the SAHS families and
their matched controls from the control families
underwent lateral cephalometry as described in chapter 3.
RESULTS
As discussed in chapter 5, 38 SAHS patients provided
first degree relatives for sleep studies. These 38 SAHS
families along with 38 control families were included in
the questionnaire survey for unexpected infant deaths.
One index relative from each of the 38 SAHS families with
a matched control participated in this survey.
All the families came from Scotland. The index family
members (21 males in both groups), answering the
questionnaire and undergoing cephalometry, were matched
for age (SAHS families 37 SEM 2 vs control families 35
SEM 2 years; p=0.2) and body mass index (SAHS families
24.7 SEM 0.6 vs control families 24.5 SEM 0.6 kg/m2;
p=0.7). Twentynine SAHS and 35 control families returned
the questionnaire (84% overall return; p=0.1 between
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groups). On the families returning the questionnaire,
information was available in 75/116 generations of SAHS
families compared to 92/140 generations in the control
families (p=0.9). The total number of family members
covered in 29 SAHS and 35 control families were 352 and
408 respectively. The average number of family members
covered in both the family types were similar (SAHS
families 12 SEM 0.5 vs control families 12 SEM 0.5;
p=0.8 ) .
Of a total of 10 deaths reported in SAHS families, 2 were
allegedly due to severe pneumonia and congenital heart
disease. One death was reported in a control family due
to rhesus incompatibility. Thus, there were 8 unexpected
and unexplained infant deaths in 6 SAHS families, and
none in the control families ( 8 infant deaths in 29 SAHS
families vs none in 35 control families, p<0.02). Looking
at the same data from another angle, 8 infant deaths were
reported out of 352 SAHS family members compared with
none out of 408 control family members (p<0.01).
Table 7.1 gives the known details about these 8 infants
for whom no cause of death was identified.
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Table 7.1 Details of unexpected infant deaths in SAHS
families
SAHS family 1. Male infant from single birth died
suddenly 6 days after birth. Mother was 27 at the time
of infant death, did not receive normal antenatal care,
was a current smoker, did not breast feed the infant and
did not take any unprescribed drugs during pregnancy.
SAHS family 2. Male infant of twin pregnancy died
suddenly 15 days after birth. Mother was 33 at the time
of infant death, breast fed the infant and did not take
any unprescribed drugs during pregnancy.
SAHS family 3. Male infant from single birth died
suddenly under one year age. Exact age at death and
other details unknown.
SAHS family 4. Male infant from single birth died
suddenly under one year of age. Mother was 38 at the
time of infant death, received normal antenatal care
during pregnancy and was a current smoker. Exact details
unknown.
SAHS family 5. Two female infants from two separate
single births both died suddenly within a few days after
birth. Mother was in her late thirties and was a current
smoker. No other details available.
SAHS family 6. Two twin infants of unknown sex both died
suddenly under one year of age. No other details
available.
149
Matched cephalometric data was available in 23 out of 38
relative-control pairs surveyed. Table 7.2 lists the
significant differences between these groups.
Table 7.2 Significant cephalometric differences between
adult members from 23 SAHS and 23 control families

















Abbreviations as explained in previous chapters
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Cephalometric data was available in 4 index subjects from
the 6 SAHS families reporting unexpected infant deaths in
and 4 matched index subjects from the control families.
The only cephalometric parameter significantly different
between these 4 SIDS families and control families was
the S-N-A angle (SIDS families 82 SEM 2 vs control
families 91 SEM 1 degrees; p=0.04).
Conclusions and Discussion
This part of the study suggests that there may be an
increased risk of unexpected infant death in families
having at least one adult with SAHS. It also showed
cephalometric differences (retropositioned maxilla)
between adult subjects in SAHS families having unexpected
infant deaths when compared to matched controls.
To avoid the likelihood of including possible ambigious
responses in the data, this study did not include cases
of near miss SIDS. These results however are compatible
with a preliminary report in which 6 cases of SIDS or
near miss SIDS were identified in 52 SAHS families as
compared to 1 instance of SIDS in 44 control families
(Ferrette V et al, 1992). In that study, retrognathia
tended to be more prominent in index SAHS patients from
SIDS families than in other members of the cohort.
Numerous previous studies have linked sudden infant death
with abnormal breathing during sleep. Kahn A et al,
1992, reported that SIDS infants have more numerous and
151
prolonged obstructive and mixed but not more central
apnoeas than control infants. SIDS infants have been
demonstrated to have fewer short central apnoeas than
controls and this difference between SIDS and control
infants has been found to exist during the second month
of life which is just before the period of maximal risk
for SIDS (Schechtman VL et al, 1991). Obstructive sleep
apnoeas in SIDS and near miss SIDS infants have been
associated with neuromuscular as well as with bony and
soft tissue abnormalities of the upper airways (Tonkins
S, 1975, Siebert JR et al, 1991) resulting in these
infants having smaller upper airways which could be
inherited (Guilleminault C et al, 1986b). As SIDS
infants, like adult SAHS patients, have abnormal
breathing during sleep, abnormal craniofacial
architecture and familial aggregation (Peterson DR et al,
1980, Oren J et al, 1987, Beal SM et al, 1988) it is
possible that SIDS and adult SAHS are different
manifestations of a common underlying abnormality which
expresses as narrowed upper airways. Upper airway
narrowing, due to inherited skeletal differences in the
facial anatomy, may then be responsible for abnormal
breathing during sleep in both conditions.
Other investigators have questioned the role of apnoea as
a common part of the initial sequence of events leading
to death or near death events in infants (Southall DP,
1988). Recording physiological signals during
unexplained near miss SIDS events in 77 infants and
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children, Samuels MP et al, 1993, identified different
mechanisms for these events. These included deliberate
suffocation by a parent, hypoxaemia induced by
convulsions, fabrication of history and data and severe
idiopathic hypoxaemia. Further analysis of the data by
Poets CF et al, 1993, confirmed prolonged severe
hypoxaemia of unknown cause as an initial step in many
such infants with subsequent and secondary bradycardia
and asphyxic apnoea.
As in any retrospective survey, the causes of death in
this study have been difficult to verify. Information
from autopsy, a prerequisite for the diagnosis of SIDS,
was not available in any case. The generations surveyed
sometimes went back to the turn of the century and very
limited, sketchy information was available. This long
time span inevitably led to the families forgetting
considerable information regarding the circumstances
surrounding these deaths. The problem is compounded by
the fact that often the immediate family members of the
infant in question are themselves now dead or unavailable
for confirmation of the event. The information in many
cases has simply been handed down the generations in the
family with the accompaning possibility of getting
distorted with the passage of time.
In order to obtain as much information as possible, the
families were asked to provide details of unexpected
infant deaths due to all causes. The three cases in whom
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the cause of death seemed reasonably certain were
excluded from the analysis. As the term "SIDS" came into
general usage and was agreed as an acceptable cause of
death only approximately 30 years back, it was
specifically not mentioned in the questionnaire which
simply enquired about unexpected infant deaths.
The vast majority of SIDS deaths occur between 2-6 months
of age (Froggat P et al, 1968). In some of the families
in this study, the infant deaths occured a few days after
birth and it may be argued that these may not be cases of
true 'SIDS7 . However 4% of the SIDS deaths occur under
one month of age (Beckwith JB, 1973). Furthermore even
if these deaths are not true SIDS, they are still
significant in their own right as no similar deaths were
reported by the control families whatsoever.
It was attempted to minimise the possible regional
geographical bias in this study by considering only those
families which came from Scotland. A bias from the
possible different socioeconomic status of the SAHS
versus control families was difficult to avoid. Though
the SAHS families were from all over Scotland and thereby
presumably encompassed all social classes, the index
control subjects were from relatively lower socioeconomic
strata (as judged by their residential postcode). This
would therefore bias against the positive results of this
study and make the findings even more remarkable.
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These results do not simply reflect increased fertility
rate or family size in SAHS as compared to control
families. The total number of family members covered in
the survey and the average number of members per family
were similar in both SAHS and control families.
Further studies are required to follow up SAHS families
on a long term prospective basis to determine the
incidence of unexpected infant deaths in these families.
Infants from SAHS families need to be studied by
polysomnography to find whether they have more abnormal
breathing during sleep than matched infants from control
families. Likewise, adult members of the families having
sudden infant death cases need to be studied to establish






The main finding of these family studies is that SAHS is
familial. The case control study shows that the first
degree relatives of non obese SAHS patients have more
sleep related symptoms, more abnormal breathing during
sleep, greater sleep disruption, different sleep
architecture and more oxygen desaturations during sleep
than the matched controls. In addition, the first
degree relatives of non obese SAHS patients have smaller
upper airways and a different craniofacial morphology
than matched controls. The studies further show a higher
incidence of sudden unexplained infant deaths in families
having adult members with SAHS as compared with control
families.
Limitations of the study
1. Exclusion criteria
In order to avoid restudying the familial nature of
obesity, relatives of only 'non obese' patients with SAHS
were studied. The direct methods of quantitating the
proportion of adipose tissue like body density, total
body potassium measurements and isotope dilution methods
are unsuitable for routine use. An indirect way of
estimating adiposity is skin fold thickness measurements
with triceps and subscapular skin folds being used most
commonly. The correlation between hydrostatic and skin
fold thickness body fat measurements has been found to be
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0.84 (Revicki DA et al, 1986). However, skinfold
thickness is not a totally relaible measure of obesity
because of considerable variation in fat deposits in
different body sites (McLaren DS et al, 1965). There is
also some question whether skinfold thickness is more
closely related to laboratory estimates of body fat mass
than combinations of weight and height (Dugdale AE et al,
1979). Moreover, the utility of skinfold thickness
measurements in large epidemiological studies remains to
be demonstrated.
For these reasons, because of its ease of use and
familiarity, body mass index (BMI) was used as an
estimate of body adiposity. Though both Quetelet index
ie, wt/ht2 (Quetelet LA, 1871) and Benn index ie, wt/ht?
(with the exponent value of p being regression
coefficient of weight on height x mean height/mean weight
of the sample; Benn RT, 1971) show similar correlation
with hydrostatic determination of body fat (0.7) and
correlate minimally with height and maximally with weight
(Revicki DA et al, 1986) only the Quetelet index was used
as BMI in these studies. However, BMI is not an ideal
measure of adiposity as it is unable to distinguish
between adiposity, muscularity and oedema.
The cutoff point of 30 kg/m2 was based on the
classification of obesity by Garrow JS, 1981, classifying
individuals of both sexes with a BMI (kg/m2) of 20-24.5
as normal, 25-29.9 as having grade 1 obesity, 30-40 as
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having grade 2 obesity and >40 as grade 3 obesity. These
grades are based on the relationship of obesity to
mortality which rises significantly with grade 2 obesity
onwards (Garrow JS, 1981). Garrow estimates that over 4%
of the British population has a BMI of over 30 kg/m2.
Six percent of adult males and 8% of adult females in
Britain were found to have a BMI of over 30 kg/m2 and
were classified in another study as obese (Rosenbaum S et
al, 1985).
Since the initial description (Whyte KF et al, 1989) of
about 85% of SAHS patients having a BMI of >30 kg/m2,
this syndrome has been increasingly recognised in the non
obese. This study found that less than half of the SAHS
patients had a BMI of >30 kg/m2 and therefore although
the conclusions from these studies cannot be extrapolated
to all SAHS patients, the familial factors found are
applicable to a significant proportion of SAHS patients.
2. Incomplete recruitment
In the case controlled study, not all the 91 relatives of
32 participating SAHS patients underwent sleep studies.
The main reason for this was financial as each relative
control pair having overnight sleep studies and related
investigations currently costs approximately £1000. Of
the 108 total relatives, the first 51 underwent sleep
studies and sleep questionnaire data was obtained on 91
(84%). The 51 relatives who underwent sleep studies were
no different in terms of any sleep symptom from the 40
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who were not sleep studied. Indeed, the 51 relatives who
had sleep studies were younger and consumed less alcohol
and fewer cigarettes and might therefore be expected to
show less abnormal breathing during sleep than the 40 who
were not studied.
Twenty four of these 40 unmatched relatives underwent
sleep studies and were found to have a similar breathing
pattern (median 11 A+H/hr of sleep) and arousals (median
34/hr of sleep) to the 51 matched relatives. Moreover,
there were no differences between these 24 and the 51
relatives in any of the acoustic reflectance measurements
or cephalometric results. One can therefore be confident
of the conclusions that the relatives of SAHS patients
have more sleep symptoms and more abnormal breathing
during sleep than their matched controls.
Sleep symptom questionnaire
The results of the questionnaire survey are consistent
with a previously reported symptom questionnaire study
(Redline S et al, 1992a) describing more daytime
sleepiness and apnoeas in relatives of patients with
SAHS. Sleep studies were not performed in that study and
SAHS patients were obese with a mean (SD) BMI of 37 (2)
kg/m2. However, the increased frequency of reported
witnessed apnoeas remained when adjustment was attempted
for the body mass of the relatives.
As in that study, a reporting bias in the sleep symptom
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questionnaire data due to the possibility of relatives
being more aware of symptoms than controls cannot be
excluded. However, this possible bias would not account
for the objective differences in sleep study and upper
airway measurement results obtained in this study.
Polysomnography
The sleep study results of this study are compatible with
a preliminary report that there is increased abnormal
breathing in the families of patients with SAHS (Redline
et al, 1992b). A limited sleep study was performed in
unselected SAHS patients and their first degree
relatives. Familial risk and black race were found to be
important determinants of abnormal breathing during sleep
in younger subjects with odds ratios of 10.8 and 10.3
respectively.
This study, in addition, reports normative data on sleep,
arousals and sleep related breathing disturbance in
different groups of control subjects.
Acoustic reflectance
Due to methodological difficulties, upper airway calibre
cannot be measured by acoustic reflectance through the
nasal route. As 50% patients have upper airway collapse
at the level of soft palate (Hudgel DW et al, 1988)
measurements of retropalatal areas is clearly important
and this region cannot be accessed via the oral route
used in this study.
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Cephalometry
The cephalometric analysis in this study indicate that
the relatives of thin SAHS patients have retroposed
maxillae and mandibles, shorter mandibles, longer soft
palates and wider uvulae than matched controls. All
these observed differences would predispose to upper
airway narrowing and SAHS patients have narrowed upper
airways even in the awake state (Schwab RJ et al, 1993).
Likewise differences in the gonion-gnathion-hyoid angle
between affected and unaffected relatives were found in
the pilot study indicating a lower positioned hyoid bone
in the affected relatives. This would predispose the
affected relatives to retroglossal airway narrowing.
Both these studies do not prove that the differences in
bony or soft tissue structures cause abnormal breathing
during sleep.
The soft tissue abnormalities observed could represent
the fundamental inherited defect in non obese SAHS
patients with abnormal breathing during sleep being a
consequence of this abnormal soft tissue pharyngeal
anatomy. A resection study (Stauffer JL et al, 1989)
demonstrated that the uvula in patients with SAHS
contains more muscle and fat than the uvula in control
subjects, possibly contributing to pharyngeal narrowing
in SAHS. This would support the notion that the
inherited and primary abnormality in SAHS patients may be
altered fat deposition in the upper airway. On the other
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hand, the increased muscle in the uvulae could represent
muscular hypertrophy in response to the increased
pharyngeal airflow resistance (Stauffer JL et al, 1989)
that is commonly seen in SAHS patients, both awake and
asleep. Sinilarily the uvular enlargement observed by
cephalometry may represent mucosal oedema secondary to
snoring induced vibratory trauma to the uvula (Cohn M et
al, 1986).
Like soft tissue abnormalities, the bony abnormalities
could also be a cause or consequence of abnormal
breathing during sleep. It has been demonstrated in
monkeys that prolonged experimental nasal occlusion
results in morphological changes in orofacial soft
tissues, facial skeleton and dental occlusion. An
increase in bony face height, increase in gonial angle,
steeper mandibular plane and downward displacement of
maxilla were commonly seen in such animals (Harvold EP et
al, 1981). Although these results from the animal model
cannot be directly extrapolated to our study due to
a different bony facial structure in humans, it is
plausible that facial remodelling can occur in humans as
a result of upper airway anatomical changes in infancy.
This study has also provided normative cephalometric data
relevant for upper airway measurements in both sexes in
British subjects. The only data in normal subject
comes from American (Cobin SE, 1955), Canadian (Popovich
F et al, 1977) and Japanese (Lowe AA et al, 1985) rather
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than from the British population and ethnic differences
in cephalometric data cannot be ignored (Angel JL, 1976,
Richardson ER, 1980).
Bhatia SN et al in 1993 published longitudinal
cephalometric growth data on subjects who participated in
a growth study between 1952-1993 at the King's College
School of Medicine and Dentistry, London. Although they
have described longitudinal profiles of cephaloraetric
variables for the subjects who developed normal
occlusion, all such data is in a sample of 15 male and 12
female subjects under 20 years of age. Moreover, the
bony cephalometric landmarks recorded in their series
exclude the hyoid bone so that no measurements to and
from the hyoid bone are possible and the soft tissue
landmarks do not include the tongue, posterior pharyngeal
wall or soft palate and therefore normative data on upper
airway soft tissue dimensions is missing. This is hardly
surprising as their aim was not to gather normative data
on upper airways but instead to establish base line
orthodontic data on normal growth changes.
Many of the cephalometric landmarks taken in the growth
study were different from the ones used in these family
studies on SAHS. Tables 8.1 and 8.2 compare the
normative cephalometric data from the growth study with
the corresponding data on controls from the present case
control study in both sexes. All the data from the
growth study is at 19 years of age in both sexes.
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Table 8.1 Some comparative cephalometric results in
normal men.
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PLANS FOR FUTURE STUDIES
These studies show that SAHS is familial but cannot
determine whether or not it is inherited. The studies
also show that first degree relatives of thin SAHS
patients have smaller upper airways and a different
craniofacial morphology than matched controls.
Relation between abnormal breathing during sleep and
abnormal craniofacial architecture
Though in the family studies described in this thesis
abnormal breathing during sleep was associated with
cephalometric abnormalities, no conclusions regarding
cause and effect can be made. This would need further
studies as demonstration of a subset of patients with
severe cephalometric abnormalities but mild abnormal
breathing during sleep would indicate abnormal breathing
to be a consequence of abnormal facial architecture.
Upper airway measurements
These family studies demonstrated that the relatives of
non obese SAHS patients have differences in soft tissues
of pharynx as compared to controls. Both the studies
showed a thicker soft palate in many relatives.
Cephalometry cannot, however, distinguish between
excessive fat, muscular tissue or oedema as the cause of
uvular enlargement. This issue can be resolved by
magnetic resonance imaging. Demonstration that the
thicker uvula in relatives of non obese SAHS patients as
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compared with controls is due to fatty infiltration would
indicate abnormal fat deposition as a primary inherited
abnormality in SAHS. Further studies are also required
to look for a difference in upper airway muscle function
between relatives and control subjects.
Genetic aspects of SAHS
The two family studies in patients with SAHS described
here are the very begining of a long and arduous journey.
These family studies have indicated a real possibility
that at least in some families SAHS may be inherited,
possibly in an autosomal dominant mode. The transmission
of SAHS from father to son seen in many families analysed
rules out an X linked mode of transmission (recessive or
dominant). The observation that over 30% of all first
degree relatives studied have abnormal breathing during
sleep makes an autosomal recessive mode of inheritance
less likely. This is because many apparently healthy new
spouses would have to be considered heterozygote carriers
of the abnormal gene to explain this high prevalance of
'affected' relatives. Taking the prevalance of SAHS as
1% of the population, the heterozygote frequency for any
SAHS gene in the normal population as per Hardy Weinberg
Law (Hardy GH, 1908, Weinberg W, 1908) would then be
approximately 20%. The presence of so many affected
relatives in these families makes multifactorial
inheritance less likely as well.
The problems are compounded by the diagnostic
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uncertainties in many relatives studied. Relatives with
A+H of less than 5 and more than 15 per hour of sleep are
probably truly unaffected and affected respectively but
those having 5-15 A+H/hr of sleep fall in a diagnostic
grey zone. The diagnostic uncertainty in such relatives
makes many families unsuitable for genetic analyses. The
variable age of onset is another problem. This implies
that those relatives, especially the younger ones, who
are presently unaffected may develop SAHS in future and
this weakens the power of many genetic analyses. Another
problem is disease heterogeneity, i.e., is SAHS one or
several disorders? Many of these issues need careful
consideration in planning future studies.
Various kinds of studies can be performed to further
explore the issue of the role of genetics in SAHS.
1. Biaaer family studies
For the reasons listed above many more families of non
obese SAHS patients need to be studied to arrive at
reasonable conclusions on the inheritance of SAHS. More
difficult, though possible, is the question of studying
more members of the same families already recruited to
increase the power of genetic studies. Showing a higher
incidence of abnormal breathing during sleep in the
second or even the third degree relatives of these SAHS
patients would add weight to the importance of genetic
factors.
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2. Demonstrating a higher frequency of abnormal breathing
during sleep in certain racial or ethnic groups and
showing that this higher frequency persists when the
group moves to a different environment would also support
the role of genetics in SAHS.
3. Twin studies
Demonstration of a greater concordance for abnormal
breathing during sleep in monozygotic twins as compared
with dizygotic twins would be an evidence of genetic
contribution to the disease. This is because differences
between members of a monozygous pair are entirely non
genetic in origin whereas differences between members of
a dizygous pair are due to a combination of genetic and
environmental influences. Despite many limitations, twin
studies are a valuable approach to the study of genetic
and environmental influences on disease.
4. Adoption studies
Demonstration that abnormal breathing during sleep is
more frequent among the biological parents of SAHS
patients than among their adoptive parents and that it is
equally prevalant among the biological and adoptive
parents of control subjects would support the role of
genetic factors in SAHS.
However these lines of investigation are at best
indicative of genetic predisposition to SAHS but give no
clues to the nature or number of genes involved.
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Molecular genetics techniques will need to be applied to
begin systematic searches of the genome for predisposing
genetic loci. These techniques are-
1. Genetic linkage studies
These studies need to demonstrate a linkage and hence the
genetic distance between a marker locus and the
presumptive locus for SAHS gene. These studies need
families having both affected and unaffected relatives
through at least two generations. The probability of
alleles at the marker locus cosegregating with the
alleles at presumptive SAHS locus because the loci are
close together on the same chromosome is compared to the
probability that this has happened by chance alone.
Affected sibling pair analysis is a robust screening tool
which makes no assumptions about the mode of inheritance
of SAHS. This would involve noting the concordance of
abnormal breathing during sleep and a marker system in
multiple sets of pairs of affected siblings.
No candidate gene(s) conferring suscepitibility to SAHS
has so far been identified. Although the inherited
defect in non obese SAHS patients may be a defective
craniofacial bony architecture, the genes coding for
facial structure are unknown and may probably be many.
This hampers the candidate gene linkage analysis. If
such a gene is identified in future and provided that
informative polymorphisms are found in or around it, its
cosegregation with SAHS can be tested. Absence of a
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candidate gene also makes mutation analysis impossible.
2. Genomic mismatch scanning
This procedure maps all the regions of identity by
descent (inherited from a common recent ancestor) between
two affected relative pairs and discards other family
members from the analysis. This method may be
particularly useful in SAHS as the penetrance of SAHS
allele may be age dependent. Determining where on the
genetic map a pair of affected relatives have inherited
identical sequences from a common source and combining
these identity by descent maps from multiple pairs of
similarly affected relatives can create a composite map.
This composite map can then be searched for loci where
genotypic concordance between affected relatives occur
more frequently than would be expected by chance. With a
sufficiently large number of affected relative pairs such
an analysis can reveal the position of genes that account
even for a slight fraction of susceptibility to SAHS.
3. Disease association studies
Though the association of SAHS with antigens of HLA
complex has already been reported from Japan, further
similar studies will confirm the association a particular
allelle with SAHS. This will be of practical value in
estimating the relative risk of developing SAHS in the
presence of a specific marker allelle.
The available data suggests that in Japanese population,
172
expressed as a relative risk, the antigen A-2 confers a
suscepitibility to the development of SAHS that is 6.4
times that in the general population. This HLA
association is particularly interesting as it is known
that genes of importance in skeletal growth and
development are located in the region of the major
histocompatibility complex (Carpenter CB, 1991).
Although association does not necessarily imply linkage
and despite a strong association the disease gene can be
present anywhere on the genome, it is logical to search
for any putative SAHS gene linked to the HLA locus
present on the short arm of chromosome 6. Alternatively
the association might be the result of linkage
disequlibrium with HLA-A2 locus genetically linked to as
yet undiscovered suscepitibility locus.
It is hoped that understanding SAHS at a molecular
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LIST OF ABBREVIATIONS
A+H: Apnoeas plus Hypopnoeas(/hr: per hour of sleep)
Aat: Anterior tubercle of atlas
ADC: Analogue to Digital Converter
ANS: Anterior Nasal Spine
APA: Average Pharyngeal Area
Ar: Articulare
Ba: Basion
BMI: Body mass Index
CI: Confidence Interval
C02: Carbon di oxide
CPAP: Continuous Positive Airway Pressure
CV: Coefficient of Variation
DAC: Digital to Analogue Converter
Desats: Oxyhemoglobin Desaturations
FRC: Functional Residual Capacity




HLA: Human Leucocyte Antigen
MP: Mandibular Plane
MPA: Maximum Pharyngeal Area
MRI: Magnetic Resonance Imaging
N: Nasion
NREM: Non Rapid Eye Movement Sleep
02: Oxygen
OPJ: Oropharyngeal Junction and its cross sectional
area
Pa: Pascal
PAS: Posterior Air Space
PhW: Posterior pharyngeal wall
PNS: Posterior Nasal Spine
PV: Pharyngeal Volume
REM: Rapid Eye Movement Sleep
REM LAT: REM sleep Onset latency
S: Sella turcica
SAHS: Sleep Apnoea/Hypopnoea Syndrome
Sa02: Arterial Oxygen Saturation
SD: Standard Deviation
SEI: Sleep Efficiency Index
SEM: Standard Error of the Mean
SIDS: Sudden Infant Death Syndrome
SOL: Sleep Onset Latency
SPT: Sleep Period Time
TB: Tongue Base
TIB: Time in Bed









Tables 1 to 25 in this section list selected raw data.
The full original data, especially on sleep symptom
questionnaire , polysomnography and cephalometry results,
is too exhaustive to be given in its entirety.
Throughout the tables the age is in years, BMI in kg/m2
and collar size is in cm. Polysomnographic variables
like TST, SPT and REM LAT are in minutes. AHI is the
number of apnoeas plus hypopnoeas per hour of sleep.
Sleep efficiency index and lowest saturations are
expressed as percentage.
Arousals throughout the pilot study and in table 8 are as
per Cheshire et al, 1992. The arousal data in tables 10
and 15 is as per different definitions which are fully
explained in the main text.
R2%, R3 %, R4%, C2%, C3% and C4% (table 21) refer to the
appropriate oxyhemoglobin desaturation data in relatives
and controls.
For most questionnaire data "Y" refers to Yes, "N" to No
and "NR" to Not Recorded. Alcohol consumption is in
units of absolute alcohol per week. Current cigarette
smokers are listed as "C", ex smokers as "EX" and
subjects who never smoked as "N" under the appropriate
headings. EDS refers to excessive daytime sleepiness.
Cephalometric distances are in mm, angles in degrees.
Acoustic reflectance areas are in cm2 and pharyngeal
volume in cm3.
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Table 1: Derails of index SAHS patients in pilot study
PATIENT AGE SEX BMI
D McFadyen 37.00 M 28.89
0 Docherty 47.00 M 29 . 52
J 0'Boyle 56.00 M 27.00
A Johnston 52 . 00 M 26 . 35
T Black 33 .00 M 24 .18
D Birse 52.00 M 27.62
G Steele 45.00 M 28. 30
A Kempsley 48 . 00 M 29.02
J McLeod 73.00 M 25. 69
G Rattray 51.00 M 24 .43
P Hocken 52.00 M 29.20
W Gosling 59.00 M 27.70
D Muirhead 56 . 00 M 26 . 23
P O'Hagan 62 . 00 M 28 . 89
M Renwick 70.00 F 28 . 56
W Dickson 54 . 00 M 27.77
N Cuthill 48 . 00 F 26 . 63
W Mabberley 66 . 00 M 26.74
o Smart 61 . 00 F 26 . 56
K Laycock 69 . 00 M 25. 64
AHI AROUSALS COLLAR SIZE
27.90 25.90 41. 91
55. 70 25.80 43 .18
70.00 16 . 20 40.64
50 . 20 11. 90 39 . 37
32.00 20.00 39. 37
58. 10 32 . 30 39 . 37
50.50 24 . 80 41. 91
20.40 10 . 00 40.64
57.40 18 . 60 40.64
31.00 10 . 50 39.37
55. 30 20 . 90 43 .18
16 . 50 10 . 50 41.91
16 . 60 10 . 00 40 . 64
45.40 13 . 60 44 . 45
26.50 9. 80
76 . 20 20 . 30 39 . 37
17.80 30 . 30
58 . 00 27.00 39 . 37
17 .00 21.70
17 . 00 28 .10 43 .18
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Table 2: Index SAHS patients providing relatives for pilot study
PATIENT AGE SEX BMI AHI AROUSALS COLLAR S
D McFadyen 37.00 M 28.89 27.90 25.90 41.91
0 Docherty 47 . 00 M 29.52 55. 70 25.80 43 .18
J O'Boyle 56.00 M 27.00 70.00 16.20 40.64
A Johnston 52.00 M 26.35 50.20 11.90 39 .37
T Black 33 . 00 M 24 .18 32.00 20.00 39 .37
D Birse 52 . 00 M 27.62 58.10 32. 30 39 . 37
G Steele 45.00 M 28 . 30 50.50 24 . 80 41.91
A Kempsley 48.00 M 29.02 20.40 10.00 40.64
J McLeod 73 . 00 M 25.69 57.40 18 . 60 40.64
G Rattray 51. 00 M 24.43 31.00 10.50 39 . 37
P Hocken 52.00 M 29.20 55. 30 20.90 43 .18
W Gosling 59.00 M 27.70 16.50 10.50 41.91
D Muirhead 56 .00 M 26.23 16.60 10.00 40.64
P 0'Hagan 62 . 00 M 28.89 45.40 13.60 44.4 5
M Renwick 70 . 00 F 28.56 26.50 9.80
W Dickson 54 . 00 M 27.77 76 . 20 20.30 39.37
N Cuthill 48 . 00 F 26 .63 17.80 30. 30
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Table 3: Selected data-unaffected relatives, pilot study
RELATIVE AGE BMI TST SE% AROUSAL/H AHI MIN SAT
G BLACK 22 23 .65 309 . 2 78 5.8 3.7 74
V BLACK 32 21. 38 343 . 7 83 0.9 84
C MCCABE 28 22 . 2 414.5 94.6 CO•CO 4.2 90
A HOCKEN 26 25.56 413 . 3 94 3.7 92
N RATTRAY 22 22 .18 343 .9 7 .1 94
P RATTRAY 23 20.31 392 . 3 9 0.6 86
G KEMPSLE 25 20 370.3 9.5 0.6 85
N KEMPSLE 26 26.57 363 . 3 12.9 6.3 80
M WEIR 60 24 . 42 384.1 10 . 9 2.5 85
H DUFFY 32 25.42 349.6 6 . 2 93
J CLARK 41 23.72 392.1 10.6 3 . 2 95
P SNAITH 43 24.25 420.4 96 7 80
E SUTHERL 30 30.2 269.8 22 80
H WALKLIN 27 27.85 328.3 9 . 3 1. 8 87
J ROBINSO 42 27.8 336 . 3 79 1.9 4.7 91
A FISHER 42 24 . 06 369 89 7.5 8.7 86
J STEELE 21 22 . 28 334 . 6 79 5.5 2 89
D JOHNSTO 25 21. 41 322 .1 88 6.3 5.7 91
L JOHNSTO 21 23.53 388.8 92 5.1 0.92 89
D MCFADYE 67 36.67 352 . 9 86 . 6 7.3 11.1 69
J MCFADYE 39 22.22 387.1 94 4 . 3 1. 4 86
M TELFORD 39 19.4 279 64 6.7 2.8 95
A HENDERS 44 23 . 25 286.5 77 6.5 0.2 90
J 0'HAGAN 33 19.71 347.1 15.6 1.2 90
M 0'HAGAN 29 26.17 351 11.1 7.35 90
A WOOD 30 18.65 342.7 77 6 . 3 0 95
G BIRSE 33 22.22 283 . 2 8.1 1.48 90
S GOSLING 19 28 . 24 320.9 15.9 80
L GOSLING 28 24.38 201.1 17.9 85
E GOSLING 55 35.16 7.6 77
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Table 4: Selected data-affected relatives, pilot study
RELATIVE AGEAFF BMIAFF TST SE% AROUSAL/H AH I LOW SAT
T BLACK 57 28.86 293 . 8 89 6.5 16.8 75
B RATTRAY 48 25.87 338.7 84.3 23.6 20 78
I MCLEOD 43 28.86 370.9 80.4 16.7 18.9 81
J MCLEOD 58 27.47 352 51.7 45.4 25.9 71
K DICKSON 50 31.12 239. 3 76 15.7 29.6 82
I RENWICK 40 24.93 325.1 90 7.7 22.7 90
SUS 0'BOYLE 28 30.74 385.5 93 11. 2 19.5 88
SEAN 0'BOYLE 26 21.29 340.6 74 13 15.6 85
A 0'HAGAN 28 25.62 277.2 79 8 . 2 18 . 2 85
D GOSLING 58 29.02 357.3 73 . 3 30.8 77
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TABLE 5: Selected questionnaire data-pilot study rel.
RELATIVE TYPE BEDPARTNERS APNEAS SNORING
G BLACK UNAFF Y N N
V BLACK UNAFF N N N
C MCCABE UNAFF Y N N
A HOCKEN UNAFF Y N N
N RATTRAY UNAFF N N N
P RATTRAY UNAFF N NR N
G KEMPSLEY UNAFF Y N N
N KEMPSLEY UNAFF Y N N
M WEIR UNAFF N NR Y
H DUFFY UNAFF Y N N
J CLARK UNAFF N NR N
P SNAITH UNAFF Y N N
E SUTHERLAND UNAFF Y N N
H WALKLINGSHAW UNAFF Y N N
J ROBINSON UNAFF Y N N
A FISHER UNAFF Y N N
J STEELE UNAFF N NR N
D JOHNSTON UNAFF N NR N
L JOHNSTON UNAFF N NR N
D MCFADYEN UNAFF Y N Y
J MCFADYEN UNAFF Y N Y
M TELFORD UNAFF Y N N
A HENDERSON UNAFF Y N Y
J 0'HAGAN UNAFF Y N N
M 0'HAGAN UNAFF Y N Y
A WOOD UNAFF Y N N
G BIRSE UNAFF Y N N
S GOSLING UNAFF Y N N
L GOSLING UNAFF Y N N
E GOSLING UNAFF N NR N
T BLACK AFF Y Y Y
B RATTRAY AFF Y Y Y
I MCLEOD AFF Y Y N
J MCLEOD AFF Y N Y
K DICKSON AFF Y N Y
I RENWICK AFF Y Y Y
SUS 0'BOYLE AFF N NR Y
SEAN 0'BOYLE AFF N NR NR
A 0'HAGAN AFF N N Y
D GOSLING AFF Y Y Y
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Table 6: Sig. cephalometrics-supine posture, pilot study
UNAFF REL Go-Gn-H AFF REL Go-Gn-H
E GOSLING 35.00 SEAN O'BOYLE 28.00
P SNAITH 19 . 00 SUS 0'BOYLE 28.00
A WOOD 28 . 00 K DICKSON 27 .00
S GOSLING 15 . 00 A O'HAGEN 34.00
L GOSLING 18 . 00 I RENWICK 26.00
M 0'HAGAN 27.00 T BLACK
J 0'HAGAN 13 . 00 J MCLEOD 43 .00
V BLACK 19 . 00 I MCLEOD
J STEEL 11 . 00 B RATTRAY 27 . 00
M TELFORD 23 . 00 D GOSLING 30.00
L JOHNSTON 15.00
G BLACK 16.00
D JOHNSTON 19 . 00
M WEIR 23 . 00
A HENDERSON 19 . 00
H WILKINSHAW 18 . 00
E SUTHERLAND 14 . 00
H DUFFY 16 . 00
J CLARK 27.00
N RATTRAY 21 . 00
A HOCKEN 22 . 00
C MCCABE 26 . 00
A FISHER 25.00
J MCFAYDEN 22 . 00
J ROBINSON 15 . 00
N KEMPSLEY 28 . 00
G KEMPSLEY 23 . 00
G BIRSE 27 . 00
P RATTRAY 31 . 00
D MCFAYDEN 24 . 00
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Table 7: Sig. cephalometrics-erect posture, pilot study
UNAFF REL





M O'HAGAN 8 .
J O'HAGAN 7.




G BLACK 8 .
D JOHNSTON 9 .
M WEIR 13 .
A HENDERSON 10 .
H WILKINSHAW 8 .
E SUTHERLAND 13 .
H DUFFY 12 .
J CLARK 12 .
N RATTRAY 12 .
A HOCKEN 5.
C MCCABE 9 .
A FISHER 13 .
J MCFAYDEN 10 .
J ROBINSON 9 .
N KEMPSLEY 13 .
G KEMPSLEY 12 .
G BIRSE 10 .
P RATTRAY 11 .











































Table 8: Details of index SAHS patients-case control study
PATIENT AGE SEX BMI AHI AROUSAL/H
I AITKEN 52 M 28 32 41
D FAIRWEATHER 68 M 23 32 140
J LAFFERTY 48 M 25 53 30
R DEMPSTER 61 M 27 33
AI NAPLES 52 F 21 31
C SILLET 42 M 26 44 18
J WILLIAMS 53 M 26 34 20
D ORROCK 61 M 29 72 48
G TAYLOR 61 M 26 28 19
C IRELAND 65 M 28 105 13
I NICHOLSON 57 M 26 53 56
R SIMPSON 57 M 27 16 36
H KERR 50 M 29 27 21
J IMRAY 59 M 29 25 22
G STEEL 45 M 28 51 25
J 0'BOYLE 56 M 26 70
A MILROY 63 M 26 76 55
W HAINING 66 M 26 24 53
M BRUNTON 34 M 24 23 25
T HAY 28 M 27 57 62
P McCONACHIE 40 M 24 20 28
C MACKAY 55 M 26 35 38
R DOCHERTY 46 M 27 20 22
D WARD 39 M 29 42 48
T HAWKINS 68 M 25 76 76
e Mcdonald 71 F 29 57 89
J MUNCIE 58 M 27 32 35
D GRAY 40 M 30 19 51
S PAXTON 57 M 23 42 92
A GALL 64 M 25 120 94
H ARMOUR 49 M 26 36 64
D HEWITT 63 M 25 47 74
G BONNAR 64 M 25 65 65
A GREENAN 53 M 24 18 30
I PETTIGREW 37 M 29 19 45
R STARK 49 M 28 37 42
J McARTHUR 44 M 23 30 53
F WILSON 52 M 30 15
A CHOPRA 33 M 26 73 87
D KELL 46 M 27 48 36
C HOPKIN 38 M 23 23 44
I SELF 45 M 30 33 49
C BARLOW 48 M 24 28 29
R SMITH 50 M 28 76
A HAMILTON 41 M 27 18 25
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TABLE 9: Questionnaire data-case control study relatives
RELATIVE SEX AGE SMOKE ALCOH CHOK BEDPART APNEAS SNORING EDS
JD HAMILTON M 51 C 13 N Y N Y N
B COLLINS F 58 N 2 N N NR N N
J SCHOFIELD F 27 N 8 N Y N N N
A IRONS F 21 N 1 N Y N N Y
S FAIRWEATHER F 28 EX 7 N N N N Y
DR. A IRELAND M 68 EX 6 N Y N N N
D BOLAN F 54 C 5 N Y N Y Y
D SIMPSON M 45 C 13 Y N Y Y Y
A AITKEN M 21 N 20 N Y N N Y
S WILLIAMS F 24 N 1 N N NR Y N
D SILLET M 41 N 17 N Y N Y Y
J SPOWART F 30 N 1 N Y N N N
L IRELAND M 33 EX 9 N Y N N N
Crg IRELAND M 20 N 0 N N NR N N
K LAFFERTY F 20 N 0 N N NR N Y
G AITKEN M 21 N 20 N N NR N Y
B CAMPBELL M 25 N 8 N Y N N N
F FAIRWEATHER F 32 C 5 Y Y N N Y
D TAYLOR F 50 C 13 N Y N N N
I TAYLOR M 52 N 20 N Y N N N
Col IRELAND M 36 EX 5 Y Y N N Y
Char IRELAND M 62 EX 6 . 5 N N NR NR N
S WILSON F 31 N 3 N Y N N Y
B ORROCK M 28 C 8 N Y N N Y
GW IRELAND M 65 EX 22 . 5 N Y N N Y
E MELLON F 48 C 50 N Y N Y Y
GH KERR M 24 N 3 Y Y N N Y
M STEELE M 22 C 20 N N NR N Y
E IMRAY F 22 N 14 N N NR N Y
A WOOD F 45 C 7 N Y NR Y Y
J GALL F 31 N 4 N Y N N Y
JE MUNCIE M 16 N 0 N N NR Y N
M McCONACHIE M 44 C 28 Y N NR Y N
A IRELAND M 28 N 6 N Y N N Y
S AITKEN F 18 N 0 N N NR N N
JA BOGIE M 46 C 0 N Y N Y N
C BRUNTON M 39 EX 20 N Y N N Y
D MILROY M 29 N 12 Y Y Y Y Y
C McMICHAEL F 32 EX 0 Y Y N N N
D McCONACHIE M 43 N 24 N N NR Y N
K MOUNTAIN F 43 N N Y N Y Y
R HAY M 31 C 27 Y Y N Y Y
K MUIR F 33 N 1 N Y N Y N
S WALKER F 28 N 4 N Y N N Y
S PAXTON M 28 EX 4 N Y N Y Y
M McCAULEY F 33 N 8 N Y N N N
S PIGGOT F 30 C 2 N Y N Y Y
e Mclaughlin F 34 N 5 N Y N N Y
D WARD M 41 C N Y N Y Y
J HAWKINS M 73 EX 0 N NR NR Y Y
P TINDALL F 44 N 2 N Y N Y N
D PAXTON M 31 EX 6 N Y N N N
J PRYOR F 39 N 14 N Y N n Y
J DOCHERTY M 40 C 12 N Y N N Y
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TABLE 9: continued...
C KERR M 54 N
M FRIEL F 56 EX
Rob SELF M 20 N
M TAIT F 59 N
J HEWITT M 30 N
RK SELF M 52 C
MG BOGIE F 74 N
H CAMPBELL F 29 C
A PETTIGREW F 62 C
T PETTIGREW M 65 C
N STARK M 20 C
V WATSON F 50 EX
C JOHNSTON F 38 N
Mag BROWN F 49 EX
M HIGHLEY F 47 N
H ARMOUR F 18 N
S ARMOUR M 22 N
T GREENAN M 46 C
J GREENAN M 55 C
T WARD M 44 C
J STARK F 17 C
S CRAWFORD F 39 N
G HAMILTON M 37 C
H DOCHERTY M 37 C
J NICHOLSON F 28 C
J IRELAND M 63 N
K HOPKIN M 68 C
J HOPKIN F 64 C
S CZABANIUK F 32 C
G BRUNTON M 48 C
J DOCHERTY M C
MJ GREENAN M 29 N
M McCALLUM F 40 C
R WARD M 51 C
R HARGIE F 37 c
M LIDDON F 33 N
M JEPHSON F 60 C
N PARKES F 73 N
E WARD F 78 N
C WILSON F 76 EX
E DOCHERTY F C
S CHOPRA M 44 N
M GALL F 68 EX
J MCGREGOR F 44 EX
R KERR F 17 N
W IMRAY M 51 EX
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Y Y Y Y Y
N Y N N Y
N N NR Y Y
N Y N N Y
N Y N Y Y
N Y Y Y Y
N Y N Y Y
N N NR Y Y
N Y N Y N
N Y Y Y N
N Y N Y N
N Y N Y Y
N Y N N N
N Y N N N
N NR N NR Y
N N N N N
N N NR N N
N Y N N N
N Y N Y Y
Y Y Y Y Y
N N NR Y Y
N Y N N N
N Y N Y Y
N Y N Y N
N Y N N N
N Y N N N
N Y N N N
N Y N N N
N Y N N N
N Y Y Y Y
N Y N N N
N Y N Y N
N Y N N Y
N Y N N Y
N Y N Y N
N Y N Y N
N N NR N Y
N Y N N N
N N NR NR N
N N NR NR N
N N NR NR Y
Y Y Y Y Y
N N NR NR Y
Y N NR NR N
N N NR NR N
























































































































































































































J GREENAN M 55 27.28 325.7 78.1 8.48 41.80
E MELLON F 48 31.44 306.9 70.6 7 .43 26 . 28
MG BOGIE F 74 29 . 76 256. 2 59.6 25.29 52 . 64
M FRIEL F 56 29. 21 279 . 9 68 . 3 22.94 51. 80
D PAXTON M 31 26.03 290 . 2 63 . 9 15.92 48 . 47
C JOHNSTON F 38 23 . 34 365.2 85.9 7.72 22.78
RK SELF M 52 23 . 85 261 .0 60.4 28.05 34 . 67
A IRELAND M 28 33.74 406 .1 97.2 6.65 23. 29
F FAIRWEATHER F 32 353 . 4 88 . 8 2 . 89 24 . 38
C BRUNTON M 39 26.72 379.3 88.6 9.65 26.17
E MCLAUGHLIN F 34 28.79 377.1 88 . 5 8.75 29 .10
V WATSON F 50 33.65 370 . 8 89 . 3 12.78 33 . 05
J HAMILTON M 51 25.75 239.5 61.9 20.80 43 . 49
G HAMILTON M 37 27.17 335.5 74 . 9 16.27 36.08
T WARD M 44 28.67 352 . 0 86.3 10.74 35. 41
C IRELAND M 62 24.75 242 .1 55.7 11. 65 52 . 68
M HIGHLEY F 47 25.72 351. 2 79.5 11. 96 26 . 87
H CAMPBELL F 29 29.17 411. 2 95.4 24 . 95 29 . 35
T GREENAN M 46 27.87 353 . 6 84.2 9.67 24 . 65
B CAMPBELL M 25 24.45 346.1 83 . 6 5.55 30. 46
CRG IRELAND M 20 24.61 360 . 0 84 .9 4 . 33 22 . 93
J GALL F 31 24 . 67 354 . 7 82 . 5 2.71 21.96
J PRYOR F 39 21.93 416.2 95.5 3 . 32 20 . 25
DR A IRELAND M 68 26.41 87 . 5 20.4 2 . 06 34 . 89
L IRELAND M 33 25.60 338 . 3 74 . 4 9.58 38. 12
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3 . 30 1.70
6.20 3 . 70
0. 30 0 . 30
0.90 0. 30






4 . 60 2 . 50
0 . 60 0.30
0.80 0.50




0.10 0 . 00
0.20 0.00
2 .10 1. 50































Table 12: Anthropometric data-all control subjects
CTRLS SEX AGE BMI
A.BELL F 64 . 00 25.04
E BRYSON F 32.00 21. 22
C COLEY F 23 .00 22 .10
A DARBYSHIRE F 30.00 20 . 53
C.HARKESS M 23 . 00 31.60
G.BAIRD M 22 .00 20.45
SA.BAIRD F 25.00 18.52
D BARRIE M 37.00 25.43
C BARLEE F 28 . 00 23 . 53
HM ARNOT M 30.00 24 . 07
S ARTHUR M 30 . 00 23 . 30
J ARKLEY F 20 . 00 21.91
Y AITKEN F 26.00 26.67
G BEAN M 23 . 00 22 .16
S HOOI M 25 . 00 24 . 30
R BURGASS M 32.00 22 . 22
M BROWN F 57.00 20.07
R BROWN M 58 . 00 29.75
N CLARK M 31. 00 32.70
J ABERDOUR M 34 . 00 23 .12
R AITKEN M 58 . 00 25 . 50
A1 BROWN F 29 . 00 27.90
Ang BROWN M 28 . 00 22 .16
Ed BURGASS F 34 .00 21 .48
Y CAMERON F 23 . 00 28 . 34
k Mckenzie M 51. 00 28 . 48
P CADDICK M 29.00 21 .33
R DONAGHUE M 52 . 00 29.09
H ENGLEMAN F 30 . 00 21.83
K STEDUL F 26 . 00 22 . 80
C LEITH F 23.00 23 .51
MD COOPER F 29 . 00 20.57
G CLABBIE M 70.00 27.94
M BRICKELL M 30.00 22.72
G BOYD F 26.00 21.34
I LAURIE F 42 . 00 23 .92
D SKUDLAERK M 30.00 23 .15
A BOWMAN M 34.00 22.40
C HOY M 17.00 21.56
J.DEAS M 63 . 00 27.43
J BURNS F 23 . 00 24.98
K BOYD M 29 . 00 23 .10
W BEIRNE M 71. 00 22.10
L CHEYNE F 33 .00 21. 45
Y BOWMAN F 34.00 30.09
S CONNOLLY F 35.00 22.66
J DALEY F 64.00 24 . 59
K CLYNE F 44 . 00 22.50
R DEWES M 24 . 00 25.14
G CHRISTIE F 24.00 23.08
S BERNARD M 27.00 27 . 78
D ARMET M 44 . 00 24.57
M CONNOLLY M 61.00 26 . 51
G ASPINALL M 66.00 28.70
A BERRY M 67.00 34.96
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Table 13: Selected questionnaire data on controls
SUBJECT SMOKE ALCOHL CHOKE BEDPART APNEAS SNORING El
M CONNOLLY C 10 N N N Y N
D ARMET EX 5 N Y N Y N
G ASPINALL C 9 N N N Y N
A BELL N 9 N N NR N N
E BRYSON N 15 N Y N N N
C COLEY N 8 N N N N Y
A DARBYSHIRE N 1 N Y N N N
J DEAS EX 19 N N NR NR N
J DALEY EX 23 N N NR N N
C HARKESS N 0 N N NR N N
G BAIRD N 8 N Y N N Y
SA BAIRD N 4 N Y N N N
D BARRIE EX 14 N Y N N N
C BARLEE N 1 N Y N N N
HM ARNOT C 30 N Y N N Y
S ARTHUR C 0 N Y N N N
A BERRY EX 12 N Y N N N
J ABERDOUR N 12 N Y N Y N
C HOY N 0 N N NR N N
S BERNARD N 6 N Y N N Y
J ARKLEY C 6 N Y N N N
Ang BROWN EX 8 N Y N Y N
Alice BROWN N 10 N Y N Y Y
P CADDICK N 0 N Y N N Y
Edith BURGASS N 2 N Y N N N
M BROWN N 0 N Y N N N
G BEAN N 26 N Y N Y Y
Y AITKEN C N N NR NR N
R BROWN EX 17 N Y Y Y N
S HOOI N 0 N N N NR N
Y BOWMAN N 2 N Y N N Y
R BURGASS N 8 N Y N N N
M BRICKELL N 12 N Y N N N
A BOWMAN N 4 N Y N N N
R DONAGHUE N 16 N Y Y Y N
J BURNS N 0 Y N NR N Y
Y CAMERON N 3 N Y N N N
G CLABBIE C 22 N Y N N N
K BOYD N 12 N Y N N Y
W BEIRNE EX 0 N N NR N N
R AITKEN N 1 N Y N N Y
G BOYD N 3 N Y N N N
D SZKUDLAREK EX 0 N N NR N N
I LAURIE EX 2 . 5 N Y N Y n
K STEDUL n 7 N N NR N Y
H ENGLEMAN C 5 N Y n N N
R DEWES N 26 N Y N N Y
N CLARK N 4 . 5 N Y N N N
C LEITH C 19 N Y N n N
k Mckenzie EX 6 N Y N N Y
Dr MD COOPER N 3 N N NR n n
S CONNOLLY C 2 n Y n n n
K CLYNE N 0 N Y n n Y
L CHEYNE n 6 N Y n n Y
G CHRISTIE EX 10 N Y n n n
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Table 14: Selected polysomnographic data on controls
CONTROL TST SOL REMLat SE% AHI
A BELL 190.90 69. 20 123.00 46.00 2 . 20
E BRYSON 340.10 26.00 130.20 86.50 0.90
C COLEY 274.70 22. 30 121.90 61.90 0.00
A DARBYSHIRE 357.40 16 . 70 99.00 85.70 1.50
C HARKESS 201.80 27. 20 310.20 51.70 1.20
G BAIRD 366.80 15. 20 80.70 84 . 90 0.70
SA BAIRD 286.90 6.80 285.00 74.00 7.70
D BARRIE 325.50 35.60 96.00 78.80 2. 40
C BARLEE 321.30 22.70 38.60 74.40 2. 80
S ARTHUR 328.60 11.10 120.30 75.70 2.90
J ARKLEY 369.90 47.50 81.10 85 . 80 5. 20
Y AITKEN 355.80 22.70 131.40 92 . 20 2.90
G BEAN 377.10 27.10 69.70 83 . 20 14. 20
S HOOI 327.40 19.10 91. 30 76. 30 11.00
R BURGASS 402.10 19. 20 68.00 91.60 3.90
M BROWN 358.90 30.80 178.50 81.70 7. 20
R BROWN 335.40 14.70 139.80 76.40 13.20
N CLARK 407.90 3 . 90 81. 50 93 . 80 5. 88
J ABERDOUR 365.20 6.60 72.00 92.70 2.60
R AITKEN 361.40 4.40 98.70 84 . 20 34.20
A1 BROWN 353.40 17. 50 53 . 40 90.60 5.40
Ang BROWN 341.80 39.10 128.30 76.50 8.10
Ed BURGASS 106.40 100.30 354.90 23.30 1.70
Y CAMERON 338.00 15.60 131.50 78.80 6. 00
k Mckenzie 434.60 1.00 52.80 95.30 12.29
P CADDICK 368.30 11.30 154.80 94.00 3 . 90
R DONAGHUE 386.70 8.30 121.20 91.60 8. 30
H ENGLEMAN 390.10 17.90 134.40 93 . 30 6. 77
K STEDUL 358.50 23 . 40 84 . 30 83.80 1.68
C LEITH 391.20 9.70 120.60 93 .10 2.76
MD COOPER 328.90 48. 30 113.90 74.90 4.38
G CLABBIE 313.50 10.20 78 . 10 73.80 64.11
M BRICKELL 315.80 6.80 258.70 74.00 2. 30
G BOYD 423.20 8.60 96 . 60 96.00 4.82
I LAURIE 395.10 13.00 80.80 92.30 7.14
D SKUDLAERK 378.70 30.90 68.60 86.30 1. 58
A BOWMAN 350.50 48.50 117.90 81.50 4.79
C HOY 399.50 23 . 40 173.80 89.00 5.55
J DEAS 93 .70 15.20 192.20 22.50 14.70
J BURNS 318.10 22.50 66 . 50 71.80 14. 30
K BOYD 399.70 25.10 183.60 80.30 0.10
W BEIRNE 186.40 18.60 85.40 44.60 5.78
L CHEYNE 279.10 26. 00 297.50 62.70 1.07
Y BOWMAN 355.10 11.70 63.60 94 . 20 1.01
S CONNOLLY 250.00 80.40 101.00 59.50 14 .16
J DALEY 103.20 5.30 76.00 46 . 40 3.30
HM ARNOT 391.60 13.40 76.80 91.70 4.00
K CLYNE 385.20 16.50 121.50 90.40 9. 35
R DEWES 408.90 4.10 111.30 93 . 60 1.17
G CHRISTIE 400.40 15.60 72.40 94 . 20 3.60
S BERNARD 392.90 8.40 137.20 93.10 0.50
D ARMET 406.40 10.30 98.60 92.60 5.40
M CONNOLLY 308.00 30. 60 96. 70 83 .10 7. 40
G ASPINALL 310.70 25. 00 120.20 85. 30 5.80
A BERRY 363.70 28. 90 110.00 83.00 4. 90
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R BURGASS 14 . 66
M BROWN 25.74














MD COOPER 26 .63
M BRICKELL 15.58



















G CLABBIE 63 .13




CHESHIRE AR ASDA AR
10. 20 31.93
11 . 35 21.03
23 . 80 25.42
9 . 30 23.35




14 . 60 14.06
7.60 12.17
6 . 90 11.47
22 . 90 24.18
11 . 20 10.08
9 . 80 10.45
21. 90 28.92
21 . 50 30.41
7.07 12.14
29 . 70 43.87
23 . 91 36.86
8. 20 12. 22
8.80 19. 31
38 . 30 47.47
10.80 14.85
19 . 47 19. 33
8.80 15.07
10 . 20 11.95
6.61 13.23
18 . 41 20.92
5. 37 13.50
9 . 49 25.72
14 . 60 16.15
9 . 36 12.62




13 . 20 21.40
8 . 10 12.73
5 .16 23.86
7. 26 16. 22
12 . 24 18.72
12 . 20 16.21
8 . 25 7.17
10 . 56 14.82
5.40 8.09
5 . 00 9.77
13 . 40 21. 39
8.80 23.65
20.00 38.37
17 . 36 23 .18
66.60 61.73










































































































































































































































































Table 17: BMI and age of matched pairs-case control study
RELATIVES RAGE RBMI CTRLS CAGE CBMI
B.COLLINS 58.00 24.97 A.BELL 64.00 25.04
J.SCHOFIELD 27.00 22.59 E BRYSON 32.00 21.22
A.IRONS 21.00 23 . 93 C COLEY 23 .00 22 . 10
S.FAIRWEATHER 28.00 23.42 A DARBYSHIRE 30.00 20 .53
D.SIMPSON 45.00 21.33 C.HARKESS 23 .00 31 .60
A.AITKEN 21.00 22.16 G.BAIRD 22.00 20 .45
S.WILLIAMS 24.00 19.44 SA.BAIRD 25.00 18 .52
D.SILLET 41.00 26.73 D BARRIE 37.00 25.43
J SPOWART 30.00 25.14 C BARLEE 28.00 23.53
Rob SELF 20.00 21.86 S ARTHUR 30.00 23 .30
S.AITKEN 18.00 22.14 J ARKLEY 20.00 21.91
K.LAFFERTY 20 . 00 27.81 Y AITKEN 26 .00 26 .67
G.AITKEN 21.00 25.05 G BEAN 23.00 22 .16
GH.KERR 24.00 25.92 S HOOI 25.00 24 .30
B ORROCK 28.00 26 .23 R BURGASS 32 .00 22.22
D.TAYLOR 50.00 29.24 M BROWN 57.00 20 .07
I.TAYLOR 52.00 21.51 R BROWN 58.00 29 .75
Col.IRELAND 36.00 31.79 N CLARK 31.00 32 . 70
I.DEMPSTER 46.00 26.79 J ABERDOUR 34.00 23 .12
G.WILLIAMS 65.00 28.40 R AITKEN 58 .00 25.50
E.IMRAY 22.00 23.95 A1 BROWN 29.00 27 .90
S PAXTON 28.00 25.84 Ang BROWN 28.00 22 . 16
S WILSON 31.00 23 . 87 Ed BURGASS 34.00 21.48
A WOOD 45.00 32 . 31 Y CAMERON 23.00 28 .34
C KERR 54.00 28 . 28 k Mckenzie 51.00 28 .48
R HAY 31. 00 22.62 P CADDICK 29.00 21.33
D McCONACHIE 43.00 29.40 R DONAGHUE 52.00 29 . 09
C McMICHAEL 32 .00 22.10 H ENGLEMAN 30.00 21.83
K MUIR 33 .00 19.95 K STEDUL 26 . 00 22 . 80
K MOUNTAIN 43 .00 24 . 39 C LEITH 23 . 00 23 . 51
S WALKER 28 . 00 21.22 MD COOPER 29.00 20 .57
J HAWKINS 73.00 27.80 G CLABBIE 70.00 27 .94
D MILROY 29.00 27.61 M BRICKELL 30.00 22 .72
M MCCAULEY 33 .00 22.32 G BOYD 26.00 21 . 34
P TINDALL 44.00 23.42 I LAURIE 42.00 23 .92
J DOCHERTY 40.00 21.23 D SKUDLAERK 30.00 23 .15
D WARD 41.00 24.98 A BOWMAN 34.00 22 . 4C
JE MUNCIE 16.00 20.09 C HOY 17.00 21.56
J BOGIE 46.00 25.66 J.DEAS 63 . 00 27. 42
S PIGGOT 30. 00 23.42 J BURNS 23.00 24.98
M McCONACHIE 44.00 22.16 K BOYD 29.00 23 . 1C
T PETTIGREW 65.00 23.81 W BEIRNE 71.00 22 . 1C
S CRAWFORD 39.00 21.71 L CHEYNE 33.00 21. 4L
M TAIT 59.00 38.46 Y BOWMAN 34.00 30.08
J STARK 17.00 18.29 S CONNOLLY 35. 00 22 . 6f
A PETTIGREW 62.00 19.57 J DALEY 64.00 24 . 58
N STARK 20.00 22. 28 HM ARNOT 30.00 24 . 0'
Mag BROWN 49.00 25.91 K CLYNE 44.00 22.5'
J HEWITT 30.00 27.80 R DEWES 24.00 25.1-
H ARMOUR 18.00 20.66 G CHRISTIE 24. 00 23.0
S ARMOUR 22.00 20.75 S BERNARD 27.00 27.7:
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Table 18: Selected questionnaire data-case control study
SUBJECT GROUP SMOKE ALCOHL CHOKE BEDPART APNEAS SNORING ED
B COLLINS REL N 2 N N NR N N
J SCHOFIELD REL N 8 N Y N N N
A IRONS REL N 1 N Y N N Y
S FAIRW'EATHER REL EX 7 N N N N Y
D SIMPSON REL C 13 Y N Y Y Y
A AITKEN REL N 20 N Y N N Y
S WILLIAMS REL N 1 N N NR Y N
D SILLET REL N 17 N Y N Y Y
J SPOWART REL N 1 N Y N N N
K LAFFERTY REL N 0 N N NR N Y
G AITKEN REL N 20 N N NR N Y
D TAYLOR REL C 13 N Y N N N
I TAYLOR REL N 20 N Y N N N
Col IRELAND REL EX 5 Y Y N N Y
S WILSON REL N 3 N Y N N Y
B ORROCK REL C 8 N Y N N Y
GW IRELAND REL EX 22 . 5 N Y N N Y
GH KERR REL N 3 Y Y N N Y
E IMRAY REL N 14 N N NR N Y
A WOOD REL C 7 N Y NR Y Y
JE MUNCIE REL N 0 N N NR Y N
M McCONACHIE REL C 28 Y N NR Y N
S AITKEN REL N 0 N N NR N N
JA BOGIE REL C 0 N Y N Y N
D MILROY REL N 12 Y Y Y Y Y
C McMICHAEL REL EX 0 Y Y N N N
D McCONACHIE REL N 24 N N NR Y N
K MOUNTAIN REL N N Y N Y Y
R HAY REL C 27 Y Y N Y Y
K MUIR REL N 1 N Y N Y N
S WALKER REL N 4 N Y N N Y
S PAXTON REL EX 4 N Y N Y Y
M McCAULEY REL N 8 N Y N N N
S PIGGOT REL C 2 N Y N Y Y
D WARD REL C N Y N Y Y
J HAWKINS REL EX 0 N NR NR Y Y
P TINDALL REL N 2 N Y N Y N
J DOCHERTY REL C 12 N Y N N Y
C KERR REL N 15 Y Y Y Y Y
Rob SELF REL N 0 N N NR Y Y
M TAIT REL N 4 N Y N N Y
J HEWITT REL N 14 N Y N Y Y
A PETTIGREW REL C 1 N Y N Y N
T PETTIGREW REL C 12 N Y Y Y N
N STARK REL C 0 N Y N Y N
Mag BROWN REL EX 11 N Y N N N
H ARMOUR REL N 3 N N N N N
S ARMOUR REL N 0 N N NR N N
J STARK REL C 9 N N NR Y Y
S CRAWFORD REL N 6 N Y N N N
A BELL CTRL N 9 N N NR N N
E BRYSON CTRL N 15 N Y N N N
C COLEY CTRL N 8 N N N N Y
A DARBYSHIRE CTRL N 1 N Y N N N
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Table 18: continued...
J DEAS CTRL EX 19 N N NR NR N
J DALEY CTRL EX 23 N N NR N N
C HARKESS CTRL N 0 N N NR N N
G BAIRD CTRL N 8 N Y N N Y
SA BAIRD CTRL N 4 N Y N N N
D BARRIE CTRL EX 14 N Y N N N
C BARLEE CTRL N 1 N Y N N N
HM ARNOT CTRL C 30 N Y N N Y
S ARTHUR CTRL C 0 N Y N N N
J ABERDOUR CTRL N 12 N Y N Y N
C HOY CTRL N 0 N N NR N N
S BERNARD CTRL N 6 N Y N N Y
J ARKLEY CTRL C 6 N Y N N N
Ang BROWN CTRL EX 8 N Y N Y
N
Alice BROWN CTRL N 10 N Y N Y Y
P CADDICK CTRL N 0 N Y N N Y
Edith BURGASS CTRL N 2 N Y N N N
M BROWN CTRL N 0 N Y N N N
G BEAN CTRL N 26 N Y N Y Y
Y AITKEN CTRL C N N NR NR N
R BROWN CTRL EX 17 N Y Y Y N
S HOOI CTRL N 0 N N N NR N
Y BOWMAN CTRL N 2 N Y N N Y
R BURGASS CTRL N 8 N Y N N N
M BRICKELL CTRL N 12 N Y N N N
A BOWMAN CTRL N 4 N Y N N N
R DONAGHUE CTRL N 16 N Y Y Y N
J BURNS CTRL N 0 Y N NR N Y
Y CAMERON CTRL N 3 N Y N N N
G CLABBIE CTRL C 22 N Y N N N
K BOYD CTRL N 12 N Y N N Y
W BEIRNE CTRL EX 0 N N NR N N
R AITKEN CTRL N 1 N Y N N Y
G BOYD CTRL N 3 N Y N N N
D SZKUDLAREK CTRL EX 0 N N NR N N
I LAURIE CTRL EX 2.5 N Y N Y N
K STEDUL CTRL N 7 N N NR N Y
H ENGLEMAN CTRL C 5 N Y N N N
R DEWES CTRL N 26 N Y N N Y
N CLARK CTRL N 4.5 N Y N N N
C LEITH CTRL C 19 N Y N N N
k Mckenzie CTRL EX 6 N Y N N Y
Dr MD COOPER CTRL N 3 N N NR N N
S CONNOLLY CTRL C 2 N Y N N N
K CLYNE CTRL N 0 N Y N N Y
L CHEYNE CTRL N 6 N Y N N Y
G CHRISTIE CTRL EX 10 N Y N N N
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154.90 56 . 80 14 . 90
126.00 79.00 6.60
84 .10 84 . 80 16.17
115.90 95.90 11. 80
239.90 44 . 50 25. 70
186.80 80.90 3 .10
94 .10 91. 00 11. 80
181.10 85.10 14.40
179.60 84 . 40 7 . 70
160.70 91. 80 11. 25
48 . 50 86 . 20 2 . 80
188.30 58.70 20. 40
197.10 81. 10 2 . 40
137.70 94 . 70 9. 40
56.70 89.90 11. 40
123.90 82.50 11 . 50
166.40 75.90 25 . 30
120.60 82.00 24 .16
195.10 82 .10 26 . 70
311.90 33 .10 67 . 46
58.40 72.50 16 . 40
284.10 92.90 8 . 30
154.40 83 . 70 10 . 40
80.10 81 .50 18 . 00
154.60 94 . 30 27 . 99
171.60 75.50 15.50
184.80 75.70 58 .30
97.00 90 .10 9 . 40
63 . 10 89 . 60 12 .73
111.00 91. 20 19 . 42
77.00 91.00 9 . 36
242.70 48.90 21.05
104.50 83 . 20 4 . 20
92.90 88.70 6 .47
149.80 84.10 16 .21
68.60 95.40 4 .48
74.90 88.20 8.87
255.40 87.90 6.09
78 . 40 88.20 15.60
201.10 90 . 30 7 .40
62 . 00 75.90 24 . 50
41. 60 74.70 16 . 04
120.20 88 . 00 7.44
277.70 84.90 88 .25
47.20 86 . 00 5.65
63.50 76.60 23 . 70
60. 00 92 . 30 11. 30
143.80 77. 50 36 . 04
83.00 85.30 16 . 08























































Table 20: Selected polygraphic data in matched controls
CONTROL TST SOL REMLat SE% AH I
A BELL 190.90 69.20 123.00 46 .00 2 . 20
E BRYSON 340.10 26.00 130.20 86.50 0.90
C COLEY 274.70 22 . 30 121.90 61.90 0.00
A DARBYSHIRE 357.40 16.70 99.00 85.70 1. 50
C HARNESS 201.80 27. 20 310.20 51.70 1.20
G BAIRD 366.80 15.20 80.70 84.90 0.70
SA BAIRD 286.90 6.80 285.00 74.00 7.70
D BARRIE 325.50 35.60 96.00 78.80 2.40
C BARLEE 321.30 22.70 38.60 74.40 2.80
S ARTHUR 328.60 11.10 120.30 75.70 2.90
J ARKLEY 369.90 47.50 81.10 85.80 5.20
Y AITKEN 355.80 22.70 131.40 92.20 2.90
G BEAN 377.10 27.10 69.70 83 . 20 14 . 20
S HOOI 327.40 19.10 91.30 76.30 11.00
R BURGASS 402.10 19.20 68.00 91.60 3 .90
M BROWN 358.90 30.80 178.50 81.70 7.20
R BROWN 335.40 14.70 139.80 76.40 13 . 20
N CLARK 407.90 3.90 81.50 93.80 5.88
J ABERDOUR 365.20 6.60 72.00 92.70 2.60
R AITKEN 361.40 4.40 98.70 84.20 34.20
A1 BROWN 353.40 17.50 53.40 90.60 5.40
Ang BROWN 341.80 39.10 128.30 76.50 8 .10
Ed BURGASS 106.40 100.30 354.90 23 . 30 1.70
Y CAMERON 338.00 15.60 131.50 78.80 6.00
k Mckenzie 434.60 1.00 52.80 95. 30 12.29
P CADDICK 368.30 11. 30 154.80 94 .00 3.90
R DONAGHUE 386.70 8.30 121.20 91.60 8.30
H ENGLEMAN 390.10 17.90 134.40 93.30 6.77
K STEDUL 358.50 23.40 84.30 83.80 1.68
C LEITH 391.20 9.70 120.60 93.10 2.76
MD COOPER 328.90 48.30 113.90 74.90 4.38
G CLABBIE 313.50 10. 20 78.10 73.80 64.11
M BRICKELL 315.80 6.80 258.70 74.00 2.30
G BOYD 423.20 8.60 96.60 96.00 4.82
I LAURIE 395.10 13.00 80.80 92.30 7.14
D SKUDLAERK 378.70 30.90 68.60 86.30 1.58
A BOWMAN 350.50 48.50 117.90 81.50 4.79
C HOY 399.50 23.40 173.80 89.00 5. 55
J DEAS 93 . 70 15.20 192.20 22.50 14.70
J BURNS 318.10 22.50 66.50 71.80 14.30
K BOYD 399.70 25.10 183.60 80.30 0.10
W BEIRNE 186.40 18.60 85.40 44 .60 5.78
L CHEYNE 279.10 26.00 297.50 62.70 1. 07
Y BOWMAN 355 .10 11.70 63.60 94.20 1.01
S CONNOLLY 250.00 80.40 101.00 59.50 14.16
J DALEY 103.20 5.30 76.00 46.40 3.30
HM ARNOT 391.60 13.40 76.80 91.70 4.00
K CLYNE 385. 20 16.50 121.50 90.40 9.35
R DEWES 408.90 4.10 111.30 93.60 1.17
G CHRISTIE 400 . 40 15.60 72.40 94.20 3 . 60
S BERNARD 392.90 8.40 137.20 93 .10 0.50
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J SPOWART 3.10 1.10
Rob SELF 5.60 1.30
S.AITKEN 1.90 1.00
GH.KERR 0.80 0.70























D WARD 0.80 0.10




J HEWITT 3.00 1.00
A PETTIGREW 9.00 4.60
N STARK 2.50 0.80
Mag BROWN 3.20 1.60
K.LAFFERTY 4.90 1.10
S ARMOUR 1.00 0.20
T PETTIGREW 1.90 0.60






















































































































































































































































































































Table 22: Acoustic reflectance data in matched relatives
RELATIVES ROPJ
B COLLINS 1. 90
J SCHOFIELD 1.10
A IRONS 1. 70
S FAIRWEATHER 1.70
D SIMPSON 1.10










I TAYLOR 2. 10
Col IRELAND 1. 70





C KERR 2. 20
R HAY 2.20
D McCONACHIE 1. 80
K MUIR 0. 60
J HAWKINS 2.00
D MILROY 1. 40
P TINDALL 1. 30
J DOCHERTY 2. 10
D WARD 2. 20




S CRAWFORD 1. 90









1.60 2.40 22 . 90
1.70 1.80 15.90
2.00 2.40 14 . 20
1. 60 1. 90 20. 30




2.70 2.70 22 .00
1.60 2. 30 19 . 30
1.60 1.90 17.10
1. 30 2 .10 13 .80
1.50 2.10 20.40
1.70 1.70 20.50
1.30 1. 80 11 .00
2 . 30 2.80 23 . 50
1.50 2 . 20 17.40
2.00 2.70 32.60
1. 30 2.30 28.60
1. 40 2.00 20.40
2.50 2 . 40 15.30
1.50 1.90 13 .10
2 . 20 2.60 19. 30
2.10 2.50 20 . 20
1.20 1.80 17.10
1. 20 0.90 7.80
1.40 2 . 00 16.60
1. 30 1.80 16.70
2.00 2 .10 15.70
1.80 2.50 23 .70
1. 50 2.20 27.40
2.50 2.80 29 . 30




1. 30 1.50 11.80
1.50 2.10 14.80
2.50 2.90 30.30
1.30 2.20 20 . 00
1.40 2 . 30 18.10
2. 70 2.90 23 .20
1.70 2.40 20.40















































Table 23: Acoustic reflectance data in matched controls
CONTROLS COPJ CMPA CGLO CAPA CPV
A BELL 1.70 2 . 90 1. 60 1.80 17 . 50
E BRYSON 1.30 2.50 1. 50 1.90 17.00
C COLEY 1.90 3 . 30 1.70 2.40 18.00
C HARNESS 1.60 5.50 2.70 3.60 39.40
G BAIRD 1.10 1.40 1. 00 1. 20 13 . 00
SA BAIRD 1. 30 2 . 40 2 .10 2.10 19.70
D BARRIE 3.10 4 .70 3 . 10 4.10 43 .10
C BARLEE 1.20 3 . 30 2.50 2.30 14 . 90
S ARTHUR 1.90 2.60 1. 60 2.10 19.10
J ARKLEY 1.60 3.80 2.00 2.60 21.00
Y AITKEN 2 . 30 3 .00 1. 50 2 .40 20.50
G BEAN 1.60 2.40 2 . 30 1.80 17.90
S HOOI 2.10 3 . 50 2 . 70 2.70 30.20
R BURGASS 2.00 4.00 2 . 80 3.00 33 . 50
M BROWN 1.80 2.50 1.70 2 . 20 19.50
R BROWN 1.80 2.60 1. 60 2 . 00 24 . 40
N CLARK 3 . 20 3 . 70 2 . 70 3.30 30.10
J ABERDOUR 2 .00 3.10 2 . 20 2 . 60 23.70
R AITKEN 1.70 3 .00 1. 40 2.10 25.70
A1 BROWN 1.60 2.10 1. 80 2.00 24.50
Ang BROWN 1.60 3 .00 2 . 20 2.30 25. 70
Ed BURGASS 1.70 2.90 2 . 30 2.30 27.60
Y CAMERON 1. 30 2 . 20 1. 40 1.60 19.50
k Mckenzie 2.00 3 .70 2.60 2.90 26. 50
P CADDICK 1.80 2.20 1. 40 1.80 21. 70
R DONAGHUE 1.10 2 . 60 2 . 40 2 . 00 21. 80
H ENGLEMAN 1.70 2 . 40 1. 30 1. 90 19.50
K STEDUL 1.60 3 .10 2 . 50 2.50 24.10
C LEITH 2 .10 2.80 1. 40 2.30 25. 20
MD COOPER 2.70 3.00 2 . 10 2.60 33. 30
G CLABBIE 1.60 2.70 2 . 20 2. 20 20.00
M BRICKELL 1 .80 2.50 1. 60 2.10 23 . 00
G BOYD 2.00 2.50 1. 40 2.10 15.40
I LAURIE 1.60 2.40 1. 80 1.80 19. 30
D SKUDLAERK 0.90 2.50 2.40 2.00 21. 80
A BOWMAN 1.60 3.50 2 . 20 2.60 31.00
J DEAS 1.60 1.70 1.20 1.50 12. 30
K BOYD 2.30 2 . 90 1. 40 2. 30 27.70
W BEIRNE 2.30 2.80 1 . 50 2.30 20. 40
L CHEYNE 1.80 2.70 2 .10 2.30 22.80
S CONNOLLY 0.70 1. 30 1 . 00 1.10 10. 40
HM ARNOT 1. 40 3.70 3 . 00 2.70 22.80
K CLYNE 2.60 3 . 60 2.70 2 . 90 38.10
R DEWES 1.90 2.80 1.70 2.30 25. 20
G CHRISTIE 2.10 2.20 1.10 1.90 20.70
S BERNARD 1.60 2 . 20 1. 40 1.80 20.80
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80 . 0 38.0
88 . 0 37.0
85. 5 43.5
89 . 5 52.0
83 . 0 41. 0
88.0 43.5
80 . 5 50.0
80 . 0 44 . 0
89 . 0 39.0
82 . 5 41.0
82 . 5 50.0
77 . 0 50.0
91 . 5 49 . 0
85 . 0 39 . 0
83 . 0 44 . 0
92 . 5 45.0
85 . 0 45.0
91 . 0 54 . 0
90.0 41.0
80 . 5 48 . 5
81 . 0 49.0
90 . 0 41.0
87 . 0 53 . 0
77 . 0 43 . 0
75.0 49.0
78 . 5 43.0
85.0 44.0
86 . 5 40.0
74 . 0 44 . 0
84 . 0 42.0
87 . 5 57.0
83 .0 50.0
80 . 0 44.0
80.0 48.0
100.5 40.0
86.0 44 . 0
78.0 38.0
75 . 5 39.0
78 . 0 48.0
85.0 48.0
80 . 5 40.0













































83 . 0 84.0
86.5 86.5
86.0 88 . 0
81.5 77.5
77.0 74 . 0





















73.5 69 . 5
79.0 82.0













76.5 73 . 0
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Is the sleep apnoea/hypopnoea syndrome
inherited?















Background—The aetiology of the sleep
apnoea/hypopnoea syndrome (SAHS) is
unclear in many patients. Snoring, a pre¬
requisite for SAHS, runs in families. A
study was carried out to determine
whether there is an increased frequency
of irregular breathing during sleep in rel¬
atives of patients with SAHS.
Methods—A prospective study was per¬
formed of first degree relatives of 20 con¬
secutive non-obese (BMI <30 kg/m2)
patients with SAHS. Questionnaires on
SAHS symptoms were sent to all first
order relatives and those living within
150 miles of Edinburgh were invited for
overnight monitoring of their breathing,
sleep, and oxygenation patterns in the
sleep laboratory.
Results—Ten of the 40 relatives had
more than 15 apnoeas + hypopnoeas/
hour of sleep, and eight had more than
five 4% desaturations/hour. These fre¬
quencies of irregular breathing and
desaturation are significantly higher
than in the British population. Cephalo-
mctric studies showed no skeletal abnor¬
mality but an increased uvular width was
found in the affected relatives.
Conclusions—There is an increased fre¬
quency of abnormal breathing during
sleep in relatives of non-obese patients
with SAHS.
(■Thorax 1993;48:719-721)
The aetiology of the sleep apnoea/hypopnoea
syndrome (SAHS)12 in many patients is
unclear. Snoring is a prerequisite for SAHS
and is known to run in families. SAHS has
been reported to run in two families'1 but this
may have resulted from an association with
obesity. We have therefore performed a pilot
study to investigate the hypothesis that SAHS
may be inherited. To avoid studying the
inheritance of obesity we have used only
index cases who were non-obese.
Methods
Twenty consecutive new patients with SAHS
(more than 15 apnoeas I hypopnoeas (A + I I)
per hour of sleep) with body mass index <30
kg/m2 without evidence of gross retrmmathia,
hypothyroidism, or acromegaly took part in
the study. These patients had a mean A + H
frequency of 42/hour (range 17-76/hour), a
mean body mass index of 27 kg'm2 (range
24-29-5 kg/m2), and a collar size of 411 cm
(range 39-4-44-4 cm). Each was asked to give
details of all first degree relatives aged 18-75
years who were then sent a questionnaire
relating to SAHS symptoms. All relatives who
lived within 150 miles of Edinburgh were
invited for a one night sleep study during
which airflow at the mouth and nostrils
was recorded by thermocouples, thoraco¬
abdominal movement by induction stetho-
gram, ear oxygen saturation by an Ohmeda
Biox 3700 oximeter, and an electroen¬
cephalogram, electro-oculogram, and elec-
tromyogram were taken. Both sleep50 and
breathing pattern0 were scored by standard
criteria. All relatives attending for sleep stud¬
ies had lateral cephalometry performed7 from
which standard bony and airway dimensions
were measured.
Differences between groups were assessed
by the unpaired Student's t test or x' test as
appropriate. Correlations were performed
with SPSS-PC.
Results
Three of the 20 patients had no eligible first
degree relatives. We thus tried to recruit all
eligible relatives of 17 patients (15 men;
mean (SD) BMI 27-4(1-6) kg/m:). They had
76 first degree relatives but 14 lived more
than 150 miles from Edinburgh. Six of the
eligible 62 relatives stated they were too ill to
attend for sleep studies and 16 refused. Forty
relatives (19 men) therefore had overnight
sleep studies. Nine of the 22 relatives who
were unable to participate came from one
family.
Twenty one (12 men) of the 36 relatives
who did not have sleep studies replied to the
questionnaire. These had a significantly
higher rate of loud snoring (15 of 21) than
the attenders (13 of 40), but were no differ¬
ent in terms of witnessed apnoeas, daytime
sleepiness, or other SAHS symptoms.
Sl-l-Ur S'lUDIHS
Ten (nine men) of the 40 relatives had more
than 15 A + H/hour of sleep (table). These
"affected" relatives were older but were not
more obese than the others. The affected
tensrics of relatives with >15 A + H/hotir of sleep or <15 A + H/liotir of sleep























145 (127 16 li
25 (16-34)
85 (80-90)
1—apnoeas + hypopnoeas; BMI—body mass index; lowest Sao,—lowest oxygen
ion overnight; TST—total sleep time; SOL—sleep onset latency; SE1—sleep
icy index; *p < 0 01 v relatives with >15 A + H/hour. tP < 0 05 v relatives
>15 A + H/hour. Values in parentheses are 95% confidence limits unless
otherwise.
relatives had more frequent arousnls from
sleep and lower minimal oxygen saturations
than the 30 unaffected relatives. Eight of the
40 relatives had more than five 4% desatura-
tions/hour. Factors significantly correlated
with abnormal breathing during sleep were
sex, body mass index (p < 0 001), and age
(p < 0 05), but not collar size.
QUESTIONNAIRES
Eight of the 10 affected relatives were
described as loud snorers compared with five
of the 30 unaffected (p < 0 01). Similarly,
witnessed apnoeas were more common in
affected relatives (5/8, 0/25, (p < 0 01)), but
there was no increase in daytime sleepiness
(2/10, 10/30).
CEPHALOMETRY
Ccphalometric measurements were compared
between the 10 affected relatives and 10 unaf¬
fected relatives matched by priority for sex,
family (possible in three cases), and height.
The only variables which were different in the
affected relatives were the gonion-gnathion-
hyoid angle (affected 30° (range 26-34°),
unaffected 21° (range 19-23°); p < 0 05) and
uvular width (12-7 mm (range 11 - 3—14 1
mm), 10-0 mm (range 9-2-10-8 mm);
p<0-01).
Discussion
This study shows that 10 of 40 first degree
relatives of non-obese patients with SAHS
had more than 15 A + H/hour of sleep. No
control group was used in this pilot study
because apnoeas, hypopnoeas, and desatura-
tions are reproducibly scored by objective cri¬
teria," and abnormal breathing during sleep is
rare with a well described frequency in ihc
British population." The major control com¬
parison for our study is a random sample of
893 middle aged British men" of whom 45
had more than five 4% desaturations hour
compared with eight of our 40 relatives
(p < 0-0001, x~ test) or seven of our 19 male
relatives (p < 0 0001). That study was per¬
formed with the same oximeter and a similar
desaturation algorithm as was used in our
study. The other comparison is with our pre¬
vious report that none of 33 asymptomatic
non-obese (BMI < 30 kg/m2) Edinburgh
subjects had more than 15 A + H/hour of
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sleep10 while eight of our 35 first order rela¬
tives who weighed <30 kg/m2 had more than
15 A + H/hour of sleep, again indicating that
our relatives had abnormal breathing during
sleep (p < 0 005).
We do not think our finding of increased
irregular breathing and desaturation during
sleep in the relatives of non-obese patients
with SAHS is affected by the recruitment of
only 40 of 62 eligible relatives. In the nine
families with 100% coverage, six of the 19
relatives (32%) had >15 A + H/hour of
sleep. In addition, the increased rate of snor¬
ing among those relatives who did not attend
for sleep studies suggests that they would
have had an even higher frequency of irregu¬
lar breathing than those relatives studied, and
the fact that they were not studied biased
against the positive findings of this study.
Even if one assumed that all the 22 relatives
who declined sleep studies had normal
breathing during sleep, our relatives still had
an increased frequency of desaturation
(p < 0 01) and irregular breathing (p < 0-05).
Our conclusion is consistent with a simul¬
taneous symptom questionnaire study report¬
ing more daytime sleepiness and apnoeas in
relatives of patients with SAHS." Sleep stud¬
ies were not performed, however, and families
of patients with SAHS might be more aware
of these features. Furthermore, the patients
with SAHS were obese (mean (SD) BMI 37
(2) kg/m2), although the increased frequency
of reported breathing pauses remained when
adjustment was attempted for the body mass
of the relatives.
Our cephalometric studies have not shown
any primary skeletal abnormality in the
affected relatives although, as there were only
10 affected relatives, confirmation of this
finding is required in a larger number of sub¬
jects. The difference in uvular width may
reflect either increased fat deposition12 or
mucosal or muscular changes12 which, like the
difference in gonion-gnathion-hyoid angle,
may be secondary to abnormal breathing dur¬
ing sleep. The inherited abnormality may
therefore be altered soft tissue or fat deposi¬
tion in the neck or a defect of the control of
upper airway calibre rather than an inherited
skeletal defect.
This pilot study provides sufficient
evidence of a familial predisposition to SAHS
to warrant further more detailed studies.
This study was supported by the Chest, Heart and Stroke
Association (Scotland and UK).
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